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Chapter I 
DOPAMINERGIC NEUROTRANSMISSION IN  
THE CENTRAL NERVOUS SYSTEM 
 
IDENTIFICATION OF DOPAMINE AS A NEUROTRANSMITTER 
The chemical 3-hydroxytyramine or dopamine (DA) was first identified in the 
rabbit brain by Carlsson and colleagues (A Carlsson, LINDQVIST, 
MAGNUSSON, & WALDECK, 1958). Although techniques currently in use did 
not allow for the discrimination of DA from other catecholamines like 
norepinephrine (NE) or epinephrine (EPI), they adapted ion exchange 
chromatography, paper chromatography, and fluorometric techniques to identify 
endogenous DA in several tissues including the brain (A Carlsson, 1959). As 
Carlsson had previously observed for NE and 5-hydroxytryptophan (5HT), 
injection of rabbits with the chemical reserpine significantly reduced the amount 
of DA they isolated from the brain. Conversely, they found that preinjection of 
3,4-dihydroxyphenylalanine (DOPA) increased the amount of DA they detected. 
These studies established that DA was present in the brain and that its levels are 
attenuated by the chemical reserpine and enhanced by DOPA. 
 DA’s role as a neurotransmitter took more time to elucidate. Work by the 
German physiologist Otto Loewi and others on acetylcholine (ACH) in frog 
preparations established several criteria that a chemical must possess to be 
classified as a neurotransmitter: 1) It must be present in the presynaptic neuron, 
2) The substance must be released from this cell following electrical stimulation, 
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3) Specific receptors for the compound must be present on the postsynaptic 
end, and 4) There must exist a mechanism for the cessation of signaling by that 
chemical (Purves, 2008). Carlsson and Fuxe, amongst others, used their new 
DA-labeling techniques to carry out studies in multiple species and 
demonstrated that DA was present in large cell bodies in the midbrain and at 
terminal fibers in the caudate nucleus and putamen (Andén et al., 1964; A 
Carlsson, DAHLSTROEM, Fuxe, & LINDQVIST, 1965; A Carlsson, FALCK, Fuxe, 
& Hillarp, 1964; A Carlsson, FALCK, Hillarp, & TORP, 1962; Dahlström & Fuxe, 
1964). These studies established that DA is located in the presynaptic regions of 
the synapse.  
  Measurement of DA’s release in response to electrical stimulation 
required the development of new technologies and experimental preparations. 
Though early physiological studies of neurons in the caudate nucleus in 
response to iontophoretic pulses of DA and stimulation of DA-containing 
neurons in the substantia nigra suggested that DA was released onto these 
neurons, direct measurement of DA itself was still lacking (Connor, 1968, 1970). 
The development of new brain perfusion techniques in combination with 
stimulation of certain brain regions allowed Portig et al. to stimulate midbrain DA 
neurons and collect ventricular perfusate around the caudate nucleus of a cat 
(Portig, Sharman, & Vogt, 1968; Portig & Vogt, 1969). Using previously 
established paper chromatographic methods, the authors determined that 
stimulation of the substantia nigra could trigger the release of DA into caudate 
nucleus perfusate. One of the most definitive studies of DA’s coupling to 
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electrical stimulation used radiolabeled DA generated by treatment of rat brain 
slices with radiolabeled DOPA. Using brain slice superfusion, the authors 
demonstrated that [H3] DOPA was taken up into catecholamine nerve terminals, 
and that radiolabeled DA product could then be detected in superfusates 
collected from these brain slices (Ng, Chase, Colburn, & Kopin, 1971). 
Moreover, they found that pretreatment of these brain slices with the neurotoxin 
6-hydroxydopamine (6-OHDA) significantly blunted the amount of electrically 
evoked DA release. The development of liquid chromatography (LC) and 
electrochemical detection of DA helped usher in a new era of understanding 
how this putative neurotransmitter is released within distinct CNS nuclei. These 
studies rely on the oxidative potential of DA in response to a positive voltage, 
whereby DA will lose two electrons to form dopamine o-quinone. The current 
generated by this oxidation is directly proportional to the concentration of DA, 
and the voltage potential at which DA oxidizes provides a useful “signature” for 
DA relative to other biogenic amines or DA metabolites.  Plotsky et al. used high 
performance LC (HPLC) coupled with electrochemical detection to measure the 
release of endogenous DA from rat brain slices treated with d-amphetamine 
(AMPH) or with chronic electrical stimulation (Plotsky, Wightman, Chey, & 
Adams, 1977). Later, this method was expanded to include the characterization 
of DA metabolites and in an intact rat brain (Ewing, Bigelow, & Wightman, 1983; 
Wightman, Strope, Plotsky, & Adams, 1978; Wightman, Strope, Plotsky, & 
Adams, 2004). Together, these studies using multiple preparations and 
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methodologies support the contention that DA is released in response to 
electrical stimulation. 
 With the development of radiolabeled compounds, including DA and 
antipsychotic drugs, researchers used these drugs to ask whether DA receptor 
sites might be present in the brain. In 1975, two studies were published using 
similar approaches that demonstrated that DA could bind specifically in 
membrane fractions isolated from the rat brain (Burt, Enna, Creese, & Snyder, 
1975; P Seeman, Chau-Wong, Tedesco, & Wong, 1975). Furthermore, Seeman 
and colleagues demonstrated that the known antipsychotic drug haloperidol 
also had saturable and specific binding to similar dopamine receptor sites. In 
later studies, Seeman et al. expanded these studies to include other mammals 
including human tissue, thereby confirming the existence of a putative plasma 
membrane receptor for DA in the human brain (P Seeman, Chau-Wong, 
Tedesco, & Wong, 1976).   
Though previous pharmacological approaches had established that 
certain compounds could act similarly to DA and elicit physiological responses, 
a more mechanistic explanation of how DA signals at postsynaptic dopamine 
receptors were facilitated by the development of molecular cloning strategies 
and in vitro molecular pharmacology. Over the course of several years, several 
groups isolated human and rodent DA receptors cDNAs and described their 
genomic positions (Bunzow et al., 1988; Giros et al., 1989; Monsma, McVittie, 
Gerfen, Mahan, & Sibley, 1989; Sokoloff, Giros, Martres, Bouthenet, & Schwartz, 
1990; Sunahara et al., 1991; Sunahara et al., 1990; Van Tol et al., 1991; Zhou et 
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al., 1990). Together, these studies suggest that there exist five dopamine 
receptors, D1-D5, in mammals that can be broadly classified into two categories 
depending on their effects on the production of the second messenger cAMP: 
D1-like receptors whose stimulation results in an increase in cAMP and D2-like 
receptors that reduce the amount of cAMP when activated by ligand.   
Around the same time that DA was being described as a 
neurotransmitter, researchers were already describing the chemical mechanisms 
necessary for its inactivation. Axelrod and others had discovered an enzyme 
from rat liver that modifies EPI and subsequently isolated an inhibitor of EPI o-
methylation (J AXELROD, 1957; Julius Axelrod & Laroche, 1959). This enzyme, 
later known as catechol o-methyltransferase (COMT) was shown to be an 
enzyme that metabolizes DA (Kopin, 1985). As DA’s role as a neurotransmitter 
followed after EPI and NE, it was not until Rutledge and Jonason discovered 
that exogenous DA injected into rat brain increased the production of the 
deaminated DA metabolites 3,4 dihydroxyphenylacetic acid (DOPAC) and 
homovanillic acid (HVA) (Rutledge & Jonason, 1967). Furthermore, inhibition of a 
molecule called monoamine oxidase (MAO) could increase the production of 
another DA metabolite 3-methoxytyrosine (3MT), DA, and its modified derivative 
NE. Together, these studies established that there exist metabolic mechanisms 
that alter the amount of DA available in the CNS.  
While researchers were elucidating the existence of DA metabolism, other 
groups were describing alternative mechanisms of neurotransmitter clearance 
via the phenomenon of sodium-dependent transport. Coyle and Snyder 
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observed the localization of catecholamine uptake, including DA, to a 
synaptosomal fraction containing reconstituted nerve terminals (Coyle & Snyder, 
1969b) and that antiparkinsonian drugs had the effect of inhibiting DA uptake in 
the rat striatum (Coyle & Snyder, 1969a). Further work by Snyder and others 
demonstrated sodium-dependent uptake of glutamic acid (GLU), glycine, and 
gamma-aminobutyric acid (GABA)(Bennett, Logan, & Snyder, 1972; Logan & 
Snyder, 1971). Similar to the DA receptor phenomenon, the precise mechanism 
of high-affinity sodium dependent transport was unclear until the advent of 
molecular cloning strategies (Blakely, Robinson, & Amara, 1988). Using these 
and related approaches, several groups reported the identification and 
characterization of mammalian cDNAs that exhibited high affinity DA transport 
(Giros et al., 1992; Kilty, Lorang, & Amara, 1991; Shimada et al., 1991). These 
studies established the role of the DA transporter (DAT) in the inactivation of DA 
signaling. 
      
ANATOMICAL DISTRIBUTION OF DOPAMINE NEURON CELL BODIES AND 
PROJECTIONS 
Localization of Dopamine Neurons 
In the CNS, DA is produced within a group of neurons located in two midbrain 
nuclei: the substantia nigra pars compacta (SNc) and the ventral tegmental area 
(VTA). Additionally, there exists a smaller group of neurons in the arcuate 
nucleus of the hypothalamus that also produce DA. These neurons are labeled 
through a number of histochemical and molecular biological approaches 
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including the production of a naturally occurring black pigment called melanin or 
by immunohistochemical staining for DA-specific genes like tyrosine 
hydroxylase (TH) or DAT (Ciliax et al., 1995; Hornykiewicz, 1966; Kitahama et al., 
1990). 
 
Dopamine Neuron Projections 
The SNc DA neurons are located more lateral and dorsal and send the majority 
of their projections to the dorsal striatum (DS) that together make up the nigro-
striatal pathway (Roeper, 2013). The VTA DA neurons are located more medial 
and ventral to the SNc and send their projections to the forebrain where they 
innervate a number of targets through two primary projections: 1) the 
mesolimbic pathway that innervates the ventral striatum or nucleus accumbens 
(NAc), the amygdala (AMY), limbic cortex, and hippocampus (HIPP) and 2) the 
mesocortical pathway that sends dopamine-releasing terminals to the prefrontal 
cortex (PFC) and the insular cortex (Figure 1). The DA neurons in the arcuate 
nucleus only send their axons to the median eminence and make up the 
tuberoinfundibular pathway (Zhaoliang Hu, Cooper, Crockett, & Zhou, 2004). 
 
Dopamine Neuron Efferents 
Midbrain DA neurons receive inputs from a number of targets throughout the 
brain. Using injection of a retrograde horseradish peroxidase (HRP) tracer, 
Phillipson showed that the VTA receives a number of inputs from areas like the 
PFC, Nac,  
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Figure 1 – Primary DA projection systems in the human brain. The substantia nigra 
send dopaminergic axons to the dorsal striatum in the nigro-striatal pathway, whereas 
the Ventral Tegmental Area sends its projections to the Nucleus Accumbens and 
Prefrontal Cortex. Figure from (Steven E Hyman, Malenka, & Nestler, 2006) 
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bed nucleus of stria terminalis (BNST), AMY, medial and lateral preoptic areas, 
multiple hypothalamic nuclei, superior colliculus, dorsal raphe nuclei (DRN), the 
parabrachial nucleus, and the locus coeruleus (Phillipson, 1979). Using a similar 
approach, Bunney and Aghajanian amongst others determined that the SNc 
receives inputs from the DS, the globus pallidus, the central nucleus of the AMY, 
and the DRN (Bunney & Aghajanian, 1976).  More modern methods using a 
modified pseudo rabies virus have expanded on previous techniques to identify 
the afferent inputs to genetically defined neuronal subtypes (Osakada et al., 
2011). The VTA and the SNc also contain numerous GABAergic neurons and the 
local injection of tracers into these nuclei does not distinguish between these 
and neighboring DA neurons. Recently, Watabe-Uchida et al. in a technical tour 
de force used pseudo rabies virus to fully map the afferents to both SN and VTA 
DA neurons (Watabe-Uchida, Zhu, Ogawa, Vamanrao, & Uchida, 2012). They 
validated the retrogradely labeled nuclei seen by previous groups and quantified 
the relative densities of each of the projections. Though a few overlapping areas 
were labeled that project to both the SNc and the VTA like the central AMY and 
the paraventricular nucleus, the DA neurons in these two areas have non-
overlapping and heterogenous inputs. The VTA, in particular, receives a dense 
projection from the lateral hypothalamus, BNST, and reciprocal projection from 
the Nac core and shell.    
 
SYNAPTIC COMPONENTS OF DOPAMINE SIGNALING 
Dopamine Biosynthesis 
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Figure 2 – Dopamine Biosynthetic Pathway. Image freely available at Wikimedia 
Commons. 
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DA is synthesized from its amino acid precursor tyrosine. The first step, shown 
to be the rate limiting step in the production of DA, involves the hydroxylation of 
tyrosine at the 3rd carbon via the actions of TH (NAGATSU, 1991; NAGATSU, 
LEVITT, & UDENFRIEND, 1964) to form L-dihydroxyphenylalanine (L-
DOPA)(Figure 2). The actions of TH are required for the production of this 
catechol group that is typical of all catecholamines including EPI and NE. A 
carboxyl group is removed from L-DOPA via the actions of aromatic acid 
decarboxylase (AADC) to form 3,4-dihydroxyphenylethylamine or DA 
(NAGATSU, 1991).  
  
Vesicular Packaging of Dopamine 
Although DA is synthesized in the cytosol, it must be packaged into synaptic 
vesicles to allow for the electrically evoked release of this neurotransmitter into 
the synapse. Early studies in the adrenal glands demonstrated that 
catecholamines could be transported into chromaffin granules and that this 
process was enhanced by addition of adenosine triphosphate (ATP) and 
inhibited by application of the antihypertensive drug reserpine (KIRSHNER, 
1962). Later studies demonstrated that similar transport processes exist for 
other biogenic amines, GABA, and GLU (Liu & Edwards, 1997). The molecular 
basis for this granular transport, however, was unclear until the cloning of two 
different cDNAs that transport biogenic amines (Erickson, Eiden, & Hoffman, 
1992; Liu et al., 1992). Topological analysis of these cDNA clones demonstrated 
that vMAT2 encodes a twelve transmembrane domain containing protein with 
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cytosolic N and C termini.  Extensive characterization of these two molecules, 
later named vesicular monoamine transporter 1 and 2 (vMAT1 and vMAT2), 
revealed that vMAT2 has a much higher affinity for biogenic amine substrates 
and that vMAT2 is the predominant transporter expressed in the midbrain 
containing DA, 5HT, and NE neurons (Peter et al., 1995). Immunoelectron 
microscopic analysis of vMAT in the nucleus of the solitary tract demonstrated 
that vMAT2 is localized to synaptic vesicles (SVs) and dense core vesicles 
(DCVs)(Nirenberg, Liu, Peter, Edwards, & Pickel, 1995). Thus, vMAT2 is 
expressed in DA neurons at synaptic vesicles and transports DA via an ATP and 
reserpine-sensitive process. 
 
Dopamine Release 
Having described the coupling of DA release to electrical stimulation, studies of 
DA release in different brain regions using methods such as brain slice 
superfusion, in vivo microdialysis, and fast scan cyclic voltammetry (FSCV) in 
combination with chemical, electrical, or optogenetic stimulation of midbrain DA 
neurons have established that excitation of DA neurons results in the release of 
DA at its targets. Furthermore electrophysiological recordings of midbrain DA 
neurons in vivo or in ex vivo brain slice preparations, have demonstrated that DA 
neurons have tonic pacemaker activity or exhibit burst firing patterns (Deister, 
Teagarden, Wilson, & Paladini, 2009; GOTO, OTANI, & GRACE, 2007). Work by 
John Williams among others have established that these patterns of burst firing 
are under the control of DA itself and that vesicular DA release onto DA neuron 
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cell bodies triggers an inhibitory post synaptic current (iPSC) that is blocked by 
a dopamine D2 receptor antagonists (Paladini, Robinson, Morikawa, Williams, & 
Palmiter, 2003) (Beckstead, Grandy, Wickman, & Williams, 2004; Usiello et al., 
2000).  These studies establish that DA is released in response to stimulation 
and that it exerts a local network feedback mechanism through activation of a 
D2 autoreceptor that controls the excitability of these neurons.  
   
Reuptake 
Following the isolation of a mammalian DAT cDNAs, researchers began to 
investigate the function of DAT in vitro and in vivo. Topological analysis of the 
DAT protein sequences demonstrated that, like vMAT, this protein has twelve 
predicted transmembrane domains with cytosolic N and C-termini (Shimada, et 
al., 1991). In the initial isolation of the DAT cDNA from a rat brain, Kilty and 
colleagues determined that treatment of HeLa cells expressing rat DAT cDNA 
with exogenous DA results in saturable high affinity DA uptake into these cells 
(Kilty, et al., 1991). The authors demonstrated that this uptake was antagonized 
by treatment with several compounds including the psychoactive drug cocaine. 
To determine the localization of the DAT in vivo, Ciliax et al. generated 
antibodies against different peptides within the DAT and performed 
immunohistochemistry on rat brain sections. They determined that the DAT was 
expressed in the SNc and the VTA and the terminal fields of the nigrostriatal, 
mesolimbic, and mesocortical pathways and that this innervation was lost by 6-
OHDA pretreatment (Ciliax, et al., 1995). The localization of the DAT in vivo and 
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its in vitro characterization suggested that the DAT might have an important role 
in the clearance of DA in vivo. To determine how the DAT functions in vivo, Giros 
et al. used emerging genetic targeting strategies to disrupt the function of the 
endogenous DAT in a mouse (Giros, Jaber, Jones, Wightman, & Caron, 1996). 
Using FSCV, the authors determined that mutation of the DAT resulted in a loss 
of DA clearance and an insensitivity to amphetamine (AMPH) induced efflux in 
the striatum. Furthermore, loss of the DAT resulted in a spontaneous locomotor 
hyperactivity and changes in postsynaptic DA receptor expression. These 
studies established that the DAT represents the primary mechanism of DA 
clearance in the brain through sodium and chloride dependent uptake.     
 
Metabolism 
As in DA biosynthesis, our understanding of DA metabolism was greatly 
enhanced by studies EPI and NE metabolism in multiple preparations. DA 
undergoes two primary chemical modifications during its metabolism by two 
distinct pathways (Kopin, 1985). One of these pathways involves the 
deamination of DA by monoamine oxidase (MAOA) (left side of Figure 3) to form 
3,4 dihyroxylphenylacetic acid (DOPAC). The other pathway involves the transfer 
of a methyl group to the 3’ carbon via the actions of the magnesium-dependent 
cytosolic catechol o-methyltransferase (COMT) to form 3-methoxytyramine 
(3MT). These two metabolic precursors can then 
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Figure 3 – Dopamine Metabolic Pathways. Schematic publically available on 
Wikimedia Commons. 
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be modified by the opposite pathway to form the final metabolite homovanillic 
acid (HVA). In areas rich in DA content, the relative amount of each of these 
metabolites and their ratio can be used to gauge the turnover of synaptic DA. 
These metabolites circulate through the body and are eventually excreted in the 
urine.  
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Chapter II 
THE C. elegans DOPAMINERGIC NERVOUS SYSTEM 
 
Anatomy of Dopamine Neurons in C. elegans 
Like mammals, the nematode Caenhorhabditis elegans has a repertoire of DA 
neurons with stereotypical morphology and network connections. The DA 
neurons were initially described through a catecholamine cross-linking approach 
known as formaldehyde-induced-fluorescence (FIF) that generates a green 
fluorescent color in areas containing catecholamine (Jonsson, Einarsson, Fuxe, 
& Hallman, 1975). As nematodes have subsequently been shown not to contain 
NE, this approach remains a valid one to determine specific genetic 
contributions to DA signaling in the worm. In an elegant anatomical study, 
Sulston et al. used FIF to characterize the position and morphology of DA 
neurons in the worm (Sulston, Dew, & Brenner, 1975). In the hermaphrodite, 
there exist two bilaterally symmetric pairs in the nerve ring between the anterior 
and posterior bulb of the pharynx that, in comparison with existing electron 
microscopic reconstructions at the time, he determined these four neurons to be 
cephalic neurons (CEP). These neurons had the most dense DA-containing 
varicosities, could be detected at early embryonic stages, and send a process to 
the cephalic sensilla at the tip of the worm proboscis. More posteriorly, Sulston 
noted a pair of neurons that send a dorsal and ventral anterior process that 
contain a moderate density of FIF+ varicosities. The dorsal projection terminates 
at the deirid pore, thus they determined these two neurons to be deirid neurons 
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(ADE). Sulston also noted FIF+ lateral cells on the left and right side that he 
suspected to be deirid sensory neurons. These cells sent processes ventrally 
and harbored varicosities that extended anteriorly along a process close to the 
ventral nerve cord. Sulston also looked at the more rare C. elegans males and 
noted the presence of an additional three FIF+ pairs in the rays of the male tail. 
Therefore in total C. elegans harbor at least three DA neuron subgroups with a 
total of eight neurons in hermaphrodites and there exist an additional six 
neurons in male-specific structures (Figure 4). Around 25 years later, the cloning 
and molecular characterization of DA neuron specific genes and the use of 
green fluorescent protein (GFP) promoter fusions to these genes independently 
validated Sulston’s seminal work on describing C. elegans DA neuron anatomy.      
 
Molecular Regulation of Dopamine Signaling 
In Sulston’s initial work describing DA neuron anatomy, he also performed a 
small scale forward genetic screen using a chemical mutagen and identified 
mutants that had altered FIF (Sulston, et al., 1975). He named these six mutants 
cat mutants for catecholamine deficient. In so doing, he provided a foundation 
for the initial work to clone DA neuron signaling genes in C. elegans. Two of 
these mutants, cat-1 and cat-2, had dramatically reduced FIF and DA levels as 
measured by alumina-based chromatography.  
Duerr and colleagues were the first to clone one of these genes when 
they demonstrated that cat-1 encodes the reserpine-sensitive homolog of  
mammalian vMAT2 (Duerr et al., 1999). They demonstrated that cat-1 was 
 19 
expressed in similar neurons as observed by Sulston, was localized to synaptic 
vesicles, and can transport biogenic amines including both DA and 5HT in vitro. 
Additionally, cat-1 loss results in alterations in specific worm behaviors including 
locomotion, and that some of these phenotypes could be rescued by expression 
of human vMAT2. 
Lints et al. was the first to take advantage of the development of the use 
of GFP promoter fusions in C. elegans to describe the genetic mechanisms of 
developmental patterning of dopamine in the male sensory rays (Chalfie, Tu, 
Euskirchen, Ward, & Prasher, 1994; R. Lints & S. W. Emmons, 1999). They 
determined the precise locus for the mutation in Sulston’s original isolate, 
rescued FIF in this strain with transgenic expression of the wildtype locus, and 
generated several strains expressing a cat-2:GFP transgene that allowed them 
to visualize the DA neurons. They determined that this gene bears 50% protein 
sequence homology to TH in Drosophila and rat and that the pattern of GFP 
expression in their transgenic animals overlaps with that of FIF. They therefore 
determined that cat-2 encodes the worm TH homolog.  
In addition to mutagenesis screens, targeted expression cloning 
strategies have enhanced our understanding of the molecular mechanisms of C. 
elegans DA signaling. Prior to the genetic identification of cat-1 and cat-2, 
Jayanthi and colleagues used a homology-based oligonucleotide plaque 
hybridization approach to screen a worm cDNA library for sequences that likely 
represent the C. elegans DAT homolog. They isolated several cDNA clones of 
T23G5.5, expressed these clones in heterologous cell lines, and used molecular 
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pharmacological techniques to determine if this gene can transport DA and how 
it responds to known dopamine transporter inhibitors (Jayanthi et al., 1998). 
They determined that T23G5.5 preferentially transports DA, is highly 
homologous to the human norepinephrine transporter (NET), and that DAT and 
known NET antagonists inhibit the transport activity of T23G5.5. The authors 
concluded that T23G5.5, later named dat-1, encodes the gene necessary for DA 
clearance in C. elegans. In vivo relevance of dat-1 actions became apparent 
when Nass et al. created a strain expressing a dat-1:GFP transgene. As in the 
cat-2:GFP strain and in Sulston’s FIF labeling, the dat-1:GFP transgene is 
expressed specifically in C. elegans DA neurons (Figure 4). Using this approach, 
the authors demonstrated a striking level of DA neuron labeling, and multiple 
labs now use this promoter as a way to express a gene of interest specifically in 
DA neurons (Cao, Gelwix, Caldwell, & Caldwell, 2005; Flames & Hobert, 2009; 
Hamamichi et al., 2008). Using this reporter, the authors determined that dat-1 
was required for the transport and subsequent toxicity of 6-OHDA such that 
brief treatment with 6-OHDA could cause specific degeneration of DA neurons 
and that this toxicity was lost in animals with a genetic lesion in their 
endogenous dat-1 locus. These studies established that dat-1 functions in vivo 
to transport DAT substrates.    
 cat-2/TH was the first gene to be identified within the DA biosynthetic 
pathway, but further clues to genes required for this process were still available 
from Sulston’s original screen. cat-4 encodes an enzyme, GTP cyclohydrolase, 
that catalyzes the biosynthesis of tetrahydrobiopterin, a cofactor necessary 
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 Figure 4 – Anatomy of the C. 
elegans dopamine system. 
A. Cartoon illustration of the 
DA neuron cell locations in the 
C. elegans hermaphrodite. B. 
Cartoon illustration of the DA 
neuron cell locations in the C. 
elegans male. C. Enlarged 
view of anteriorly positioned 
DA neurons. D. Enlarged view 
of the PDE neurons. E. 
Enlarged view of the male tail 
DA neurons R5A, R7A, and 
R9A pairs. F. Enlarged view of 
a worm expressing pdat-1:GFP 
demonstrating expression in 
CEP and ADE neurons. G. 
Enlarged view of a worm 
expressing pdat-1:GFP 
demonstrating expression in 
PDE neurons. H. Enlarged 
view of a worm expressing pdat-
1:GFP demonstrating 
expression in the ray neurons. 
DIC is overlaid. Figure taken 
from (Paul W McDonald, 
Jessen, Field, & Blakely, 2006). 
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for the decarboxylation of L-DOPA and 5-hydroxytryptophan (5HTP) by AADC, 
which was later identified as bas-1 in the worm (Hare & Loer, 2004; Sawin, 
Ranganathan, & Horvitz, 2000). Together with the previous characterization of 
cat-2, there now existed a fuller picture of DA biosynthesis in the worm. 
Furthermore, with the description of cat-1, cat-2, and dat-1, many of the critical 
presynaptic genes necessary for presynaptic maintenance of DA signaling had 
been cloned.  
 Following the publication of the first draft of the human genome and the 
already published draft of the C. elegans genome sequence, researchers began 
using bioinformatic approaches to identify DA receptors in the worm. By using 
sequence similarity of predicted proteins in C. elegans against known protein 
sequences of mammalian DA receptors, Suo et al. cloned and characterized the 
first C. elegans DA receptors, dop-1 and dop-2 (Suo, Sasagawa, & Ishiura, 
2002, 2003). Suo et al. found that the amino acid sequence of dop-1 was 43% 
identical to the human D1 receptor and that this receptor had a high affinity for 
dopamine using radioactive ligand displacement assays. For dop-2 they used 
similar molecular pharmacological approaches in heterologous systems to 
demonstrate that the dop-2 receptor has a 44% protein sequence similarity to 
mammalian D2 receptors, exhibits a high affinity for DA relative to other biogenic 
amines, demonstrated that its activation reduces the production of cAMP, and 
used a GFP promoter fusion strain to demonstrate that dop-2 is expressed in 
many neurons of the nerve ring, but is also expressed presynaptically in DA 
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neurons. Thus dop-2 likely functions as a Gαo-coupled D2-like receptor and 
represents a putative autoreceptor in the worm.   
 Chase et al. characterized the identity of another postsynaptic dopamine 
receptor (Chase, Pepper, & Koelle, 2004). Similar to Suo and colleagues, they 
used sequence similarity to the human D2 receptor to identify the existence of 
eighteen different putative receptors in C. elegans. After RT-PCR of the T14E8.3 
cDNA, they determined that the dop-3 receptor has 50% protein sequence 
similarity to the human D2 receptor. Using strains expressing GFP promoter 
fusion transgenes of dop-3 and the previously cloned dop-1, they determined 
that both of these receptors were expressed in postsynaptic areas of the worm 
motor circuit including body wall muscle (dop-3 only), cholinergic neurons (dop-
1 and dop-3), and GABAergic neurons (dop-3 only). Interestingly, the expression 
of dop-1 and dop-3 overlap in the mechanosensitive PVD touch neuron (Smith 
et al., 2010).  
 Lastly, Sugiura and colleagues validated the cloning of dop-3 and 
identified a novel DA receptor that they named dop-4. Using bioinformatic 
approaches, they determined that dop-4 functions as a D1-like receptor to 
increase the production of cAMP and is expressed in neuronal cells like the 
ASG, ASL, PQR, and CAN neurons and non-neuronal cell types like the vulva, 
rectal epithelial cells, and Ray 8 of the male tail (Sugiura et al., 2005).  
 In summary, the C. elegans genome contains four known and 
characterized DA receptors: dop-1, dop-2, dop-3, and dop-4. dop-1 and dop-4, 
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Figure 5 – Dopamine Signaling Genes in C. elegans. Cartoon diagram of the DA synapse in C. elegans illustrating pre and 
postsynaptic signaling genes. Schematic adapted from (R	   Nass	   &	   Blakely,	   2003).	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based on the characterization of their function in human cell lines, are likely D1-
like receptors, whereas dop-2 and dop-3 are D2-like. These receptors are 
expressed in a variety of neuronal and non-neuronal tissues that suggests that 
they function to regulate multiple aspects of C. elegans physiology and 
behavior.      
 
Dopamine Regulation of Locomotion in C. elegans 
Our understanding of the C. elegans DA signaling network has been enriched by 
study of several behaviors that are altered by reduction or elevation of DA 
signaling such as egg-laying, defecation, habituation to touch, learning, and 
locomotion (reviewed in (Paul W McDonald, et al., 2006) and (Chase, 2007)). 
Rather than reviewing DA’s role in modulating each of these behaviors, I will 
concentrate the following review solely on DA’s role in modulating locomotory 
states in C. elegans.  
Early research on 5HT and the biogenic trace amine, octopamine, 
indicated that these neurotransmitters could inhibit locomotion, but no such role 
for DA had been described (Horvitz, Chalfie, Trent, Sulston, & Evans, 1982). 
Schafer and Kenyon demonstrated that both biogenic amines could inhibit C. 
elegans locomotion, that worms could adapt to this paralysis over time, and that 
the calcium channel unc-2 was required for adaptation to either compound 
(Schafer & Kenyon, 1995). Though these studies clearly established that 
exogenous DA could inhibit the vigor of worm locomotion, the role of 
endogenous DA during ethologically relevant behavior was still unknown.  
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Sawin and colleagues made one of the most important observations 
about DA’s role in modulating locomotory behavior (Sawin, et al., 2000). They 
discovered that worms slow their locomotory rate in response to a lawn of 
bacteria, a phenotype they dubbed the basal slowing response (BSR). 
Furthermore, they noticed that worms previously starved displayed a more 
exaggerated slowing response that they conveniently named the enhanced 
slowing response (ESR). The authors determined that the previously described 
cat-2 mutant had a defective BSR but intact ESR, whereas bas-1 and cat-4 
mutants had defective BSR and ESR. As bas-1 and cat-4 mutants ought to 
harbor alterations in both DA and 5HT and the cat-2 mutant only disrupts DA 
signaling, the authors concluded that endogenous DA mediates the BSR, while 
the ESR requires endogenous 5HT. Using exogenous DA and 5HT 
preincubation, they demonstrated that DA and 5HT restoration was sufficient for 
BSR and ESR. In the process they also replicated Schafer’s previous findings 
that exogenous DA and 5HT could inhibit C. elegans locomotion. Consistent 
with their genetic experiments, they performed laser ablations of the DA neurons 
in full and in combinations and determined that the DA neurons function 
redundantly to mediate the BSR, but that ablation of the CEP neurons generated 
a dramatic reduction in the BSR. Lastly, they sought to determine the sensory 
mechanism by which the worm generates the BSR. As the anatomy of the DA 
neurons suggested that they might be mechanosensitive and a lawn of bacteria 
might trigger mechanical stimulation of the DA neuron dendrites, they found that 
wildtype animals also display BSR in response to a matrix of glass beads. 
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Importantly, as in the food-dependent BSR, cat-2 animals or DA neuron laser 
ablated animals had a defective BSR to glass beads. The latter experiment 
suggested that mechanical stimulation alone was sufficient to trigger DA-
mediated behavioral responses and hinted that mechanical stimulation of DA 
neurons might trigger their excitation and release of DA into the extrasynaptic 
space though methods for monitoring DA neuron excitability in vivo were not 
available at the time. These studies were a critical first step in elucidating DA’s 
role in regulating locomotion in the worm, but a more mechanistic explanation of 
how DA acts postsynaptically was still lacking. 
The pace of understanding DA’s role in modulating locomotion matched 
that of the cloning of dopamine receptors and as new mutant alleles of these 
genes became available (Chase, et al., 2004). Chase et al., following the cloning 
of dop-3, isolated several new mutant alleles in dop-1, dop-2, and dop-3. As 
Sawin and colleagues had already established an assay to measure 
contributions of endogenous DA signaling, the authors screened these alleles 
using the BSR assay. Importantly, they discovered that loss of the dop-3 
receptor resulted in a complete loss of the BSR and that transgenic restoration 
of wildtype dop-3 could restore BSR. Thus dop-3 was required for a locomotory 
phenotype modulated by endogenous DA. As in Schafer et al., they 
demonstrated that exogenous DA was effective at promoting paralysis, but that 
mutations in dop-3 resulted in resistance (Schafer & Kenyon, 1995). They used 
the sensitivity to exogenous DA, cell specific restoration of dop-1 and dop-3 in 
the GABAergic and cholinergic motor neurons, and a forward genetic screen for 
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DA-resistant mutants to paint a complete picture of the postsynaptic 
mechanism of dopamine signaling. dop-1 functions through the G-protein egl-
30 and its downstream effector phospholipase Cβ egl-8, whereas dop-3 
functions through the G protein goa-1 and its downstream effector dgk-1. These 
two pathways function antagonistically to promote normal BSR and exogenous 
DA-induced paralysis.  
 
Identification of the Swimming Induced Paralysis Phenotype 
The previous studies established the critical pre- and postsynaptic components 
of the DA signaling network, but researchers had not yet exploited the full 
potential of the model to augment our understanding the entire genetic network 
that is critical for maintenance of DA signaling. C. elegans has long been used in 
forward genetic mutagenesis screens to reveal novel, conserved genes for 
particular behavioral or physiological processes (Brenner, 1974). To carry out 
such a screen, we required a novel, quick, robust phenotype mediated by 
endogenous DA. In an effort to eventually carry out a screen for novel regulators 
of dat-1, we analyzed the locomotory behavior of a newly acquired deletion 
allele of dat-1. Unfortunately, in assays of normal movement on plates, the dat-1 
strain resembled the wildtype strain. In other words, DA clearance through dat-1 
did not dramatically impact crawling behavior. In an independent line of 
research for the presynaptic choline transporter, cho-1, we found that this strain 
had deficits in sustained swimming behavior that were revealed by growing this 
strain on a low choline producing bacteria (Matthies, Fleming, Wilkes, & Blakely, 
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2006). As previous studies had described DA’s role in locomotion, we 
hypothesized that dat-1’s contributions to this process might be revealed in an 
alternative locomotory context. McDonald, Hardie and colleagues discovered 
that loss of dat-1 results in a rapid all-or-none paralysis after a few minutes of 
swimming. Whereas wildtype animals will swim at a sustained rate after 10 
minutes, loss of dat-1 results in complete paralysis of each worm assayed 
during the same time frame (P. W McDonald et al., 2007). They then 
demonstrated that this phenotype, Swimming Induced Paralysis (Swip), was 
completely rescued by a loss of either TH/cat-2 or the D2/dop-3 receptor, or 
partially rescued by pretreatment with the vMAT2 inhibitor reserpine. As in 
Sulston’s original FIF experiments, reserpine pretreatment of the dat-1 strain 
resulted in a dramatic suppression of the Swip phenotype (Sulston, et al., 1975). 
Importantly as in Chase et al., the authors transgenically restored dat-1 and 
rescued the Swip phenotype, thereby demonstrating that loss of dat-1 function 
was required for the Swip phenotype.  
 
With the robust Swip phenotype and an acute rescuing agent (reserpine) in 
hand, I therefore set out to identify novel presynaptic regulators of DA signaling 
using forward genetics.       
 
Specific Aims 
Aim #1 – Perform a forward genetic screen for novel regulators of DA signaling 
using the dat-1-like Swip phenotype.  
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Aim #2 – Validate the dopaminergic phenotypes of the isolated mutation strains 
and the design of the screen by characterization of novel dat-1 alleles. 
Aim #3 – Map, identify and characterize a novel gene containing mutations in 
one or more of the isolated Swip strains.    
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CHAPTER III 
A FORWARD GENETICS SCREEN FOR NOVEL REGULATORS OF DOPAMINE 
SIGNALING IN C. ELEGANS1 
 
 
INTRODUCTION 
 
The catecholamine dopamine (DA) is a phylogenetically conserved 
neurotransmitter that in vertebrates, including humans, regulates motor and 
cognitive behavior.  Altered DA signaling contributes to multiple brain disorders 
including Parkinson’s Disease (PD), dystonia, attention-deficit hyperactivity 
disorder (ADHD), schizophrenia and addiction (A. Carlsson, 1993; Kurian et al., 
2011; Michelle S Mazei-Robison, Couch, Shelton, Stein, & Blakely, 2005; P. 
Seeman, 2010). DA signaling is achieved through both presynaptic and 
postsynaptic mechanisms that have been studied largely using biochemical, 
pharmacological and reverse genetic approaches. These studies have 
uncovered and characterized many fundamental components that control DA 
signaling, such as the genes that provide for DA synthesis, release, reuptake 
and response. The powerful, modulatory control exerted by DA over both 
cognitive and motor behavior and the incomplete understanding of the 
determinants of risk for DA-associated brain disorders suggest that a broader 
array of genes exist that controls DA signaling. Identification of these genes may 
benefit therefore from unbiased approaches, such as those afforded by forward 
genetic screens. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  Adapted from Hardaway and Hardie et al. Genes, Genomes, and Genetics. 
2012 
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Among the most critical of known determinants of DA signaling, one 
molecule, the presynaptic DA transporter (DAT, SLC6A3), has special roles in 
controlling access of pre- and post-synaptic DA receptors to DA, in recycling DA 
into presynaptic terminals after release, and in maintaining levels of DA needed 
for sustained release (Giros, et al., 1996; Torres, Gainetdinov, & Caron, 2003). 
Knockout of DAT through homologous recombination in mice demonstrates an 
obligate role for the transporter in AMPH and cocaine-induced hyperlocomotion, 
as well as DA release and clearance (Giros, et al., 1996). Conversely, mice 
overexpressing DAT display reduced extracellular DA levels and heightened 
sensitivity to AMPH (Salahpour et al., 2008). These studies also demonstrate 
that genetic manipulation of DAT in mice leads to changes in the expression of 
genes that encode pre- and postsynaptic DA receptors and neuropeptides, 
underscoring the importance of DAT as a key regulator of a broad DA signaling 
network (Giros, et al., 1996).  Following the cloning of DAT cDNAs (Brüss, 
Wieland, & Bönisch, 1999; Giros, et al., 1992; Jayanthi, et al., 1998; Kilty, et al., 
1991; Shimada, et al., 1991), many have explored the impact of DAT mutations 
using heterologous expression models in vitro (Schmitt & Reith, 2010), though, 
as yet, the significance of many of these findings in vivo is unknown. Recently, 
we and others have identified rare, functionally penetrant, mutations in DAT in 
subjects with ADHD and juvenile dystonia (Kurian et al., 2009; M. S Mazei-
Robison et al., 2008), compelling a better understanding of the impact of DAT 
mutations and altered DAT regulatory mechanisms in vivo. 
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 Forward genetic strategies that rely on DAT-dependent phenotypes 
provide a path to the identification of key DAT structural elements as well as the 
elucidation of novel regulators of DA signaling. Although such methods 
overcome the bias of studies focused on known genes and pathways (Mohn, 
Yao, & Caron, 2004), they are typically quite difficult to implement in mammals, 
due to the time and cost associated with animal breeding, mutation mapping 
and functional characterization in vivo. The nematode Caenorhabditis elegans 
has long been used in forward genetic screens (Brenner, 1974), including 
identification of genes supporting DA signaling (Allen, Maher, Wani, Betts, & 
Chase, 2011; Chase, et al., 2004; Sawin, et al., 2000; Schafer & Kenyon, 1995; 
Sulston, et al., 1975; Wani et al., 2012). These and homology based approaches 
have revealed C. elegans orthologs of mammalian genes required for DA 
biosynthesis, TH/cat-2 (R. Lints & S. Emmons, 1999), GTP cyclohydrolase/cat-4 
(Loer & Kenyon, 1993), and AADC/bas-1 (Bamford et al., 2004), the vMAT/cat-1 
(Duerr, et al., 1999), genes involved in DA response including the D1 and D2 
type DA receptors dop-1/2/3/4 (Chase, et al., 2004; Sugiura, et al., 2005; Suo, 
Ishiura, & Van Tol, 2004; Suo, et al., 2003), and the presynaptic DA 
transporter/dat-1 (Jayanthi, et al., 1998). In a previous study, we demonstrated 
that worms lacking functional DAT-1 (dat-1(ok157)) demonstrate a robust, DA-
dependent phenotype when placed in water, termed Swimming-induced 
paralysis (Swip), a behavior that is dependent on activation of the postsynaptic, 
D2-like receptor DOP-3 (P. W McDonald, et al., 2007). Here, we describe our 
efforts to capitalize on the Swip phenotype to capture modulators of 
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endogenous DA signaling using forward genetic approaches. Lines derived from 
this effort are subjected to conventional biochemical and pharmacological 
methods, as well as to a novel analytical platform that can more finely dissect 
features of disrupted motor function. We describe the isolation of multiple, 
independent mutant lines, including two (vt21 and vt22) that possess novel 
alleles of DAT-1. Disrupted expression and trafficking of the vt21 mutant 
provides the first demonstration of functional relevance in vivo of a highly 
conserved, structural feature of SLC6 transporters. Two additional lines, vt25 
and vt29, lack dat-1 mutations, map to different genomic loci, and sustain 
distinct components of DA signaling.  
 
MATERIALS AND METHODS 
C. elegans Strains, Husbandry, and Genotyping 
C. elegans strains were cultured on bacterial lawns of OP50 and maintained at 
12 to 20°C using standard methods (Brenner, 1974) unless otherwise noted. The 
wild-type strain is N2 Bristol. The dat-1(ok157)III strain was a gift of J. Duerr and 
J. Rand (Oklahoma Medical Research Foundation, Oklahoma City), and is a 
complete loss of function mutation that eliminates the majority of the DAT-1 
coding sequence. BY200 and BY250 are stable integrants (Richard Nass, Hall, 
Miller, & Blakely, 2002) that expresses the transcriptional fusion Pdat-1::GFP 
(pRB490) on an N2 background. BY250 (vtIs7) was used for imaging DA neuron 
morphology of cloned and outcrossed swip lines and for 6-OHDA experiments. 
A line producing a loss of function disruption of DOP-3 (dop-3(vs106)X) was 
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obtained from the Caenorhabditis Genetics Center (University of Minnesota, 
Minneapolis) and cat-2(tm2261) from Shohei Mitani at the National Bioresource 
Project at the Tokyo Women’s Medical University. C. elegans genomic DNA was 
isolated as described previously (Richard Nass et al., 2005) and used at a 
concentration of 1ng/µL to genotype lines by polymerase chain reaction (PCR). 
For all crosses, either males were generated using the method originally 
described by Sulston and Hodgkin (Hodgkin, 2005), or alleles were crossed to 
males of publically available strains containing integrated fluorescent transgenes 
that mark distinct nematode structures.  After 24 hours of mating, 
hermaphrodites were separated onto individual plates and considered 
successful if ~50% of the progeny from an individual hermaphrodite are males 
and/or if the F1 progeny contained the fluorescent transgene from the male 
parent. For generation of the dat-1(ok157);vt29 strain, markers of LGIII and LGX 
were used, and the double mutant genotype was confirmed by re-segregation of 
the two genes and confirmation with PCR genotyping of ok157 and SWIP 
testing for vt29. Generation of vt25,dat-1(ok157) will require recombination of 
the two alleles after identification of the vt25 functional variant and will be 
presented in a later report. 
 
C. elegans Assay for Swimming-Induced Paralysis (Swip)  
In both batch and automated analyses, we generated synchronous populations 
of these strains by hypochlorite treatment and harvesting arrested L1 animals.  
Early-mid stage L4 animals were identified by characteristic morphology and 
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used for behavior as N2 animals show some stochastic Swip and quiescence 
bouts during the last larval molt. For automated analysis, single L4 
hermaphrodites were placed in 20µL water in a single well of a Pyrex Spot Plate 
(Fisher catalog number 13-748B), and 10 minute movies (uncompressed AVI 
format) of their swimming behavior were created and analyzed as described 
previously (Matthies, et al., 2006; P. W McDonald, et al., 2007), with slight 
modifications. We processed thrashing data using an in-house movement 
processing program (Worm Tracker, available on request) that fits a 5-point 
spine to the worm in each frame.  The 5-point spines consist of 4 segments and 
3 “joints”.  In Worm Tracker, a spine is specified by the x and y positions of the 
spine center, the rotation of the spine with respect to the vertical axis, and finally 
the angles of the 3 joints.  The spine positions are fit using a particle filter and 
motion detection.  The Worm Tracker software processes a video and records 
the position of the fitted spine for each frame.  A MATLAB script reads the 
exported files and computes the frequency of swimming using Fast Fourier 
Transform and by counting frames between angular extrema.  This script then 
produces a data file that provides the frequency of motion of a given worm over 
time. These individual files are then grouped by genotype into a large data 
matrix and an accompanying annotation file made for each of the animals to be 
analyzed. These two files are then used as the input for a custom script written 
in the free publically available statistical program R. The program (SwimR, 
available upon request) smoothens individual data traces using a specified 
moving window and identifies any outliers in the sample file using a modified z 
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score calculation (Iglewicz & Hoaglin, 1993). SwimR then generates several 
output text and PDF files including a scatter plot of average frequency vs. time, 
a heat map of the samples ordered by strength of paralysis and a histogram of 
the binned frequency data. For paralyzers, the script calculates the latency to 
paralyze and several parameters that define the ability of individual animals to 
revert from paralysis to regular thrashing activity, including reversion probability 
(total time in reversion/total time after paralysis), time to 1st reversion, average 
reversion duration and reversion strength (area under the curve during all 
reversion events). The user can set parameters related to paralysis. We defined 
paralyzed animals in our studies as those animals that fall below 20% of their 
maximal thrashing value and stay below this threshold for at least 20 seconds. 
Revertants are defined as those animals that, after paralyzing, re-cross a 
threshold equivalent to 50% of their maximum thrashing rate for any length of 
time. For batch analysis, 10-20 worms were visually scored in a single well of 
the Pyrex Spot Plate.  Worms displaying Swip after a 10 minute assay period 
were counted and in some cases isolated by hand for further tests. For 
reserpine treatments, worms from each line were first synchronized by 
hypochlorite treatment and L1 larvae are grown on OP50 plates containing 
0.6mM reserpine. After ~48 hours of reserpine or vehicle treatment, the 
population Swip analysis was repeated on groups of L4 animals from each line.  
 
Exogenous DA Sensitivity Assay  
Assays were performed as described in (Chase, et al., 2004), except that L4 
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animals were used in lieu of young adults, as this stage is most relevant to the 
DAT-1-dependent Swip phenotype. Briefly 10 L4 animals were transferred to 
1.7% agar plates containing 2 mM glacial acetic acid and various 
concentrations of DA, incubated for 20 minutes and then scored as paralyzed or 
moving. Animals were defined as moving if they were able to propagate a body 
bend through a minimum or maximum amplitude. All concentrations of DA were 
utilized on the same day.  
 
C. elegans Mutagenesis Screen  
Standard methods for a non-clonal, F2 screen were performed as originally 
described (Brenner, 1974) and were used on wild-type hermaphrodite worms 
carrying a DAT-1 promoter-driven GFP transgene (BY200)(Richard Nass, et al., 
2002). A semi-synchronous population of healthy, well-fed late L4 animals was 
exposed to either 47 mM ethylmethanesulfonate (EMS) or 0.5mM N-ethyl-N-
nitrosourea (ENU) at room temperature for 4 hrs in a chemical fume hood. After 
24 hours of recovery, 30 gravid adult worms were placed on each of 8 10cm 
OP50 plates and allowed to lay ~50 eggs each (the F1s) before being discarded.  
After reaching adulthood and laying 20-30 eggs each for a total of 1000-1500 
developing F2 animals per plate, the F1 animals were discarded.  When F2 
animals reached the L4 stage, they were batch screened for the Swip phenotype 
by rinsing off the plate and analyzing 50-100 animals per well as described 
above. We tracked the source plate of each F2 so that only one stable mutant 
line was kept for each plate of the mutant F1s. After 10 min, animals that exhibit 
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Swip were replated and allowed to recover. Swip-positive animals that 
recovered normal movement on solid media were cloned and retested in Swip 
assays to establish phenotype stability. Only lines where at least 50% of the 
animals displayed Swip on retest were saved for a test of reserpine reversal of 
Swip, as described above. In later rounds of screening this convention was 
increased to 80% to improve recovery of stable lines. Stable lines that 
demonstrated a significant rescue of Swip after reserpine treatment were kept 
for further analysis. All recovered lines passing the reserpine test were 
outcrossed to the N2 strain a minimum of three times before further analysis. 
After each outcross, lines were re-homozygosed and re-tested for stable Swip 
on separate days with multiple parental founders before proceeding to the next 
cross. All lines recovered from the screen were sequenced with sense and anti-
sense primers that span all DAT-1 exons and includes 1 kb upstream of the 
transcription start site as well as 50 bp downstream of the translational stop 
codon) using Big Dye Terminator Cycle Sequencing Mix (ABI, Foster City, CA, 
USA). PCR products were sequenced on an ABI 3730xl DNA Analyzer (DNA 
Sequencing Core Facility, Vanderbilt Division of Medicine). 
 
SNP Mapping  
Mapping of mutant loci was performed as described previously (Davis et al., 
2005). Briefly stable outcrossed swip strains were crossed to the CB4856 strain. 
For bulk segregant analysis, lysates from both Swip-positive and Swip-negative, 
F2 populations were generated and used as the input for genome-wide, 96 well 
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PCR. N2 animals were not used as a control in these efforts as we found 
nonspecific N2 Bristol islands in both the Swip-positive and Swip-negative F2s 
on the left arm of LGI. The bulk segregant protocol was used to identify linkage 
groups that can serve for fine mapping with experiments replicated at least 
twice with separate populations to demonstrate consistent linkage. For fine 
interval mapping, individual Swip-positive F2s were cloned and their F3 progeny 
were tested for a stable Swip phenotype. Swip mutations were considered 
homozygous if the F3 population demonstrated Swip comparable to the original 
strain. Populations were manually scored in at least 4-5 assays using 40-50 
worms. DNA from individual clones was then used as the input for PCR of 
individual intervals to ascertain a specific Bristol island on the mapped linkage 
group.  
 
Creation of plasmids and transgenic animals  
Plasmids: Pdat-1:GFP::DAT-1(Carvelli, McDonald, Blakely, & DeFelice, 2004) 
(Carvelli, et al., 2004) and Pdat-1::GFP (Richard Nass, et al., 2002) have been 
described previously. The following plasmids were created to examine DAT-1 
mutations in heterologous mammalian expression systems: pRB1026 (DAT-
1(G460D) in pcDNA3); pRB1027 (DAT-1(W283*) in pcDNA3); pRB1028 (N-
terminally HA-tagged DAT-1(G460D) in pcDNA3); and pRB1029 (N-terminally 
HA-tagged DAT-1 (W283*) in pcDNA3) were developed to examine the DAT-1 
mutations Swip2 (G460D) and Swip3 (W283*). pRB1030 (DAT-1(G460D) in 
pRB491) and pRB1031 (DAT-1(W283*) in pRB491) were created to evaluate the 
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DAT-1 mutations vt21 (G460D) and vt22 (W283*) alleles in C. elegans in vivo. 
Lines shown in Fig. 6 are ex21, ex62 and ex65 for DAT-1, vt21, and vt22. All 
mutations were created using the Quick Change XL site-directed mutagenesis 
kit (Stratagene, La Jolla, CA, USA).  Transgenic animals: Fully sequenced 
constructs (90 ng/µl) were coinjected with the lin-15 rescuing plasmid pJM23 
(40 ng/µl) into dat-1(ok157);lin-15(n765ts) animals using methods described 
previously (Jin, Jorgensen, Hartwieg, & Horvitz, 1999). vtIs18 is an outcrossed 
integrant of ex21 which expresses a Pdat-1:GFP::DAT-1, rescues the dat-1 strain,  
and maps to LGV.  
 
Mammalian Cell Culture and Western Blot Analysis  
Methods for western blot analysis and surface biotinylation of the C. elegans 
DAT-1 expressed in COS-7 have been described elsewhere (Carvelli, et al., 
2004; Richard Nass, et al., 2005). Briefly, COS-7 cells were plated and allowed 
to attach for 24 hours prior to transfection. Cells were transfected with 250ng of 
either HA-tagged DAT-1 cDNA (pRB606, (Jayanthi, et al., 1998), HA-tagged 
DAT-1(G460D) cDNA (vt21, pRB1028), HA-tagged DAT-1(W283*) cDNA (vt22, 
pRB1029), or an empty vector (pcDNA3, Invitrogen, Carlsbad, CA) using 
TransIT-LT1 (Mirus, Madison, WI) as the transfection vehicle. At 48 hrs post-
transfection, cells were harvested as previously described and equal amounts of 
sample protein were resolved on a 4-20% TRIS SDS-Page Ready Gel (Bio-Rad 
Cat# 161-1105) followed by transfer overnight to an Immobilon-P PVDF 
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membrane (Millipore Cat# IPVH00010). Membranes were blocked for 1 hr in 
PBS containing 0.5% TWEEN20 and 5% instant nonfat dried milk. After 
blocking, the membranes were incubated with a rat monoclonal anti-HA-
peroxidase labeled antibody [High Affinity (3F10), Roche Diagnostics] at a 
1:2000 dilution for 1 hr at room temperature. After washing, blots were 
developed with Western Lightening chemiluminescense reagents (Perkin Elmer) 
and exposed to High Performance Chemiluminescence film (Amersham, 
Piscataway, NJ, USA). To analyze surface expression, cells were biotinylated 
with sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate-(sulfo-NHS-SS-
Biotin) (1.0 mg/mL; Pierce, Rockford, IL, USA) and following detergent 
extraction, samples were incubated with Streptavidin beads and eluted for SDS-
PAGE analysis as previously described (Richard Nass, et al., 2005). 
 
In vivo GFP imaging  
In vivo imaging of DAT-GFP fusion protein expression and distribution was 
performed as previously described (P. W McDonald, et al., 2007). Briefly, a 
series of 1.2µm image planes was obtained using a Zeiss LSM 510, creating a 
“Z stack”. Because of differences in GFP expression, different laser settings 
were used for imaging of the head neurons (CEP and ADE) and PDE neurons. 
Higher laser settings are also used to detect the GFP tagged vt22 DAT variant. Z 
stacks were used to create 3D reconstructions of images as noted in the Figure 
Legends. Image stacks containing either cell body or synaptic regions were 
thresholded, rank filtered and pseudocolored using Metamorph (Molecular 
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Devices, Sunnyvale, CA). Final images of either CEPs and ADEs or PDEs were 
processed using identical brightness and contrast values. 
 
HPLC measurement of DA levels  
Synchronized L4 worms were washed in water, pelleted, frozen and then 
sonicated in buffer containing EDTA as previously described (Benedetto, Au, 
Avila, Milatovic, & Aschner, 2010).  Protein content was measured by a BCA 
assay (Pierce) using 10 µl of the lysate. 5 ng/ml isoproterenol was added to the 
remaining sample, which was then applied to an alumina column to extract DA.  
Eluted samples were then analyzed by HPLC using a Waters 717+ autosampler 
and an Antec Decade II electrochemical detector (oxidation: 0.5V).  Reverse 
phase HPLC was performed using a Phenomenex Nucleosil (5u, 100A) C18 
column (150 x 4.60 mm) with a mobile phase of 89.5% 0.1M TCA, 0.1 M sodium 
acetate, 1mM EDTA and 10.5% methanol (pH 3.8) at a rate of 0.6ml/min, with 
data acquired by Millennium 32 software. 
 
6-OHDA Toxicity Assay  
DA neuron sensitivity to 6-OHDA was assessed as described previously (P. W 
McDonald, et al., 2007; Richard Nass, et al., 2005; Richard Nass, et al., 2002). 
Briefly, strains containing the vtIs7 (pdat-1:GFP) transgene were grown on NA22 
media containing plates seeded with 8P bacteria (8P/NA22) and synchronized at 
the L1 stage by hypochlorite treatment. Animals were plated onto 10 cm 
8P/NA22 plates for 1 day at 20oC until they reached the L2-L3 stage. Worms 
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were then washed off the plate and incubated with 2, 5 or 10 mM ascorbic acid 
+/- 10, 25, or 50 mM 6-OHDA, respectively, for 1 hr on a covered Nutator. 
Worms were then pelleted and re-plated onto 8P/NA22 plates without removal 
of the 6-OHDA and incubated for 3 days at 20oC until the worms reached 
adulthood. Degeneration of CEP neuron dendrites was scored blind on a 4 point 
scale (where 4 = all dendrites intact and 0 = complete loss of dendrites). For 
scoring, 100-200 worms were placed on a freshly prepared 2% agarose pad 
and immobilized using 225 mM 2,3 butanedione monoxime (Sigma-Aldrich) and 
2.5 mM levamisole (Sigma-Aldrich) in 10 mM Na HEPES. Fifty worms were 
scored per slide in triplicate for each strain assayed. 
 
RESULTS 
Forward genetic screen for reserpine-sensitive Swip phenotype 
An artificial increase in extrasynaptic DA produced by incubation of nematodes 
with exogenous DA leads to increased activation of inhibitory DA receptors 
expressed on cholinergic motor neurons (Chase, et al., 2004), decreasing the 
release of ACH from these neurons (Allen, et al., 2011), resulting in paralysis. 
Our previous studies demonstrated that dat-1(ok157) worms display a paralytic 
phenotype in water in the absence of exogenous DA that we named Swimming 
Induced Paralysis or Swip (P. W McDonald, et al., 2007). The Swip phenotype 
exhibited by dat-1 animals is absent in cat-2/TH;dat-1 double mutants and can be 
rescued by pretreatment of animals with the cat-1/vMAT inhibitor reserpine, a 
reagent that depletes vesicular DA stores (P. W McDonald, et al., 2007). 
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Importantly, dat-1;dop-3 animals (Sugiura, et al., 2005) also lack Swip behavior, 
establishing Swip as a phenotype that can derive from hyperdopaminergic 
signaling. As schematized in Figure 6A, we hypothesize that incubation of worms 
in water (but not in isotonic medium-J. A. Hardaway and R. D. Blakely, personal 
communication) evokes DA release that in wild type animals is limited in action 
by DAT-1.  In dat-1 animals, DA cannot be recaptured and spills over to 
extrasynaptic sites, where it can activate DOP-3 on motor neurons, decreasing 
cholinergic, neuromuscular signaling (Allen, et al., 2011), producing Swip. 
Since the Swip assay is a simple, rapid, and highly reproducible method 
for detecting genetic contributions to endogenous DA signaling, we implemented 
Swip in a forward genetic screen, using multiple, secondary tests to eliminate 
non-specific mutants. Screening was performed over four independent rounds of 
screening using EMS and ENU as mutagens. We performed one round of 
screening using ENU and only recovered one stable mutant line(vt25), so EMS 
was used as the mutagen in subsequent studies. As outlined in Figure 6B, L4 
BY200 (Pdat-1::GFP) animals were mutagenized with EMS, and their F2 progeny 
batch were tested for Swip. Animals exhibiting Swip were individually cloned and 
their progeny (F3s) were tested to determine Swip penetrance, scored as the 
percent of animals of a clonal population exhibiting Swip. Animals that failed to 
move normally on plates, and thus where Swip might reflect mutation of genes 
required for movement more generally (e.g. unc mutations), were eliminated. As 
a tertiary screen, we tested animals for Swip reversal after incubation with 
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Figure 6 – Generation of reserpine-sensitive Swip establishes a phenotype for forward 
genetic identification of modulators limiting hyperdopaminergic signaling. A, C. elegans 
hermaphrodites contain eight DA neurons: four CEPs, two ADEs and two PDEs (not shown). 
These neurons release DA that can act humorally on the motor circuit through stimulation of the 
DA receptors DOP-1 and DOP-3 that are coexpressed in cholinergic motor neurons. [Inset: 
illustration of presynaptic DA terminals with gene products responsible for DA synthesis (CAT-2, 
CAT-4, BAS-1), packaging (CAT-1), release (DOP-2, acid-sensing ion channel 1 – ASIC-1) and 
inactivation(DAT-1)]. In DAT-1 deficient animals, the release of endogenous DA leads to a much 
larger increase in extrasynaptic DA, leading to hyperactivation of DOP-3 DA receptors and 
paralysis. B, Design of Swip-based forward genetic screen. We treat synchronized L4 animals 
with EMS, allowed animals to self-fertilize and isolate F1s. F2s are Swip tested in batch and 
paralyzing animals are cloned. Animals that do not display grossly normal movement on 
standard solid medium are eliminated, F3s are generated and then re-tested to insure 
transmission of Swip. Clones that demonstrate at least 80% paralysis (our pilot efforts used 
>50% but yielded poor stable transmission) are grown on 0.6 mM reserpine to deplete vesicular 
DA stores and tested for rescue of Swip. Clones that are rescued by reserpine pretreatment are 
given vt mutation designations and their progeny are used in all subsequent experiments.   	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reserpine (P. W McDonald, et al., 2007). Since Swip in the dat-1 strain is fully 
penetrant, lines that exhibited >80% paralysis were pretreated with 0.6 mM 
reserpine, and animals were retested for Swip. In early rounds 1-3 which 
screened a lower number of haploid genomes, we used 50% as our convention, 
but this was later increased to 80% to maximize the chance that we would 
recover primary lines that could be stablely outcrossed. From this reserpine 
tertiary analysis, we identified mutants that were either unaffected, rescued or, 
surprisingly, enhanced by reserpine treatment. To date we have sampled 
~10,000 mutant haploid genomes, and have isolated 25 primary mutant lines 
(vt20-vt44) that demonstrate a stable Swip phenotype and can be rescued by 
reserpine pretreatment. Of these 25, we found that 12 lines maintain their 
phenotype after 3X outcrossing, of which 10 lines are consistently rescued by  
reserpine pretreatment (Figure 7A). Flaherty et al. performed another round of 
clonal screening of 1,000 haploid genomes at Eckerd College, but it is unknown 
which of these primary lines are stable and are suitable for future 
characterization. They are currently being outcrossed. In this study, we report our 
genetic, biochemical and behavioral analysis on four of these lines: vt21, vt22, 
vt25, and vt29.  
In order to demonstrate that vt21, vt22, vt25 and vt29 possess normal DA 
neuron morphology, we examined their CEP, ADE and PDE neurons via 
expression of a transcriptional reporter (Figure 8) and found that cell bodies and 
processes appear unaltered relative to N2 animals. These findings are consistent  
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Figure 7 – vt25 and vt29 demonstrate alterations in DA-dependent locomotory 
behaviors. A. After a screen of ~10,000 haploid genomes, twenty-five vt mutant lines 
were outcrossed, of which ten were found to maintain their reserpine sensitivity. 
Populations of at least 10 worms were assayed in a single well and after 10 minutes, 
with animals scored as # animals swimming/total animals. Each bar represents at least 
20 assays performed over several experimental days by multiple, blinded 
experimenters. Drug treatment effects were analyzed using an unpaired Student’s t test 
comparing against basal Swip activity for that line, where * = p < 0.05, ** = p < 0.01 and 
*** = P<0.001 and error bars represent SEM. B. Dat-1 and vt29 display enhanced 
sensitivity to exogenous DA on a solid substrate, whereas vt25 maintains an N2-like DA 
dose response.  For these assays, 10 L4 stage worms were placed on plates containing 
increasing concentrations of exogenous DA, incubated for 20 min and then scored for 
10 sec as paralyzed or moving. Dose-response curves were compared using two-way 
ANOVA with Bonferroni posttests comparing mutants to N2, where dat-1 + vt29 were all 
found to be significantly different from N2 with a P<0.001 at 15 + 20 mM DA. Data 
derive from at least 8 tests per strain per concentration. Error bars represent SEM. C. 
vt25 demonstrates a higher average frequency of swimming at later time points as 
compared to dat-1 animals, whereas vt29 paralyzes faster. Individual animals were 
recorded using a video capture system and then analyzed with customed-designed 
Thrasher software that assigns multiple linear elements projecting from the worm 
centroid.  The position of these linear elements are tracked and converted off-line to 
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Figure 7(cont’d) – movement frequency as a function of time. Batch conversions are 
generated, providing mean values and SEM along moving averages. Error bars are not 
shown in these plots for simplicity. Average thrashing plots were analyzed using two-
way ANOVA with Bonferroni’s multiple comparison analysis. vt25 and vt29 swimming 
frequencies were found to be significantly reduced from N2 after 58 sec and 39 sec, 
respectively. Although we observed no overall significant difference in these assays in 
comparing dat-1(ok157) and vt25, the thrashing frequency of vt29 was found to be 
significantly reduced from dat-1(ok157)  between 52 sec and 2 min 25 sec. D. Swip 
behavior of vt25 and vt29 is dependent on DOP-3 and CAT-2, respectively. The figure 
represents the mean swimming behavior as measured by manual scoring. Data derive 
from observations from  > 24 trials for each strain. For vt25; dop-3(vs106) and cat-
2(tm2261); vt29, the vt genotypes were confirmed via an independent complementation 
test. Data were analyzed using one-way ANOVA with multiple Bonferroni posttests 
where *** = P<0.001 and error bars represent SEM.    
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Figure 8 -  Swip mutants possess normal DA neuron morphology. The left panels show that 
CEP and ADE neurons and processes are intact in all strains, possessing visibly normal 
dendrites(arrows) and terminals(arrowheads). On the right, PDE neurons and projections are 
shown for each strain, where a normal morphology is also evident. For all strains used, fully 
outcrossed vt21, vt22, vt25 and vt29 were crossed onto a strain bearing an integrated pdat-1:GFP 
transgene(BY250, vtIs7). Swip mutant genotypes were confirmed by Swip behavioral tests as the 
vtIs7 line shows no paralysis on its own. Anterior is left in all images shown. Scale bar is equal to 
50 uM. 
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with our hypothesis that Swip is a hyperdopaminergic phenotype that is unlikely 
to derive from gross alterations in DA neuron circuitry. 
 
Isolation of novel dat-1 null mutations  
If our Swip screen is both specific and robust with respect to recovery of genes 
that control DA signaling, it should recover animals with dat-1 alleles, as well as 
novel mutants. To assess this issue, we first crossed vt21, vt22, vt25 and vt29 
with dat-1(ok157), performing Swip complementation tests on their F1 progeny. 
From these experiments we found that N2 can complement dat-1 and each of the 
mutant strains (Figure 9A) and that vt25 and vt29 both complement dat-1(Figure 
9B) and one another (data not shown), indicating that vt25 and vt29 likely do not 
derive from mutations in dat-1. Likewise, these studies indicate that a single copy  
of dat-1 is happlosuficient to generate normal swimming behavior. In contrast,, 
vt21 and vt22 fail to fully complement Swip when crossed to dat-1(ok157)(Figure  
9B). Likewise, when we crossed vt21 and vt22, we observed a failure to 
complement (data not shown), indicating that they are likely alleles of the same 
gene, that most likely is dat-1.  
To test this hypothesis, we overexpressed GFP-tagged DAT-1(Pdat-
1::GFP:DAT-1) in vt21 and vt22 and tested for Swip in lines verified to express 
GFP in DA neurons.  As previously demonstrated for the DAT-1 deletion allele 
dat-1(ok157) (P. W McDonald, et al., 2007), transgenic expression of GFP:DAT-1 
rescued the Swip in vt21 and vt22 (Figure 10A), suggesting that these mutants 
reduce DAT activity.  Whereas sequencing of the genomic DAT-1 locus  
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Figure 9 – Complementation assays of swip strains to N2 and dat-1. A, swip mutant 
heterozygotes are fully rescued in their Swip behavior. vt21/rhIs2 does show a significant 
reduction from control levels, but Swip is greatly suppressed from that seen in homozygotes 
(see Fig. 2). Lines containing integrated fluorescent transgenes were crossed to fully outcrossed 
swip hermaphrodites and fluorescent cross progeny were tested for Swip. These balancer lines 
display normal swimming behavior on their own. Data were analyzed using one-way ANOVA 
with selected Bonferroni post-tests comparing to controls bearing a single copy fluorescent 
transgene. Fractions below the bars represent # paralyzed/# assayed.  B, vt21 and vt22 fail to 
complement dat-1, whereas vt25 and vt29 suppress Swip to control levels. Dat-1(ok157) males 
bearing a fluorescent transgene in trans were crossed to fully outcrossed swip mutants and 
fluorescent cross progeny were tested for Swip. Data were analyzed as in A. 	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Figure 10 – Isolation of novel dat-1 mutants. A. GFP:DAT-1 rescues swimming behavior 
of vt21 and vt22 animals. vt21;lin-15(n765ts) and vt22;lin-15(n765ts) were coinjected with 
GFP:DAT-1(pRB491) and lin-15(pJM23) and separate transgenic lines were manually scored for 
paralysis in water. Data are derived from > 10 trials for each line. Data were analyzed using one-
way ANOVA with selected Bonferroni post tests - *** = P<0.001.  B. Gene structure of dat-1 and 
position of mutant nucleotides in vt21 and vt22 as verified by DNA sequencing. Also illustrated is 
the dat-1(ok157) allele that derives from a 1.8 kb deletion encompassing exons 4-11 of dat-1. In 
vt22, a G->A transition at nucleotide 1687(from ATG start) results in the conversion of tryptophan 
(T) to a premature stop codon (*). In vt21, a G->A transition at nucleotide 2395 results in the 
conversion of a highly conserved glycine (G) to aspartic acid (D). C-E, Expression and trafficking 
deficits of vt21 and vt22 alleles of dat-1.  Animals injected with pdat-1::GFP:DAT-1 I display 
readily detectible expression and localization to CEP and ADE soma (white arrows) and 
terminals (white triangles) whereas mutant transporters (D and E) are much more weakly 
expressed and restricted in localization to DA neuron cell bodies. L4 animals were anesthetized 
and Z-stacks of CEP/ADE neurons were acquired and flattened to generate images of GFP:DAT-
1 expression in vivo. Each image is representative of three separate transgenic lines that 
produced equivalent results. 
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in vt25 and vt29 yielded sequence identical to that found in N2 animals, vt21 and 
vt22 were found to bear single base-pair substitutions predicted to impact the 
DAT-1 coding sequence (Figure 10B). The DAT-1 gene contains thirteen exons 
that encode a 615 amino-acid protein with twelve transmembrane I domains and 
intracellular N and C-termini (Jayanthi, et al., 1998). vt21 bears a G->A 
substitution at the beginning of exon 10 that results in the conversion of a highly 
conserved glycine residue to aspartic acid (G460D). G460 (conserved in hDAT) 
is predicted to lie in the small extracellular hairpin turn between TMs 9 and 10 
(Figure 11A). Vt22 possesses a G->A substitution in the middle of exon 6 that 
results in a stop codon at amino acid 283, as opposed to a tryptophan (W283*). 
To examine the deleterious impact of the DAT-1 mutations identified in 
vt21 and vt22 lines, we implemented a previously described heterologous 
expression protocol (Richard Nass, et al., 2005). Our assay of [3H]DA transport 
activity in COS-7 cells revealed that both dat-1(vt21) and dat-1(vt22) display 
significantly reduced DA uptake relative to that displayed by WT HA:DAT-1 
(Figure 11C). Whereas dat-1(vt22) produced no significant [3H]DA uptake above 
nontransfected cells, dat-1(vt21) exhibited low, but detectible, transport activity 
(Figure 11C). Analysis of total and cell-surface protein extracts demonstrated that 
dat-1(vt21) and dat-1(vt22) exhibit reduced cell surface expression levels and a 
premature truncation product respectively relative to WT DAT-1(Figure 11D). 
Furthermore, whereas GFP:DAT-1 expression rescued the Swip of dat-
1(ok157)(Figure 11E), neither GFP:DAT-1(G460D) nor GFP:DAT-1(W283stop) 
rescued Swip. Confocal analysis of wildtype GFP:DAT-1 expression in CEP  
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Figure 11 – Modeling and 
functional analyses of dat-1 
mutations. A and B. Positions 
of vt21 and vt22 mutations on 
DAT-1 protein, as predicted from 
the solved crystal structure of 
the bacterial leucine transporter 
(LeuTAa). Mutant residues are 
shown in red and TMs 9 and 10 
adjoining the vt22 mutation are 
colored in yellow. A – side view, 
B – extracellular view.  C. Vt21 
and vt22 (dat-1(vt21) and dat-
1(vt22), respectively) exhibit 
reduced DA transport activity in 
vitro. COS-7 cells were transiently transfected with either empty vector (pcDNA3), or 
constructs expressing DAT-1(pRB606), DAT-1(vt21)(pRB1026) or DAT-
1(vt22)(pRB1027) proteins and assayed for DA transport activity as described in 
Methods. Both of the mutant DAT-1 proteins yielded significantly reduced transport 
activity as compared to WT DAT-1. Values represent the mean % DA uptake of WT +/- 
SEM of six independent experiments and were compared using one-way ANOVA with 
Bonferroni post tests to WT. ***P<0.001. D. Mutant DAT-1 proteins display altered 
levels and trafficking of transporter protein. Total and surface protein expression of HA-tagged DAT-1(pRB491), DAT-1(vt21)(pRB1028) and DAT-
1(vt22)(pRB1029) were determined by western blot analysis, as described in Methods. Wildtype DAT-1 expression is evident as an immature 
species of ~45 kDa and a mature, glycosylated band at ~ 80 kDa, with the 80 kDa species detected in surface fractions. DAT-1(vt21) expression is 
detected as both an immature and a full length species, with a higher relative abundance of the immature species.  Little to no expression of these 
species is detected in surface fractions.  No full length product is evident in the total or surface lysates from DAT-1(vt22) transfected cells with only 
a short ~25 kDa fragment evident, consistent with the site of the nonsense mutation. Image presented is representative of 4 independent 
experiments with equivalent results. E. vt21 and vt22 mutations, engineered into GFP:DAT-1 expression constructs, fail to rescue Swip behavior of 
dat-1(ok157);lin-15(n765ts) animals. In contrast, expression of GFP:DAT-1 fully rescues Swip. Behavior plotted of animals expressing GFP:DAT-
1(wt) is the average of four independent transgenic lines. Data from vt21 and vt22 mutant GFP:DAT-1 lines derives from at least 20 animals, with 
three lines scored for each test. Traces were compared using two-way ANOVA and multiple Bonferroni posttests where swimming behavior of 
GFP:DAT-1 fusions bearing vt21 and vt22 mutations was significantly reduced from WT (p<0.001 for all values along the running average after the 
first minute of swimming). The behavior of the two mutants was not significantly different from each other. 
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neurons revealed moderate levels of transporter expression in DA cell bodies 
(Figure 10C, white arrows), low levels in dendrites and axons and high 
expression in presynaptic terminals (white arrowheads). In contrast, GFP:DAT-
1(G460D) demonstrated robust CEP cell body expression but failed to label CEP 
processes and terminals (Figure 10D). Animals expressing GFP:DAT-
1(W283stop) demonstrated lower levels of GFP signal than was observed in 
GFP:DAT-1 or GFP:DAT-1(G460D), with all labeling confined to CEP cell bodies 
(Figure 10E).Together, these findings provide in vitro and in vivo support for the 
determinants of Swip in the vt21 and vt22 lines as derived from dat-1 alleles.  
Since we did not observe mutations in DAT-1 in vt25 and vt29, we further 
mapped the sites of these mutations as described in Methods. We found that 
vt25 maps to LGIII whereas vt29 maps to LGX (Figure 12). Likewise, we did not 
observe mutations in dat-1 for vt31, vt32, vt33, vt34, vt39, vt42 and vt44. These 
mutations were mapped to other positions in regions not containing known 
Daergic regions, and will require further study to identify the molecular lesion that 
is required for Swip. In the process of mapping, we made an important 
observation that the left arm of LGI is prone to non-specific N2 Bristol linkage. 
This non-specific linkage point increased the difficulty of fine mapping the interval 
for Swip mutants that mapped to LGI such as vt31, vt34, and vt39. No genes 
known to impact DA signaling lie in the region mapped in vt25. The vt29 region 
harbors the dop-4 gene. Sequencing of this gene in vt29 animals revealed no 
mutations, indicating that the altered DA signaling of vt29 is produced through a 
 57 
vt29
vt31
vt34
vt32
vt42
swip17 
vt39
vt44
1 Mb 
LGI 
ast-1 
LGII 
LGIII 
LGIV 
LGV 
LGX 
- + goa-1 
dgk-1 
gpb-2 
eat-16 egl-30 
egl-10 
egl-8 dop-5 
	  
Figure 12 – Genomic Positions of all stable mutants that exhibit reserpine-sensitive Swip. vt21, vt22, vt25, vt29, vt31, vt32, 
vt33, vt34, vt39, vt42, and vt44 were mapped by cross to the CB4856 strain and areas of N2 Bristol enrichment were determined in 
bulk and clonally by PCR of SNP-containing regions across all six chromosomes and restriction digest with DraI. 
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novel mechanism. These findings confirm that vt25 and vt29 do not harbor Swip-
causing dat-1 alleles, nor do they involve mutations in the same gene. 
 
vt25 and vt29 exhibit dat-1-like locomotive behaviors but distinct 
sensitivities to exogenous DA 
To determine the similarity of vt25 and vt29 behavior to that of dat-1, we 
conducted a series of DA signaling dependent locomotor tests. We also assayed 
dat-1(vt21) and dat-1(vt22) in parallel to explore whether this test might reveal 
dat-1 allele-specific effects. Using an automated assay of swimming behavior 
(Matthies, et al., 2006; P. W McDonald, et al., 2007), we found that vt25 lacked a 
fully penetrant Swip phenotype, as evident by its ~50% paralysis in manual 
scoring (Figure 7A) and an average ~0.5 Hz thrashing frequency by our final 
assay time point (10 min) under automated recording (Figure 7C). In contrast, 
vt29 displayed fully penetrant Swip, yielding ~100% paralysis in manual scoring 
assays (Figure 7A), and an even more rapid rate of paralysis than dat-1 (Figure 
7C and Table 1). In these and further assays, we determined that dat-1(vt21) and 
dat-1(vt22) behave similar to the dat-1(ok157) strain (Figure 13 and Table 1). 
 The Swip of dat-1 animals requires the function of the Gαo-coupled DA 
receptor DOP-3 (Allen, et al., 2011; Chase, et al., 2004; P. W McDonald, et al., 
2007) that is expressed by body wall muscle and ventral cord motor neurons. As 
with dat-1(ok157) animals, dat-1(vt21) and dat-1(vt22) paralysis was completely 
suppressed in a cross to dop-3 (Figure 13).  Vt25 paralysis was modestly, but 
significantly rescued by dop-3 (Figure 7D). We could not examine rescue of vt29  
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with dop-3 as they both map to the same chromosome. Therefore we crossed 
this line to a line deficient in the rate-limiting enzyme in DA biosynthesis, tyrosine 
hydroxylase (cat-2), as cat-2 suppresses the Swip of dat-1(ok157) (MCDONALD et 
al. 2007). As with dat-1 alleles, we found that cat-2 completely suppressed the 
paralysis behavior of vt29 (Figure 7D).  
The application of exogenous DA to worms on solid substrate induces 
motor slowing and paralysis (Schafer & Kenyon, 1995). We found that dat-1 
animals transferred to plates containing increasing amounts of DA displayed a 
two-fold increase in DA sensitivity when compared to N2 animals (Figure 7B and 
Figure 13D), possibly reflecting a lack of DAT-1 dependent clearance of 
exogenous DA once the catecholamine permeates the cuticle. Vt29 displayed 
sensitivity to exogenous DA like that of dat-1 (Figure 7B). In contrast, vt25 
exhibited a DA dose-response more similar to N2 (Figure 7B). We also tested the 
response to exogenous DA for vt31, vt32, vt33, and vt34. Like vt29, vt33 shows 
displays an enhanced sensitivity to intermediate doses of exogenous DA (Figure 
14). More experiments will be necessary to make definitive conclusions about 
vt31, vt32, and vt34. Preliminarily, we observed that vt31 and vt34 display 
paralytic responses to exogenous DA that resemble N2 (Figure 14), while vt32 
displayed a reduced sensitivity to exogenous DA.   
 Automated analysis of Swip behavior reveals a differential impact 
on thrashing behavior for vt25 and vt29. In order to probe more precisely 
quantify the thrashing behavior of our swip mutants, we developed software 
tools (SwimR, see Appendix A, Hardaway and Wang et al) that can provide  
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Figure 13 – Behavioral Analyses of the dat-1(vt21) and dat-1(vt22) strains. A. Vt21 and vt22 
mimic the dat-1 Swip phenotype as measured by automated thrashing analysis. Individual 
animals were recorded using a video capture system and then analyzed with customed-
designed Thrasher software that assigns multiple linear elements projecting from the worm 
centroid.  The position of these linear elements are tracked and converted off-line to movement 
frequency as a function of time. Batch conversions are generated, providing mean values and 
SEM along moving averages. Error bars are not shown in these plots for simplicity. Dat-1(ok157), 
vt21 and vt22 were found to be significantly different from N2 using two-way ANOVA with 
Bonferroni posttests of mutants to N2, with each mutant possessing a P<0.001 after the one 
minute mark. B. Mutation of the postsynaptic receptor DOP-3 fully rescues the paralysis 
phenotype of vt21 and vt22. Analyses were performed as described in B, where vt21 and vt22 
were both found to be significantly different from the double mutants vt21;dop-3(vs106) and 
vt22;dop-3(vs106) with P< 0.001 after 1 minute. C. Heat map representations of dat-1(vt21) and 
dat-1(vt22) swimming traces. Analyses were performed as described in Figure 4. D. vt21 and 
vt22 display enhanced sensitivity to exogenous DA when tested on solid medium, as compared 
to N2, but are indistinguishable from dat-1. For these assays, 10 L4 stage worms were placed 
on plates containing increasing concentrations of exogenous DA, incubated for 20 min and then 
scored for 10 sec as paralyzed or moving. Dose-response curves were compared using two-way 
ANOVA with Bonferroni posttests comparing mutants to N2, in which dat-1, vt21 + vt22 were all 
found to be significantly different from N2, with a P<0.001 at 15 and 20 mM DA. Data derive 
from at least 4 tests per strain per DA concentration. Error bars represent SEM. Exogenous DA 
dose response profiles and data analysis were performed as described in the Methods and in 
Figure 3..   
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for a more detailed kinetic analysis of individual animals that may reveal patterns 
of behavior not readily detected in population averages (Table 1).  For 
visualization, our software plots each animal’s swimming behavior horizontally 
(Figure 15A), assigning a color code that ranges from red (high frequency) to 
green (low frequency) for each time block, and that orders the animals within 
each genotype so that more rapid paralyzers are displayed at the bottom and 
slower paralyzers (or relatively constant swimmers) are displayed at the top. 
These analyses revealed several significant differences between the mutants. All 
mutants recovered in the screen demonstrated significantly reduced maximal 
thrashing frequencies in water, with vt29 being the most impacted, and 
accompanied by a greater percentage of animals displaying lower thrashing 
frequency values (Figure 17).  With respect to paralysis, vt25 animals again 
resembled dat-1, whereas vt29 differed from these lines with a significantly 
reduced latency to paralyze. Although by definition, all lines paralyze in water, 
our single worm analyses revealed that dat-1 and vt25 lines feature a significant 
number of animals that revert back to relatively normal swimming behavior that 
we tabulated as reversion incidence (# revertants/# paralyzers)) and reversion 
probability (time in reversion/time after paralysis). Vt29 demonstrated a 
significantly reduced reversion incidence from other lines (and dat-1), which can 
be readily detected in both the heat map plots and in selected individual 
thrashing traces (Figure 15B). When animals that did revert were analyzed 
separately, we found that the reversion frequency (# of events/animal), time to 
first reversion, and the average reversion event length did not differ among all  
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Figure 14 – Exogenous DA responses of vt29, vt31, vt32, vt33, and vt34. Experiments were 
performed as previously described. For all experiments, dose-response curves were compared 
using two-way ANOVA with Bonferroni posttests comparing all strains. Data derive from at least 
4 tests per strain per DA concentration. Error bars represent SEM.  A. dat-1 was significantly 
different from N2 with a P<0.001 at 10, 15 and 20 mM DA. vt29 was significantly different from 
N2 with a P<0.05 at 5, 10, 15, and 20 mM DA. B. vt31 and vt34 are not significantly different 
from N2 at any dose. C. vt32 displays a reduced sensitivity to exogenous DA with significant 
reductions at 15 and 20 mM DA.  
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Figure 15 - vt25 and vt29 display distinct paralytic attributes. A. Heat map analysis for N2, 
dat-1(ok157), vt25 and vt29 animals, generated using SwimR software as described in 
Methods. Individual swimming frequencies as a function of time, color coded as shown by 
the vertical bar on the right, are stacked with the fastest animals to initiate paralysis for each 
genotype placed on the bottom. B. Individual traces of N2, dat-1 and vt29 behavior illustrate 
that a proportion of dat-1 animals demonstrate spontaneous reversal of paralysis (reversals 
marked with *), behavior that is rarely seen with vt29 animals. Traces shown reflect individual 
traces from the full data set used for heat map generation, selected using a random number 
generator. Full quantitative analysis of reversal behavior elements is provided in Table 1. 
Scale bar for fraction swimming and time in sec is shown below vt29 plots. 
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mutant strains (Table 1). These analyses suggest that differences exist in the 
functional impact of dat-1, vt25 and vt29 mutations prompting a further 
investigation of the differential behavior of these lines. 
   
Evaluation of vt25 and vt29 sensitivity to osmolarity  
Previously, we demonstrated that the dat-1 Swip phenotype is highly dependent 
on the osmolarity of the swimming medium (Hardaway et al., personal 
communication to WBG), with a near complete loss of Swip when these animals 
are subjected to aqueous solutions buffered to 300 mOsm with sucrose, or in M9	  
We used manual scoring of the fraction of animals paralyzed at 10 min to assay 
swimming behavior of N2, dat-1, vt25, and vt29 as a function of medium 
osmolarity. N2 animals, as expected, maintained a relatively constant swimming 
rate regardless of osmolarity (Figure 16A), whereas dat-1 animals displayed the 
expected loss of paralysis with increasing osmolarity. Vt29 animals exhibited a 
virtually identical sensitivity to osmolarity as dat-1, except a slight, yet 
significantly increased paralysis at higher osmolarities. Remarkably, vt25 animals 
displayed a lack of sensitivity to the osmolarity of solutions used in swimming 
assays. Although only minimal paralysis of dat-1 and vt29 animals was detected 
in M9 medium using hand scoring, automated analyses revealed that both dat-1 
and vt29 exhibited reduced average rates of movement (Figure 16B). At a single-
worm level, several parameters distinguished dat-1 and vt29 in M9 medium 
(Figure 16C-F, Table 1). Vt29 animals did not reach the same maximal swimming 
frequency as dat-1 animals in M9, and unlike water, dat-1 maximal rates were  
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   Maximal  
Frequency (Hz) 
Latency to  
Paralyze (sec) 
Reversion  
Incidence¶ 
Reversion 
Frequency 
(events/ 
animal) 
Reversion  
Probability‡ 
Time to 1st  
Reversion 
(sec) 
Average 
Reversion Event 
Length (sec) 
N2 (n = 52) 1.76 +/- 0.01 N/A N/A N/A N/A N/A N/A 
dat-1(ok157) (48) 1.45 +/- 0.04†* 174 +/- 17.5 0.25 3.22 +/- 0.571 0.031+/- 0.006 145 +/- 35.8 5.77 +/- 1.4 
dat-1(vt21) (43) 1.28 +/- 0.04* 130 +/- 14.4 0.365 1.76 +/- 0.302 0.015 +/-0.003 185 +/- 32.3 4.02 +/- 0.93 
dat-1(vt22) (47) 1.24 +/- 0.04*** 131 +/- 14.5 0.391 2.00 +/- 0.271 0.020 +/- 0.004 112 +/- 17.7 4.54 +/- 0.93 
vt25 (47) 1.28 +/- 0.04* 178 +/- 21.8 0.267 3.50 +/- 0.620 0.032 +/- 0.01 183 +/- 67.1 4.22 +/- 0.88 
vt29 (37) 1.13 +/- 0.04*** 81.2 +/- 6.05*** 0.0540§* 2.50 +/- 0.500 0.018 +/- 0.007 146 +/- 108 3.59 +/- 0.69 
vtIs18 (42) 1.64 +/- 0.02†ns N/A N/A N/A N/A N/A N/A 
vt25; vtIs18 (38) 1.45 +/- 0.03 337 +/- 61.9* 0.333 N/A N/A N/A N/A 
vt29; vtIs18 (44) 1.45 +/- 0.02 165 +/- 22.4 0.294 3.90 +/- 0.706 0.051 +/- 0.019 107 +/- 30.7 4.43 +/- 1.14 
M9  
N2 (53) 1.76 +/- 0.01 N/A N/A N/A N/A N/A N/A 
dat-1(ok157) (56) 1.66 +/- 0.02 166. +/- 34.1 0.810§### 5.06 +/- 0.774 0.052 +/- 0.014 110 +/- 11.7 4.18 +/- 1.10 
vt29 (53) 1.29 +/- 0.03**** 298 +/- 24.5 0.640§## 4.19 +/- 0.647 0.040 +/- 0.008 171 +/- 25.7 4.20 +/- 0.76 	  
Table 1 – Kinetic Attributes of Swip-harboring strains in water and M9. 	  
‡ Reversion Probability = total time spent in reversion/ total time after paralysis onset 
¶ Reversion Incidence = fraction of animals that reverse from paralysis 
Asterisks(*) indicate a significant difference to dat-1(ok157) as determined by one-way ANOVA with Bonferroni’s multiple comparision test where  
* = p < 0.05, ** = p < 0.01, and *** = p < 0.001. Numeral signs(#) indicate a comparison within the same genotype between water and M9. 
† comparison to N2(ns = not significant) 
§ Chi-square test  
N/A = not applicable(no comparisons were made to N2 for paralytic features as the N2 strain does not paralyze significantly) 
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Figure 16 - Swip in dat-1, vt25 and vt29 are variably suppressed at high buffer 
osmolarities. A. The Swip penetrance of dat-1 and vt29 is reduced by increasing the 
osmolarity of the swimming medium, whereas vt25 displays no sensitivity to changes in 
osmolarity. Manual Swip assays were performed as described previously with water 
supplemented with sucrose to produce 100, 200 + 300 mOsm. M9 was used as a high 
osmolarity control and was experimentally determined to be ~325 mOsm. Data were 
analyzed using two-way ANOVA, with the goal of evaluating a genotype X molarity 
interaction.  Significant interactions were found for dat-1 (P<0.0001) and vt29 
(P<0.0001)), whereas vt25 displayed a non-significant interaction (P=0.2385). Bonferroni 
post hoc comparisons of each genotype at each osmolarity were performed to assess 
the ability of each buffer to suppress Swip. B. vt29 bears an enhanced Swip penetrance 
in M9 as measured via automated thrashing analysis. Individual traces of N2, dat-1 and 
vt29 were acquired as described previously except M9 was used in lieu of water. Data 
were analyzed using two-way ANOVA with Bonferroni posttests along the running 
averages. The thrashing frequency of vt29 was significantly reduced from dat-1 from 3 
min 14 sec – 3 min 17 sec and 4 min 37 sec to 4 min 39 sec and dat-1 significantly 
reduced from N2 from 5 min 42 sec  to 5 min 45 sec and 8 min 50 sec  to 8 min 52 sec. 
C. Heat map analysis using SwimR software for N2, dat-1(ok157) and vt29  animals in 
M9 generated as described in Methods. D. Quantitative analysis of Swip behavior 
displayed graphically in C. M9 buffer significantly increases the latency to paralyze for 
vt29, but not for dat-1. Mean latency values were compared using an unpaired, two 
tailed t test (P<0.001). E. M9 buffer significantly increases the reversion incidence of 
both dat-1 and vt29. The distribution of revertants between the two buffers was 
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Figure 16(cont’d) – (325 mOsm).  
 
not significantly different from N2 (Table 1). In M9, vt29 animals exhibited a 
significantly greater latency to paralyze than dat-1 animals (Table 1 and Figure 
16D), opposite to their relative sensitivities in water. Both dat-1 and vt29 lines 
demonstrated an increase in the number of revertants in M9 as compared to 
water (Figure 16E) without changing the length of reversion events (Figure 16F), 
though this effect was greatest in vt29 animals. Therefore, vt29 are more likely to 
paralyze in M9 than dat-1, but as a population reach paralysis more slowly and 
are more likely to reverse from paralysis than when assayed in water. 
 
Suppression of Swip in vt25 and vt29 with DAT overexpression   
Although we did not detect mutations at the DAT-1 locus in vt25 and vt29, these 
mutations may still impact DA clearance, either through a functional impact on 
DAT-1 at DA terminals, or through changes in the somatic export of DAT-1 
protein. To assess this issue, we crossed vt25 and vt29 onto a line containing an 
integrated pdat-1::GFP:DAT-1 transgene and monitored swimming behavior. 
Overexpression of GFP:DAT-1 restored swimming behavior of vt25 (Figure 19A) 
to near wildtype levels. Single worm analyses (Figure 19B + C) demonstrated 
that, although Swip is largely rescued when overexpressing DAT on the vt25 
background, short paralytic bouts are still evident. GFP:DAT-1 overexpression 
only modestly suppressed vt29. Automated analyses revealed that the partial 
suppression of vt29 by overexpression of GFP:DAT-1 does not derive from an 
increased reversion probability or latency to paralyze (Table 1), but rather 
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appears to result from a reduction in Swip penetrance, with a reduced fraction of 
animals swimming at or near the rates observed with vt29 alone (Figure 19A 
compared to Figure 15C).  To examine whether the findings from the rescue 
experiments with pdat-1::GFP:DAT-1 reflect a failure to synthesize or traffic the 
transporter, we examined the impact of vt25 and vt29 backgrounds on the 
localization of GFP:DAT-1 to the soma, dendrites, axons and presynaptic 
terminals of CEP, ADE and PDE neurons. We could detect no changes in the 
pattern of GFP:DAT-1 localization with the vt25 and vt29 strains, comparing 
animals with GFP:DAT-1 expressed on an otherwise wildtype background to 
(Figure 18).  
 
vt25, vt29 and dat-1 have reduced tissue DA content  
One reason for vt29 to possess a stronger, DA-dependent Swip phenotype than 
dat-1(ok157) would be for vt29 to store excess DA in synaptic vesicles that, upon 
release, could produce higher levels of extrasynaptic DA than seen with wildtype 
DA levels and a loss of DAT-1 mediated DA clearance. To investigate this issue, 
we measured DA levels in vt25 and vt29 animals in parallel with assays of N2, 
dat-1(ok157) and cat-2(tm2261) lines. As expected, cat-2(tm2261) displayed a 
highly significant reduction in DA levels compared to N2 (Figure 19D). Dat-1 DA 
levels were also reduced, in keeping with findings of reduced tissue DA content 
in DAT knockout mice believed to derive from a need to recycle extracellular DA 
to maintain vesicular stores (Giros, et al., 1996). Interestingly, both vt25 and vt29 
also displayed reduced DA levels, suggesting that, analogous to dat-1, vt25 and  
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Figure 17 - Histogram of automated thrashing behavior in N2, dat-1(ok157) and  
swip lines generated by SwimR software. For all plots (A-F), the total # of data 
points for all animals within a genotype were grouped into successive 0.1 Hz bins 
and plotted as the fraction of the total # of data points. In the swip mutants (C-F), the 
y-axis and first column are broken in order to visualize the patterns of lower 
frequency bins.   	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Figure 18 - vt25 and vt29 do not alter GFP-DAT somatic export: Expression pattern of pdat-
1::GFP:DAT-1(vtIs18) in the head(CEP and ADE neurons, A,B + C) and posterior(PDE, D,E + F) 
in WT, vt25 and vt29 were analyzed by confocal microscopy. The expression pattern of 
GFP:DAT-1 is not altered on the vt25 or vt29 backgrounds, with diffuse expression in DA 
neuron cell bodies(arrows) and punctate expression visible at terminal regions (arrowheads). 
Scale bar equal 10 uM. 
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Figure 19 - Behavioral analysis of 
GFP-DAT overexpression, 
biochemical analysis and neurotoxic 
profiles of vt25 and vt29.  A, pdat-
1::GFP:DAT-1 transgene suppresses 
Swip behavior of vt25 and vt29 lines.   A 
line containing an integrated functional 
pdat-1:: GFP-DAT-1 (vtIs18) transgene 
was crossed onto vt25 or vt29. Lines 
were tested manually over at least three 
experimental days with > 72 trials tested 
for each strain. Data were analyzed 
using a one-way ANOVA with multiple 
Bonferroni posttests. *** = P< 0.001 B, 
Automated thrashing analysis of vt25 
and vt29, generated as previously 
described, demonstrate rescue of Swip 
in cross to pdat-1: GFP-DAT-1 (vtIs18). C, 
Heat map representations of vt25; 
vtIs18 demonstrate that whereas the 
overexpression of GFP:DAT-1 fully 
rescues the paralysis of vt25 (compare 
Fig XA), with transient bouts of paralysis 
evident, while vt29; vtIs18 animals 
demonstrate a reduction in Swip 
penetrance relative to vt29 (compare Fig 
4A) and are not fully rescued. D. 
Analysis of DA levels in vt25 and vt29. 
dat-1(ok157), cat-2(tm2261), vt25 and 
vt29 lines all contain significantly 
reduced DA levels as compared to N2. 
For each strain, DA was extracted from 
synchronized L4 populations and 
measured using high performance liquid 
chromatography as described in 
Methods. Data were analyzed using a 
one-way ANOVA with Dunnett’s multiple 
comparison. *, **, *** indicate a 
significant reduction from N2 where P< 
0.05, 0.01 and 0.001 respectively. Error 
bars represent SEM and derive from >7 
experiments for each strain.  E. DA 
neurons in N2 are highly sensitive to 
treatment with the neurotoxin 6-OHDA, 
which requires the presence of DAT-1. 
vt29 is fully sensitive to 6-OHDA 
treatment, whereas vt25 is partially 
resistant. Treatments were performed 
as described in the methods. Data were 
analyzed using a one-way ANOVA with 
multiple Bonferroni posttests where ** 
and *** indicate a significant reduction 
from N2 where P < 0.01 and P < 0.001 
respectively. F. dat-1(ok157); vt29 
demonstrates an enhanced Swip 
penetrance relative to dat-1(ok157) and 
vt29 alone at an intermediate osmolarity 
(100 mOsm). Lines were tested 
manually over at least three 
experimental days with > 48 trials for 
each strain. Data were analyzed using 
one-way ANOVA with multiple 
Bonferonni posttests. dat-1(ok157); vt29 
was found to be significantly reduced 
from either mutant line alone. G. Model 
for differential contributions of swip-
6(vt25) and swip-10(vt29) to Swip. 
Vt21/vt22 impact DAT activity directly 
vt29 is fully sensitive to 6-OHDA treatment, whereas vt25 is partially resistant. Treatments were 
performed as described in the methods. Data were analyzed using a one-way ANOVA with multiple 
Bonferroni posttests where ** and *** indicate a significant reduction from N2 where P < 0.01 and P < 
0.001 respectively. F. dat-1(ok157); vt29 demonstrates an enhanced Swip penetrance relative to dat-
1(ok157) and vt29 alone at an intermediate osmolarity (100 mOsm). Lines were tested manually over at 
least three experimental days with > 48 trials for each strain. Data were analyzed using one-way 
ANOVA with multiple Bonferonni posttests. dat-1(ok157); vt29 was found to be significantly reduced 
from either mutant line alone. G. Model for differential contributions of swip-6(vt25) and swip-10(vt29) to 
Swip. Vt21/vt22 impact DAT activity directly through mutation of DAT-1 and loss of function. swip-10 is 
hypothesized to function in a pathway parallel and upstream of DAT-1 activity, whereas swip-6 acts to 
constrain both extracellular DA release and re-uptake. 	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vt29 animals produce a hyperdopaminergic phenotype that precludes the 
maintenance of normal presynaptic DA levels. 
 
vt25 and vt29 demonstrate differential protection against 6-OHDA 
neurotoxicity in vivo  
The reduction in DA levels in vt25 and vt29, in the context of a 
hyperdopaminergic phenotype, raised the possibility that the mutations harbored 
by these lines produces a loss of DAT-1 loss function that might be masked by 
other effects, and thus not detected via the methods we had employed to this 
point. Our lab previously demonstrated that treatment of worms with 6-
hydroxydopamine (6-OHDA) results in a necrotic loss of DA neurons, and that 
this process requires transport of the compound by presynaptic DAT-1 to 
produce neural degeneration (Richard Nass, et al., 2002). This phenotype 
presented us with an opportunity to more directly examine the function of DAT-1 
in vt25 and vt29 lines in vivo. Consistent with our published studies, we observed 
degeneration of DA neurons in N2, but not dat-1 animals, after an acute (1hr) 
treatment with 6-OHDA (Figure 19E). 6-OHDA was significantly less effective in 
lesioning DA neurons in vt25 animals compared to N2, suggesting that the gene 
responsible for Swip in this line normally plays a role in modulating DAT-1 
activity.  In contrast, vt29 demonstrated full sensitivity to the toxin, consistent with 
the mutation in this line impacting a process parallel to DAT-1 in constraining DA 
signaling. 
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Dat-1 and vt29 exhibit additivity for Swip when assayed under hypotonic 
conditions  
With evidence that vt29 impacts DA signaling in a DAT-1-independent pathway, 
we returned to our assessment of Swip behavior under hypotonic conditions, 
examining paralysis at an intermediate osmolarity using single and double 
mutant lines. At a medium osmolarity of 100 mOsm, we observed a significant 
increase in Swip in the dat-1;vt29 double mutant, as compared to the Swip 
penetrance of dat-1 or vt29 alone (Figure 19F) and consistent with the mutation 
harbored by vt29 impacting a pathway parallel to that impacted by dat-1 (Figure 
19G).  
 
DISCUSSION 
The C. elegans gene T23G5.5 (DAT-1) was the first invertebrate SLC6 family 
member to be cloned and characterized, revealing structural and functional 
characteristics similar to those of vertebrate catecholamine transporters 
(Jayanthi, et al., 1998). In vitro heterologous expression studies revealed DAT-1 
to exhibit substrate specificity for DA over other catecholamines, and to be 
antagonized by imipramine, amphetamine and cocaine. Subsequent in vivo 
efforts (Richard Nass, et al., 2002) demonstrated that a 700bp DNA element 
immediately upstream of the DAT-1 transcription start site confers expression of 
GFP in all C. elegans DA neurons (CEP, ADE, PDE in the hermaphrodite). Nass 
and coworkers capitalized on the visibility of DA neurons in living nematodes to 
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monitor neurotoxin (6-OHDA)-induced DA neuron degeneration and demonstrate 
the dependence of cell death on toxin accumulation by DAT-1.   
The discovery of a DAT-1 dependent phenotype provided an initial 
opportunity to implement forward genetic approaches for the identification of 6-
OHDA toxicity suppressors (R Nass & Blakely, 2003; Richard Nass, et al., 2005). 
As the basis for this screen derives from sensitivity to an exogenous agent, the 
utility of the 6-OHDA screen for the elucidation of molecules regulating 
endogenous, DAT-1 dependent DA synaptic events is limited. Therefore, we 
sought to identify behavioral alterations arising from compromised, endogenous 
DA signaling, as revealed in studies of a genetic loss of DAT-1. Although loss of 
DAT in mice produces a dramatic motor phenotype (Giros, et al., 1996), and 
exogenous DA can paralyze worms (Chase, et al., 2004; Sawin, et al., 2000; 
Schafer & Kenyon, 1995), deletion of a large portion of the C. elegans DAT-1 
gene fails to induce an overt motor phenotype on solid substrate. DA neurons in 
the worm are mechanosensitive (Sawin, et al., 2000), and thus we reasoned that 
insufficient physical stimulation is present under normal culture conditions to elicit 
sufficient DA release, thereby reducing the sensitivity of measures focused on a 
dat-1 mutation. Wild type worms placed in water thrash rapidly for 20 minutes or 
longer, and we considered whether this more vigorous mode of motion might 
trigger more elevated DA release. Indeed, when we placed dat-1(ok157) animals 
in water, we discovered that these animals swim briefly at normal rates and then 
paralyze – a phenotype we termed Swip (P. W McDonald, et al., 2007). Swip in 
dat-1 animals requires the biosynthesis of endogenous DA, packaging of DA into 
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synaptic vesicles, and activation of the DOP-3/Gαo pathway (P. W McDonald, et 
al., 2007). The current study confirms that Swip can be used to screen for 
molecular alterations that impact DAT-dependent DA clearance.  
 In our initial screen, many of the lines we identified, when retested in a 
subsequent generation, demonstrated incomplete penetrance of the Swip 
phenotype, and, thus we chose to save only those clones where at least 80% of 
animals in subsequent generations exhibited Swip. The current report represents 
an analysis of ~10,000 haploid genomes, where we uncovered ten stable lines 
originating from mutations in at least three distinct genes, as determined through 
direct sequencing, rescue experiments, mapping, and complementation 
analyses. Visualization of GFP-labeled DA neurons on the mutant backgrounds 
verified that gross morphological deficits of DA neurons do not account for the 
Swip phenotype of the lines presented in the current report. Our design also 
reduced the probability that mutations recovered would arise in shared elements 
of neurotransmitter release machinery or determinants of cholinergic and 
GABAergic signaling, as these lines would be predicted to exhibit locomotor 
dysfunction on solid substrate. Evidence that the lines recovered in our screen 1) 
display cat-2 and/or dop-3 reversal, 2) can be rescued by the presynaptically-
directed vMAT/cat-1 inhibitor reserpine, 3) include two novel dat-1 alleles, 4) 
produce changes in DA levels (for vt25 and vt29) and 5) (for vt25) reduces 6-
OHDA sensitivity lead us to infer that the approach we have used provides for a 
preferential identification of presynaptically acting genes. Of course, we cannot 
rule out that our design and subsequent tests could recover mutants acting 
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postsynaptically, though it seems more likely that a screen to identify 
suppressors of dat-1 mediated Swip would be more useful in recovering such 
animals(Wani, et al., 2012). Finally, although we chose not pursue them, we also 
identified multiple lines that exhibited enhanced Swip following reserpine 
treatment, which could reflect an influence of octopamine, tyramine or serotonin, 
as these neurotransmitters can also modulate motor activity and their vesicular 
packaging by CAT-1 should also be reserpine-sensitive(Alkema, Hunter-Ensor, 
Ringstad, & Horvitz, 2005; Duerr, et al., 1999).    
Two of the lines recovered in our screen harbor point mutations in the 
coding region of DAT-1. Vt22 bears a nonsense mutation, predicted to truncate 
the DAT-1 protein at Trp283, whereas vt21 possesses a missense mutation 
predicted to generate a nonconservative substitution of Gly for Asp at amino acid 
460. All eukaryotic SLC6 family members possess a Gly residue at this position, 
though ours is the first study to demonstrate a functional significance of this site 
in vivo.  Importantly, our studies of vt21 and vt22 provide critical proof of concept 
that a Swip-based, forward genetic screen can target genes critical for the 
regulation of DA signaling.  
In addition to the isolation of new dat-1 alleles, we present a functional 
characterization of two additional stable lines exhibiting Swip, vt25 and vt29. 
These two lines share reserpine-sensitive Swip with dat-1(ok157), dat-1(vt21) 
and dat-1(vt22), and like these mutants, their Swip is suppressed by dop-3 or 
cat-2 mutations. Complementation analyses and mapping of the mutant genes 
harbored by vt25 and vt29 revealed that they bear mutations in two independent 
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loci that do not overlap or contain mutations in known regulators of DA signaling 
and thus likely represent novel genetic components of DA signaling.   
In parallel with dat-1(vt21)  and dat-1(vt22), we assayed the response of 
vt25  and vt29 to increasing doses of exogenous DA. Relative to N2, all dat-1 
mutants, as well as vt29, exhibited a statistically significant, two-fold increase in 
sensitivity to exogenous DA on solid substrate. In contrast, vt25 demonstrated a 
more N2-like response to DA, our first indication that these genes support DA 
signaling via separate pathways. The molecular mechanisms supporting a 
hypersensitivity to exogenous DA are yet to be determined, though in the case of 
the dat-1 mutants, a plausible basis is a reduced requirement for exogenous DA 
to achieve DOP-3 activation in animals that cannot capitalize on the DA 
clearance activity provided by DAT-1. This mechanism has some support from 
the demonstration that DAT-1 can accumulate other exogenous substrates, such 
as the dopaminergic toxin 6-OHDA (Richard Nass, et al., 2005). A second 
possibility is that, in DAT-1 deficient animals, chronically elevated levels of 
extrasynaptic DA may lead to a desensitization of a DA autoreceptor that may 
normally act to suppress DA release via a negative-feedback mechanism. In 
mammals, the D2 receptor serves both to suppress DA neuron firing and to 
reduce DA release (Beckstead, et al., 2004; Bello et al., 2011; Schmitz, 
Schmauss, & Sulzer, 2002; Usiello, et al., 2000). Although such a mechanism 
has not been defined in nematodes, a D2-like DA receptor DOP-2 is also 
expressed by C. elegans DA neurons (Suo, et al., 2003). By inference, 
desensitization of presynaptic DOP-2 produced by constitutively elevated 
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extracellular DA could result in enhanced DA release that synergizes with 
exogenous DA, thereby reducing the amount of DA needed on plates needed to 
produce immobility. Studies are needed that utilize lines with DA neuron-specific 
elimination of DOP-2 to test this possibility.  Such animals would also be useful in 
testing whether mutants recovered in our screen produce their 
hyperdopaminergic phenotype by suppressing DOP-2 mediated, inhibitory 
control of DA neuron excitability and/or DA release. 
As our studies progressed, we recognized that our automated movement 
analysis software (SwimR) could be augmented to provide a much more detailed 
analysis of activity patterns than is reported in standard thrashing assays.  To 
accomplish this goal, we developed a new suite of analytical tools that would 
allow for an unbiased assessment of the behavior of animals, both as individuals 
and across a population. Although the essential patterns among the strains we 
assayed were consistent, finer aspects of their swimming behavior were now 
observable. One such novel observation concerns the finding that a significant 
fraction of dat-1 animals spontaneously recovered from paralysis for short 
intervals (termed here “reversals”). Since we observe these reversals in the 
context of a hyper-dopaminergic phenotype, it is possible that excess 
postsynaptic DA signaling produces reversals in the course of moving between 
two distinct behavioral states. In this regard, Vidal-Gadea and colleagues 
demonstrated that DA is necessary and sufficient for C. elegans transit from 
swimming to crawling (Vidal-Gadea et al., 2011). Whereas the Swip of dat-1 
animals is dependent solely on DOP-3, the swim-crawl transition requires DOP-1 
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and DOP-4 (Vidal-Gadea, et al., 2011). Alternatively, reversals may derive from 
recruitment of other circuits that stimulate movement and that become evident 
when DOP-3 receptors are desensitized. Regardless, the relative presence of 
Swip revertants amongst our mutant strains suggests that these reversions can 
be triggered or unmasked by specific genetic perturbations in DA signaling. 
Specifically, we found that vt29 exhibits a significantly reduced reversion 
incidence from dat-1 and vt25. Multiple automated tracking systems for C. 
elegans swimming have been developed (Buckingham & Sattelle, 2008; Fang-
Yen et al., 2010; Ghosh & Emmons, 2008, 2010; Pierce-Shimomura et al., 2008). 
Our system and its associated analytical tools (Hardaway et al, manuscript under 
review) has been designed to detect multiple parameters of swimming behavior 
and subtle fluctuations between mobile and immobile states. 
 Our automated thrashing analysis of vt25 and vt29 revealed striking 
differences between them, and with dat-1. Using SwimR, we observed that fewer 
vt25 animals fail to paralyze than dat-1, and that vt29 has a shorter latency to 
paralyze and a lower incidence of Swip reversion from the dat-1 strain. Reversion 
analysis also revealed that incidence of reversion is more sensitive to genotype 
than reversion frequency (# of reversals/animal), time to first reversion, or 
average reversion event length. These findings reveal that vt29 differs from dat-1 
and vt25 in its threshold for reversion, and that behavior during reversion, as well 
as transition back to a paralytic state, is determined by independent factors. 
Based on additional functional data discussed below, we propose that the 
biological mechanism impacted by vt29 may determine overall sensitivity to the 
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physical environment encountered in the Swip assay, whereas vt25, like dat-1, 
impacts mechanisms more directly supporting DA inactivation. 
 The kinetic differences in Swip behavior observed for vt25 and vt29 raised 
the question as to whether the strength of Swip in these lines is maintained under 
conditions in which Swip is suppressed in the dat-1 strain. Previous study of the 
environmental dependence of the dat-1 Swip phenotype revealed that an 
increase in the osmolarity of the swimming media significantly suppresses the 
Swip phenotype (Hardaway et al. – personal communication/WBG). In this study, 
we were able to replicate that finding using both manual assays and automated 
thrashing analysis. Remarkably, vt25 maintained its Swip behavior across all 
osmolarities, whereas vt29 swimming behavior, like dat-1, was recovered as the 
osmolarity of the medium approached that of M9. We also assayed the behavior 
of the dat-1; vt29 double mutant across these osmolarities and observed an 
increase in Swip penetrance at intermediate osmolarities. These findings suggest 
that dat-1 and vt29 act in parallel, independent pathways that can sum to 
produce an additive paralytic response at intermediate osmolarities.  Although 
both the dat-1 and vt29 strain demonstrated recovery of swimming in the isotonic 
buffer M9, our automated analysis demonstrated that, nonetheless, dat-1 
behavior could be differentiated from vt29 in that the latter line maintains a 
stronger Swip phenotype even in media of high osmolarity. It is commonplace to 
use salt-buffered solutions in the study of neurotransmitter regulation of 
swimming, despite the fact that the organism normally resides in an environment 
with variable ionic content. Together, these studies demonstrate that the 
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attribution of genes to DA signaling pathways, as well as their epistasis, will 
benefit from the use of osmotic profiling.   
To investigate the potential pathways in which vt25 and vt29 reside, we 
assayed their Swip phenotypes in the context of DAT-1 transgenic 
overexpression, This transgene fully rescues the dat-1 mutant (P. W McDonald, 
et al., 2007), and almost completely restored the swimming behavior of vt25, 
though short transient bouts were still evident. In contrast, vt29 swimming 
behavior was only partially restored by DAT-1 overexpression. Since the vt25 
strain displays a weaker phenotype, the relative magnitude of suppression 
between vt25 and vt29 is roughly equivalent, and suggests that overexpression 
of DAT can partially restore disruptions in multiple pathways regulating DA 
homeostasis. Manipulation of multiple DAT-interacting proteins have been 
implicated in the folding, trafficking, stability and activity of the transporter 
including PICK1 (Torres et al., 2001), Hic-5 (Carneiro et al., 2002), syntaxin1A 
(K.-H. Lee, Kim, Kim, & Lee, 2004), RACK1 (K.-H. Lee, et al., 2004), α-synuclein 
(F. J. Lee, Liu, Pristupa, & Niznik, 2001), synaptogyrin-3 (Egaña et al., 2009) and 
the D2 dopamine receptor (F. J. S. Lee et al., 2007), though the significance of 
these interactions in vivo has not been studied. Mutation of the C. elegans 
orthologs (where they exist) of these genes is unlikely to contribute to the 
phenotypes of vt25 and vt29 based on their absence from mapped loci. 
Additionally, since we observed no difference in the somatic export of GFP:DAT-
1, we doubt they produce Swip through alterations in transporter trafficking to the 
synapse. This is particularly evident with vt29 animals that retained the full 6-
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OHDA sensitivity exhibited by N2. However, vt25 displayed a more moderate 6-
OHDA sensitivity and thus part of its actions may involve local, synaptic DAT-1 
trafficking to the plasma membrane or control of transporter activity.  
Finally, as vt25 or vt29 display a hyperdopaminergic signaling phenotype, 
release of enhanced, synthesized, or stored DA could explain their phenotypes. 
However, when we measured the DA content of these lines by HPLC, we found 
that, as with dat-1, both exhibited a significant decrease in DA levels, though not 
as reduced as the cat-2 mutant that actually fails to Swip. Measurement of 
synaptic DA in vivo in C. elegans is not currently feasible. Interestingly, however, 
DAT KO mice demonstrate tonically elevated synaptic DA, accompanied by a 
reduction in tissue DA (Giros, et al., 1996), which these investigators ascribed to 
a failure to replenish resting vesicular stores via recapture of synaptic DA. 
Although, as noted above, a contribution of vt25 to DAT trafficking or activity 
could result in reduced DA levels, multiple lines of evidence do not support such 
a role for vt29. Rather we hypothesize that the gene mutated in vt29 causes 
excess DA release that cannot be restored through the normal pathways of DA 
synthesis and recapture.   A reasonable hypothesis for the phenotype of the vt29 
mutant (and to a lesser degree vt25), and one that now can be targeted in future 
studies, is that the vt29 gene normally exerts suppression of DA neuron 
excitability and/or DA vesicular release (Figure 19G). Efforts are underway to 
identify the sites of the molecular lesions borne by vt25 and vt29 animals. The 
conservation of components of DA signaling throughout phylogeny suggests that 
our efforts in this regard may identify molecules whose intensive study can 
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provide insights into brain disorders involving compromised DA signaling, as well 
as the development of novel therapeutics. 
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Chapter IV 
IDENTIFICATION OF swip-10 in C. ELEGANS 
 
INTRODUCTION 
In our previous study, we identified a number of mutant strains that demonstrate 
a reserpine-sensitive hyperdopaminergic phenotype. We demonstrated that one 
of these mutants, vt29 maps to a distinct genomic locus from dat-1, has a 
normal neurotoxic response to DAT-dependent 6-OHDA, and functions in 
parallel with dat-1 to trigger Swip. In this study, I aim to determine the site of the 
molecular lesion in vt29. 
 
MATERIALS AND METHODS 
C. elegans strains, husbandry, and genotyping 
C. elegans strains were cultured on bacterial lawns of OP50 and maintained at 
12 to 20°C using standard methods (Brenner, 1974) unless otherwise noted. The 
wild-type strain is N2 Bristol. 
The following strains were used in this study:  
BY810 swip-10(vt29)   - G->A substitution 3289 bp downstream of start site 
BY828 swip-10(vt33)   - G->A substitution 3243 bp downstream of start site 
BY1010 swip-10(tm5915)  - 339 bp deletion (bp 31-370 from start) generated by 
Shohei Mitani 
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The following lines were acquired from the Caenhorhabditis Genetics Center (U. 
Minnesota), the National Bioresource Project, or the noted lab by request: 
cat-2(tm2261) 
LX703 dop-3(vs106) 
RM2702 dat-1(ok157) 
 
Genetic Crosses 
Crosses were performed using publically available integrated fluorescent 
reporter strains to mark chromosomes in trans. Single worm PCR were 
performed to confirm the presence of the indicated mutation. For all deletions, 
we used a three primer multiplex strategy that produces PCR amplicons with 
100-200 bp difference between N2 and mutant. This was highly effective in 
eliminating preferential amplification of a lower molecular weight species. In all 
cases, a synthetic heterozygous control was utilized to ensure that heterozygous 
clones could be identified within that experiment. All PCR reactions were 
performed with Platinum PCR Supermix (Life Technologies). 
 
The following strains were generated by cross: 
BY957 cat-2(tm2261); swip-10(vt29) 
PCR Genotyping of cat-2(tm2261) was performed using the following primers: 
5’ sense – ctccaacaactgaacgacgaagg 
3’ antisense – atttctcgtagacagccttccacg 
inner antisense – agcagctctgccgagtgaattaa 
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swip-10(vt29) was determined by Sanger sequencing of PCR amplicons 
generated using the following primers: 
Sense – ccagAACGATACGATGAACC(Sequencing primer) 
Antisense – GCAACCATAGCGCCTTCTAG 
BY873 cat-2(tm2261); swip-10(vt33) 
swip-10(vt33) was determined by Sanger sequencing of PCR amplicons 
generated using the same primer set for swip-10(vt29). 
BY1034 cat-2(tm2261); swip-10(tm5915) 
PCR genotyping of swip-10(tm5915) was performed using the following primers: 
5’ sense – GGAAAACACTCGTTCTCTCACCAATTG 
3’ antisense – TGTATCATACTTGCAAGTTGCTCATAGTC 
inner antisense – GCAAACATTCCCCCTTGACTTATCATT 
BY1030 swip-10(tm5915) dop-3(vs106) – The two alleles were crossed and 
recombinant progeny were identified via PCR. 
PCR genotyping of dop-3(vs106) was performed using the following primers: 
5’ sense – tcaagaagtgggagacggaacgaa 
3’ antisense – gacctggcaatgtctgggtagaaa 
inner antisense – gtggtgttgtccagccaacattct 
 
C. elegans Assay for Swip 
 
In both batch and single worm analyses, we generated synchronous populations 
of these strains by hypochlorite treatment and harvesting arrested L1 animals.  
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Early-mid stage L4 animals were identified by characteristic morphology and 
used for behavior as N2 animals show some stochastic Swip and quiescence 
bouts during the last larval molt. For automated analysis, single L4 
hermaphrodites were placed in 20µL water or drug in a single well of a Pyrex 
Spot Plate (Fisher catalog number 13-748B), and 10 minute movies 
(uncompressed AVI format) of their swimming behavior were created and 
analyzed as described previously (Hardaway and Wang et al.). For testing 
responses to dat-1 blockade, Imipramine HCl(Sigma) was dissolved in MilliQ 
water at 10 mM and serially diluted to the indicated dose. Assays with N-acetyl 
cysteine were performed by dissolving NAC (Sigma) at 100 mM in MilliQ water 
and serially diluting the drug to the indicated dose.  
 
Preparation of gDNA for Whole Genome Sequencing 
gDNA was isolated as in Sarin et al.{Sarin, 2008 #233} Briefly, BY200 (parental 
strain), vt25, vt29, vt31, vt32, vt33 and vt34 worms were harvested from a 10 cM 
8p/NA22 plate by rinsing with M9. After a brief pre-clearing wash with M9, the 
worms were rocked in M9 for 2-3 hours to allow them to clear ingested bacteria. 
Worms were washed with M9 and then pelleted for DNA extraction. Prior to 
extraction the worm pellet was incubated at -80 degrees for 1 hour to o/n. gDNA 
was extracted from the worm pellet using a Qiagen Gentra Puregene kit as 
described by the manufacturer and a post-hoc phenol/chloroform extraction, 
RNAse A digestion, and additional phenol/chloroform digestion. The quality of 
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the gDNA was confirmed on a 2% agarose gel prior to submitting the samples 
for Illumina sequencing (Vanderbilt Genome Technology Core).  
 
Whole Genome Sequencing  
Sequencing libraries were generated from gDNA as described in Sarin et al. 
Each sample was assigned a unique barcode so that samples could be pooled 
onto several flow cells of an Illumina Genome Analyzer Iix for sequencing as 
single-end 76mers. Sequence reads were filtered for quality and offloaded in a 
Fastq format for subsequent analysis. Sequence data were analyzed in 
MaqGene (Bigelow, Doitsidou, Sarin, & Hobert, 2009) and a text file containing 
mutations against the reference sequence (WS180) were extracted. We then 
compared these mutant strain lists against the parental strain (BY200) to identify 
mutagen-induced SNPs. For vt29 and vt33, we compared the SNPs on LGX to 
identify the mutant sites on F53B1.6. 
 
swip-10 rescue experiments 
 
A full length 4.3 Kb genomic fragment from -738 to 3569 downstream of the 
ATG start site was amplified and injected at 20 ng/μl onto swip-10(vt29) and 
swip-10(vt33) with punc-122:GFP to generate vtEx74-75 and vtEx76-78 
respectively. 
 
Bioinformatic Analysis 
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Homologs of swip-10 were identified using online databases at the National 
Center for Biotechnology Information (NCBI), most notably AceView. Multiple 
sequence alignments were performed in the MegAlign plugin of DNAStar.  
 
Secondary Structure Prediction for swip-10 
The predicted and molecularly determined protein sequences for swip-10 were 
input into two independent secondary structure prediction programs – 
PredictProtein (https://www.predictprotein.org/) and XtalPred 
(http://ffas.burnham.org/XtalPred-cgi/xtal.pl). Both of these programs predict 
structural features and potential post-translational modifications of the input 
sequence based on hydrophilicity and known sequence motifs from other 
proteins. 
 
Cloning of the swip-10 cDNA 
Total RNA was harvested from asynchronous N2 animals and first strand cDNA 
was generated using Superscript III First-Strand Synthesis System (Invitrogen-
Carlsbad,CA). We amplified a 1.6 kB PCR product using the following primers: 
ATGCTTTTTCATTTTCTAATCGCTA(S) and TTAACATTTCAAAGCTTTCTT(A). 
This fragment was TA cloned into PCR8/GW/TOPO for further manipulations. 
 
RESULTS 
 
vt29/vt33 Complementation Analysis 
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In our previous study we identified several reserpine sensitive mutants and 
mapped the genomic locus of the Swip-causing mutation. In these analyses we 
determined that vt29 and vt33, while isolated in separate rounds of screening, 
both harbor mutations that map to the negative end of LGX (see Figure 12 in 
Chapter III). To determine if vt29 and vt33 are different alleles of the same gene, 
we crossed them together and performed Swip on their F1 cross progeny. We 
determined that vt29 and vt33 are complemented by the corresponding wildtype 
allele, but fail to complement when crossed together (Figure 20). Thus vt29 and 
vt33 likely harbor mutations in a shared gene and these mutations display an a 
recessive pattern of inheritance.    
 
Identification of F53B1.6 
To determine the exact site of the molecular lesion in vt29 and vt33, we 
performed whole genome sequencing on these mutants in parallel with the 
parental strain used for mutagenesis (Flibotte et al., 2010; Hardaway et al., 2012; 
Sarin, Prabhu, O&apos;meara, Pe&apos;er, & Hobert, 2008). We mapped the 
sequence reads to a reference genome, excluded SNPs present in the parental 
strain, compared SNPs with our previously mapped locus on LGX, and identified 
shared SNPs present in both vt29 and vt33. We identified one gene, F53B1.6, 
which harbors a mutation in both vt29 and vt33. To determine if F53B1.6 is the 
Swip-causing mutation, we used two parallel approaches. We obtained a 
deletion in F53B1.6 (tm5915) and determined that it displays a highly penetrant 
Swip phenotype comparable to vt29 and vt33 (Figure 21). 
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Figure 20 – Complementation Analysis of vt29 and vt33. F1  progeny were generated 
by cross of either N2 males, vt29 males, or vt33 males into the corresponding dat-1, 
vt29, or vt33 hermaphrodite. Cross progeny were tested for Swip over 3 independent 
experiments. Data were analyzed by one-way ANOVA with selected Bonferonni multiple 
comparisons post tests between homozygote and heterozygote cross progeny. * and 
**** indicate a p value of <0.05 or <0.0001 respectively. 
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Figure 21 – swip-10 Swip is cat-2 and dop-3 dependent. swip-10(vt29) and swip-
10(vt33) were crossed to the cat-2(tm2261) strain and assayed for Swip. Sequencing of 
the vt29 and vt33 SNPs confirmed that the presence and homozygosity of these 
mutations. cat-2(tm2261) was crossed to swip-10(tm5915) and genotyped by PCR. 
swip-10(tm5915) was recombined with dop-3(vs106) and recombinant clones were 
identified by PCR. Swip assays were performed as described in the Methods section. 
Data were analyzed by one-way ANOVA with selected Bonferroni post tests between 
the double mutant strain and its corresponding single mutant allele. **** indicates a 
p<0.0001.   
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Furthermore, we determined that the Swip phenotype in tm5915, as in vt29 and 
vt33, is DA dependent as double mutants lacking cat-2/TH, are suppressed to 
wildtype levels. Because of their proximity to dop-3, our previous study had only 
used reserpine and cat-2 alleles to validate the DA dependence of vt29 and vt33 
(Hardaway, et al., 2012). We recombined tm5915 with dop-3 and found that 
dop-3 is required for the Swip phenotype, restoring the swimming behavior to 
near wildtype levels (Figure 21). To demonstrate that these mutations are 
required for the Swip we observe in vt29 and vt33, we transgenically 
overexpressed a PCR fragment spanning the wildtype F53B1.6 genomic locus. 
Assay of Swip in both non-transgenic and transgenic progeny in multiple 
transgenic lines demonstrated that expression of the wildtype F53B1.6 locus 
rescues Swip in vt29 and vt33 (Figure 22). Thus, mutations in F53B1.6 are 
necessary and sufficient to trigger DA and dop-3 dependent Swip. Hereafter we 
refer to F53B1.6 as swip-10. 
 
Alignment of swip-10 with vertebrate orthologs 
As swip-10 had not been described in any previous report, we used available 
bioinformatics tools to determine if any orthologs of swip-10 existed in 
vertebrates, including humans. We discovered that swip-10 has a highly 
conserved homolog throughout phylogeny. In mammals, the swip-10 homolog is 
known as Mblac1 and has not been studied to date. To determine the extent of 
their homology, we performed a multiple sequence alignment of the swip-10 
protein sequence and its orthologs in Caenhorhabditis briggsae, Drosophila 
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Figure 22 – Rescue of vt29, vt33 and tm5915 with exogenous F53B1.6 expression. 
A full length F53B1.6 genomic PCR fragment containing the endogenous F53B1.6 
promoter(2nd and 9th bars) or an expression construct containing a cassette containing a 
full length F53B1.6 cDNA:GFP fusion under the control of a pan glial promoter(ptr-10, 
3rd,10th and 12th bars), DA neuron specific promoter(dat-1,5th bar), CEPsh promoter(hlh-
17, 6th bar), or the swip-10 4th intron(7th bar) were injected into swip-10(vt29). We found 
that expression of swip-10 in glial cells, but not CEPsh glia, restores normal swimming 
behavior in swip-10 mutants. 4th bar – mutation of histidine residues necessary for metal 
binding significantly reduces swip-10 function.  At least two independent transgenic 
arrays were recovered from each of the injections and tested for rescue of Swip. For 
testing, transgenic and non-transgenic progeny were picked onto separate plates by 
virtue of a fluorescent coinjection marker, allowed to acclimate for several hours, and 
then tested for Swip. For each transgenic line, at least 100 animals were tested. The 
bars indicate pooled values from each of the transgenic lines assayed. Data were 
analyzed by an unpaired student’s t test between the transgenic and non-transgenic 
progeny that were assayed, where **, ***, and **** represent p < 0.01, 0.001, and 0.0001 
respectively. Comparison of the His-> Ser mutant construct was performed by a t test 
between transgenic animals expressing the wildtype ptr-10 rescue construct and 
transgenic progeny expressing the mutant construct. Non-transgenic progeny shown 
above are representative of each of the experiments performed.  	  	  
 95 
melanogaster (fruit flies), Danio rerio (zebrafish), Mus musculus(mice), Rattus 
norvegicus (rats), and Homo sapiens (humans) using ClustaW. We determined 
that although the 5’ end of the swip-10 protein is not highly conserved, the 
vertebrate and invertebrate orthologs of swip-10 bear extensive homology to the 
3’ end of the swip-10 protein (Figure 23). Overall swip-10 had a 39% sequence 
identity with human MBLAC1 and mouse Mblac1. We used available secondary 
structure prediction tools (PredictProtein and XtalPred) to identify whether the 3’ 
end of the swip-10 protein and its homologs contain known functional domains. 
swip-10 and each of its vertebrate orthologs contain a metallo β-lactamase 
domain that is typified by several motifs that harbor histidine residues necessary 
for the binding of a catalytically active zinc ions (highlighted blue residues in 
Figure 23)(Callebaut, Moshous, Mornon, & de Villartay, 2002). These include the 
canonical HxHxDH motif that is present in the catalytic core of all metallo β-
lactamase family members. Following the alignment of swip-10 and its 
orthologs, we found that swip-10(vt29) is predicted to truncate this important 
domain and that swip-10(vt33) harbors a nonconservative mutation in a highly 
conserved glycine residue within the metallo β-lactamase domain (yellow 
highlighted residues in Figure 23). We also assayed secondary structural 
elements at the 5’ end and determined that this end of the protein, while not 
conserved, contains a predicted signal peptide sequence in the first 18 amino 
acids of the N-terminus and a potential coiled-coil motif just 5’ of the metallo β-
lactamase domain. Thus prediction of swip-10 structural elements suggests that 
it contains a highly conserved metallo β-lactamase domain at its 3’ end, a 
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Figure 23 – Sequence 
Alignment of the isolated 
swip-10 protein sequence. 
The swip-10 protein is highly 
conserved with its nematode 
homolog CBG14084 at the 5’ 
end. The vertebrate homologs 
have much shorter protein 
sequences and only begin to 
align at 260 amino acids into 
the swip-10 protein sequence. 
Shaded residues indicate 
amino acids that match the 
swip-10 sequence. Red bar 
indicates the span of the 
metallo β-lactamase domain 
that begins with a canonical 
“ILVDTG” motif. Blue boxes 
indicate histidine residues that 
are predicted to be critical for 
metal binding including a 
canonical HxHxDH motif that 
is typical of the entire metallo 
β-lactamase superfamily. 
Yellow boxes indicate amino 
acids that are altered in the 
strains isolated from the Swip-
based mutagenesis screen. 
swip-10(vt29) harbors a SNP 
that results in the conversion 
of a conserved tryptophan at position 377 to a stop codon, resulting in a truncated metallo β-lactamase domain. The mutation in 
swip-10(vt33) converts a conserved glycine at position 362 to glutamic acid. Sequences were aligned using ClustalW(DNAStar).
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nonconserved coiled- coil motif in the middle of the protein and a nonconserved 
secretory motif at its 5’ end.  
These analyses also revealed that three swip-10 metallo β-lactamase 
domain containing paralogs exist in the worm: C23H3.9, C25D7.5, C03F11.2. 
None of these genes have been characterized via reporter fusions, there are no 
phenotypes reported via genomewide RNAi screens, and there are no alleles 
currently available to assess their impact on dopamine-regulated behaviors. To 
determine the extent of conservation between swip-10 and its metallo β-
lactamase paralogs, we performed multiple sequence alignment on the 
predicted protein sequences for each of these genes in parallel with swip-10 
(Figure 24). We found that swip-10 was 36% identical to C03F11.2 largely due 
to extensive identity within stretches of the metallo β-lactamase domain, 
including the histidine residues predicted for metal binding and metallo β-
lactamase activity. By comparison, swip-10 was only 23 and 22% identical to 
C23H3.9 and C25D7.5 respectively.  
 
Isolation of the swip-10 cDNA     
To determine how the swip-10 gene is transcribed and is organized, we set out 
to isolate the swip-10 cDNA. We located putative clones of the swip-10 cDNA in 
a genomewide open reading frame (ORF) cloning project (WORFDB - 
http://worfdb.dfci.harvard.edu/) that included 3 ORF sequence tags (OSTs): one 
OST that spanned that the 5’ group of exons (but included an exon that was not 
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Figure 24 – 
Alignment of swip-
10 and its worm 
paralogs. C. 
elegans contains 
three other putative 
β-lactamase 
domain-containing 
genes known only 
as C03F11.2, 
C23H3.9, and 
C25D7.5. Blue 
shading indicate 
conserved histidine 
residues that are 
predicted to be 
required for β-
lactamase activity. 
Sequences were 
aligned using 
ClustalW(DNAStar).
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predicted), one OST that spanned the 3’ group of exons, and one OST that 
spanned the full predicted full length ORF including the 5’ and 3’ group of 
exons. As there existed a predicted start site that was present in the latter OST 
containing the 3’ metallo β-lactamase domain, we injected a PCR fragment 
containing only the large intron and the 3’ group of exons into swip-10(vt29) to 
test if the 5’ end of the gene was required for rescue. This fragment failed to 
rescue swip-10(vt29). Combined with the presence of Swip in a deletion allele of 
the 5’ group of exons (tm5915), we therefore conclude that the F53B1.6 gene 
consists of two groups of 5 exons separated by a large 5th intron and that the 5’ 
end of the sequence, while not conserved, is required for protein function. To 
pursue functional studies of swip-10, we amplified a full length swip-10 cDNA 
from a wildtype cDNA library using gene specific primers at the predicted 
translational start site and the 3’ end (see Methods). We did not observe the 1.2 
Kb OST present in WORFDB, but rather a 1.4 Kb product that included an 
additional exon at the 5’ end (Figure 25) that was also present in WORFDB 
OSTs. 
 
DISCUSSION 
In our previous report we described the implementation of a forward genetic 
screen to identify novel, conserved regulators of DA signaling using C. elegans. 
Using a combination of SNP mapping and whole genome sequencing we 
showed that two allelic mutant lines, vt29 and vt33, harbor mutations in a 
previously undescribed gene F53B1.6 that we named swip-10. Genetic  
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vt29(Trp ->stop)
vt33(Gly-> Glu)
1 Kb
Promoter
Promoter
F53B1.6
4th IntronPrevious Gene Model:
New Gene Model: 5th Intron
tm5915
      
Figure 25 – Gene model for swip-10. The top gene model represents the predicted model according to WormBase. The bottom 
model is the revised model prediction based on isolation of a 1.4 swip-10 cDNA, functional studies using minimal PCR fragments 
spanning only the 3’ end of the gene, and the presence of Swip in the tm5915 deletion.
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experiments using vt29, vt33 and a novel allele tm5915 demonstrated that 
mutations in swip-10 all trigger the hyperdopaminergic phenotype Swip. Similar 
to dat-1, swip-10 Swip requires the function of the tyrosine hydroxylase 
homolog cat-2 and the D2-like receptor dop-3 (Chase, et al., 2004; Sulston, et 
al., 1975). To establish that the mutations we observed in vt29 and vt33 were 
required for the Swip phenotype, we transgenically overexpressed the wildtype 
swip-10 gene and observed that its overexpression significantly rescues Swip in 
vt29 and vt33.  
 swip-10 is highly conserved throughout phylogeny. We identified its 
homologs in vertebrates by virtue of the presence of conserved functional 
domain known as a metallo β-lactamase domain. In addition, analysis of the 
swip-10 protein sequence using secondary structure prediction algorithims 
revealed that the 5’ end may harbor an 18 amino acid long signal peptide 
sequence and that the middle of the protein may contain a coiled coil motif. 
Neither of these domains, however, is conserved in the swip-10 human 
homolog, MBLAC1. Anecodotally, imaging of the functional GFP-tagged swip-
10 cDNA was very difficult as the GFP is very diffuse (see Chapter IV), and some 
of the GFP may accumulate in the coelomocytes (data not available). This is 
consistent with the hypothesis that swip-10 may be secreted by glia to act on its 
substrate. Importantly, bioinformatic analysis of glial-enriched transcripts have 
revealed an enrichment for secreted proteins that function in assembly of 
amphid neuron structures (Bacaj, Tevlin, Lu, & Shaham, 2008).   
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Through searching the C. elegans genomic and protein databases, we 
identified three swip-10 paralogs that also contain metallo β-lactamase 
domains: C03F11.2, C23H3.9, and C25D7.5. To date, there has been no 
description of the expression pattern or the impact of mutations on worm 
phenotypes of these genes. As swip-10 does not harbor overt morphological 
phenotypes, the disruption of other swip-10 paralogs may have only subtle 
effects on C. elegans circuitry only revealed through behavioral screening or 
analysis of neuronal physiology.  
To understand how the swip-10 gene is transcribed, we searched 
available databases for ESTs and ORFs that might predict its exon organization. 
The available clones suggested that swip-10 might be expressed as either: a full 
length cDNA containing both the 5’ and 3’ groups of exons, as just the 5’ group, 
or just the 3’ exons. Our original experiment expressing the full length genomic 
region of swip-10 did not allow us to determine which of these regions were 
required for its rescue. Expression of truncated swip-10 fragments not 
containing the 5’ exons or the upstream promoter did not rescue swip-10(vt29). 
We therefore concluded that the entire gene was required for a functional swip-
10 protein. We therefore isolated a full length cDNA of swip-10 using gene 
specific primers to determine how the predicted gene model matches our 
empirically determined one. The cDNA we isolated was 1.4 Kb long and the 
organization of the exons matched the predicted except for an additional exon 
in the 5’ group. The swip-10 gene, therefore, consists of a 700 bp promoter, a 
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group of 5 exons at its 5’ end, a large 5th intron, and a group of 5 exons at the 3’ 
end. Importantly, expression of this cDNA can rescue swip-10 (next chapter).  
 
FUTURE DIRECTIONS  
The isolation of swip-10 prompts new questions about the role of metallo β-
lactamase domain containing proteins in cellular physiology. Currently, we know 
little about how these genes are expressed and genomically organized. Analysis 
of their expression patterns using overlap PCR fusion and expression of GFP 
promoter fusions for C03F11.2, C23H3.9, and C25D7.5 may provide new 
insights into the diversity of gene expression for metallo β-lactamases.   
To determine if swip-10 has a unique role in affecting DA signaling, alleles 
of C03F11.2, C23H3.9, and C25D7.5 must be acquired. Assay of these lines 
using DA-dependent behavioral assays will be a critical first step toward 
determining if swip-10’s has a specialized role. Based on the expression 
patterns of these genes, we might assay the contribution of these genes to other 
neurotransmitter signaling pathways including 5HT, tyramine, octopamine, 
GABA, and ACH.     
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Chapter V 
CHARACTERIZATION OF SWIP-10 IN C. ELEGANS 
 
INTRODUCTION 
In the previous chapter we described the identification of the molecular lesion in 
the vt29 and vt33 strains as occurring in a novel, conserved gene that we named 
swip-10. In this chapter we describe the characterization of the swip-10 gene 
expression pattern, the impact of its loss on DA neuron physiology, and our 
initial efforts to understand how swip-10 impacts dopamine signaling through a 
novel pathway containing glutamate transporters and receptors. 
 
MATERIALS AND METHODS 
C. elegans strains, husbandry, and genotyping 
C. elegans strains were cultured on bacterial lawns of OP50 and maintained at 
12 to 20°C using standard methods (Brenner, 1974) unless otherwise noted. The 
wild-type strain is N2 Bristol. 
 
BY810 swip-10(vt29)   - G->A substitution 3289 bp downstream of start site. The 
following strains were used in this study: 
 
BY828 swip-10(vt33)   - G->A substitution 3243 bp downstream of start site 
 
BY1010 swip-10(tm5915)  - 339 bp deletion (bp 31-370 from start) generated by 
Shohei Mitani 
 
The following lines were acquired from the Caenhorhabditis Genetics Center (U. 
Minnesota), the National Bioresource Project, or the noted lab by request: 
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cat-2(tm2261) 
LX703 dop-3(vs106) 
RM2702 dat-1(ok157) 
MT6308 eat-4(ky5) 
KP4 glr-1(n2461) 
RB1808 glr-2(ok2342) 
glr-2(tm669) 
glr-4(tm3239) 
glr-5(tm3506) 
glr-6(tm2729) 
glr-7(tm2877) 
VM487 nmr-1(ak4) 
nmr-2(tm3285) 
mgl-1(tm1811) 
mgl-2(tm355) 
mgl-2(tm355); mgl-1(tm1811) – Avery Lab 
mgl-3(tm1766) 
ZB1106 glt-3(bz34); glt-1(ok206) – subsequently outcrossed  
RB2185 glt-4(ok2961) 
ZB1098 glt-4(bz69)  
ZB1099 glt-5(bz70) 
RB1615 glt-5(ok1987) 
glt-6(tm1316) 
glt-7(tm1641) 
OS2649 hlh-17(ns204) – Shaham Lab 
OS2659 hlh-17(ns204) hlh-31(ns217) hlh-32(ns223) – Shaham lab 
OS1914 nsIs105(phlh-17:GFP) – Shaham Lab 
OS1917 nsIs108(pptr-10:mRFP) – Shaham Lab 
TQ800 lite-1(Xu7)  - Xu Lab 
TQ733 XuIs14(pdat-1:GCaMP, pdat-1:dsRed2) – Xu lab 
VPR128 vprIs128 (phlh-17:dsRed2) 
 
 
Genetic Crosses 
Crosses were performed using publically available integrated fluorescent 
reporter strains to mark chromosomes in trans. Single worm PCR were 
performed to confirm the presence of the indicated mutation. For all deletions, 
we used a three primer multiplex strategy that produces PCR amplicons with 
100-200 bp difference between N2 and mutant. This was highly effective in 
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eliminating preferential amplification of a lower molecular weight species. In all 
cases, a synthetic heterozygous control was utilized to ensure that heterozygous 
clones could be identified within that experiment. All PCR reactions were 
performed with Platinum PCR Supermix (Life Technologies). 
 
The following strains were generated by cross: 
 
BY890 eat-4(ky5); swip-10(vt29) 
PCR genotyping of eat-4(ky5) was performed using the following primers: 
5’ sense – gtgactgaaaagaaggggcgttt 
3’ antisense – TCTCCATGACACTAAGCTCATCTATTGTC 
inner antisense – GCACCAGTTGCAGATGCAGC 
BY891 eat-4(ky5); swip-10(vt33) 
BY1103 glr-1(n2461); swip-10(vt29) 
n2461 was determined by Sanger sequencing of PCR amplicons generated by: 
sense - ggagttttcagGAGCAAATCTCAACAG 
antisense- CCGAGTGCAGCCAACATTGAAAT 
BY1102 glr-2(ok2342); swip-10(vt29) 
PCR genotyping of glr-2(ok2342) was performed using the following primers: 
5’ sense – gcgaaATGAATAAGAACCTACTAGTATTCGGA 
3’ antisense – CTTCGTCTGATGGTGCctgagatt 
inner antisense – tccacacaaaagtgaatcatatgcctatttg 
BY919 glr-4(tm3239); swip-10(vt29) 
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PCR genotyping of glr-4(tm3239) was performed using the following primers: 
5’ sense - TACCGATGTATGAACGGATgtaagtcac 
3’ antisense – GCTTTTTCAGAAGGCGGAGGG 
inner antisense – CTCGTCGATCTCTCCACCATTTATTTTTTAGT 
BY926 glr-5(tm3506); swip-10(vt29) 
PCR genotyping of glr-5(tm3506) was performed using the following primers: 
5’ sense – GAACTTCTCATGCTGCACAGCAC 
3’ antisense – GAATTGCATTGTCGATCCTCCGC 
inner antisense – ACCAGGTAAAATACCCACCACGTAC 
BY1032 swip-10(tm5915) glr-6(tm2729) 
Recombinant clones were screened via PCR using the following primers: 
5’ sense- GAAGAGCTTGGAAATCAAACTGAGTACAAC 
3’ antisense – CCAAGAGCGAGGAGAAGAAACAAAC 
inner antisense – CCATTGGATCCAAGAACAACGTTGC 
BY1031 swip-10(tm5915) mgl-1(tm1811) 
Recombinant clones were screened via PCR using the following primers: 
5’ sense – GCAGCAGTAGTAGGTGGTAGTTATAGTTCTGTGTCTG 
3’ antisense – gcggttgttccaaatccagatccagaaaattacatt 
inner antisense – gctgaatgactggagtttctgaactgatgacgc 
BY942 mgl-2(tm355); swip-10(vt29) 
PCR genotyping of mgl-2(tm355) was performed using the following primers: 
5’ sense – CTGATGGATGGGCTGATAGAAATGATGTT 
3’ antisense - CTTCTTTTGAAACCGCGAACTGGC 
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inner antisense – cctaccgtttgattcatgaactttcagg 
BY943 mgl-3(tm1766); swip-10(vt29) 
PCR genotyping of mgl-3(tm1766) was performed using the following primers: 
5’ sense – ggtcttgtagctctaacttcggaggg 
3’ antisense – CCAATTCGGTATGTCCTTCAGCTACA 
inner antisense – TGCAGGTTGTCTGGTGGAACAAC 
BY914 nmr-1(ak4); swip-10(vt29) 
PCR genotyping of nmr-1(ak4) was performed using the following primers: 
5’ sense – GTGATCGAGATAGTGTAGATGCTGAATGG 
3’ antisense – CCTATTCCATAGGCACTTCTTCCAAACA 
inner antisense – ggggttgaagatgcagtaaaaatttttgg 
BY923 nmr-2(tm3285); swip-10(vt29) 
PCR genotyping of nmr-2(tm3285) was performed using the following primers: 
5’ sense – GGTGATCCATATTGGGACAATGGGA 
3’ antisense – CCCAATCACAGATGGATCCctgaa 
inner antisense – CAGAGTGACCACTTTCACGTGAAAC 
BY1052 swip-10(tm5915) glr-6(tm2729) mgl-1(tm1811)  -  
swip-10(tm5915) glr-6(tm2729) was recombined with mgl-1(tm1811) 
BY1053 glr-4(tm3239); swip-10(tm5915) mgl-1(tm1811)  
BY1054 glr-4(tm3239); swip-10(tm5915) glr-6(tm2729) 
BY1097 glr-4(tm3239); swip-10(tm5915) glr-6(tm2729) mgl-1(tm1811) 
BY1068 glr-4(tm3239); glr-6(tm2729) mgl-1(tm1811) –  
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swip-10(tm5915) was recombined with wild type swip-10(+) on LGX using 
BY1097 
BY1101 dat-1(ok157); glr-4(tm3239)  
PCR genotyping of dat-1(ok157) was performed using the following primers: 
5’ sense - gcaatcacaacttggggaag 
3’ antisense –aaagtggaagacacctatgttcatagc 
inner antisense -  ggttttccagatttgcagga 
BY1088 dat-1(ok157); glr-6(tm2729) 
BY1089 dat-1(ok157); mgl-1(tm1811) 
BY920 cat-2(tm2261); glt-1(ok206)  
PCR genotyping of glt-1(ok206)  was performed using the following primers: 
5’ sense - agttcatttttcagATGGTATCCTGGATAAGG 
3’ antisense - gaaaacaaaacCGATTGAGTGAGATCTGG 
inner antisense – GAGAGAACTCATGATAAGTGGGAGAATCAT 
BY931 cat-2(tm2261); glt-3(bz34)  
PCR genotyping of glt-3(bz34)  was performed using the following primers: 
5’ sense – AATCAAGCCGTCTCGTGTTCGC 
3’ antisense – tgagagcattacCTGCATTGCATTC 
inner antisense – gcgcctgatatttcgcagtttcc 
BY927 cat-2(tm2261); glt-4(bz69) 
PCR genotyping of glt-4(bz69) was performed using the following primers: 
5’ sense – CCGATCGCAGAAAATCTGCCTGAAG 
3’ antisense – ctgcaaaaaaagtttgtttcaaaggaaatagc 
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inner antisense – CCCATCAAACGATGCAACTCTTGTCC 
BY1033 swip-10(tm5915) glt-1(ok206)  
BY1057 glt-3(bz34); swip-10(vt29) 
BY1058 glt-3(bz34); swip-10(tm5915) 
BY1046 swip-10(tm5915) glt-4(bz69) 
BY1098 dat-1(ok157); glt-1(ok206) 
BY1099 dat-1(ok157); glt-4(bz69) 
BY1100 dat-1(ok157); swip-10(tm5915) 
BY1056 swip-10(tm5915) lite-1(Xu7)  
Recombinant clones were genotyped for lite-1(Xu7) by response to brief UV 
illumination and the point mutation was confirmed by sequencing of PCR 
amplicons generated by the following primers: 
sense – gcagTCTCAAATGACATTCTTCACCTTCC 
antisense – TGGAGACTCTGGTTGTTCTTGATATCAA 
BY1059 XuIs14(pdat-1:GCaMP, pdat-1:dsRed2); lite-1(Xu7)  
BY1060 XuIs14; swip-10(tm5915) lite-1(Xu7) 
BY1061 XuIs14; dat-1(ok157); lite-1(Xu7) 
 
swip-10 promoter: GFP manipulations  
All PCR reactions performed for subcloning or germline transformations were 
performed using KAPA HIFI Hotstart Taq Polymerase. Additionally, PCR 
products and plasmids injected for germline transformation were purified via a 
Uprep column (Genesee Scientific) before generation of an injection mix. 
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Injection mixes were spun at max speed (13000 rpm) in a microcentrifuge prior 
to microinjection. All injection mixes were buffered to at least 100 ng/μl final 
concentration with pBSKII(-)(if necessary).   
 
Promoter Fusions 
Determination of swip-10 cis elements were performed using overlap PCR 
fusion. Three different fragments were assayed for their ability to drive the 
expression of a flourophore. 
Minimal 5’ promoter: 
A fragment spanning -738 to the ATG start site was fused to CFP and injected at 
50 ng/μl onto a lin-15(n765ts) background with a lin-15(+) rescue plasmid 
(pJM23) to generate vtEx83, vtEx84, and vtEx85.  
5th Intron (Internal Promoter): 
A fragment spanning 1013 to 2504 downstream of the ATG start site was fused 
to GFP and injected at 50 ng/μl onto a lin-15(n765ts) background with pJM23 to 
generate vtEx191 and vtEx192. This fragment was also coinjected with pdat-
1:mCherry and pJM23 onto a lin-15(n765ts) background to generate vtEx182-
184.  
Full length Promoter (containing all putative cis elements): 
A fragment spanning -738 upstream to 2504 downstream of the ATG start site 
was fused to CFP and injected at 50 ng/μl onto a lin-15(n765ts) background 
with pdat-1:mCherry(20 ng/μl) to generate vtEx94, vtEx95, vtEx96, and vtEx97 
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swip-10 rescue experiments 
 
A full length 4.3 Kb genomic fragment from -738 to 3569 downstream of the 
ATG start site was amplified and injected at 20 ng/μl onto swip-10(vt29) and 
swip-10(vt33) with punc-122:GFP to generate vtEx74-75 and vtEx76-78 
respectively. To pursue functional studies related to the cell autonomous 
function of swip-10, we chose to use the swip-10 cDNA exclusively owing to the 
presence of a large internal promoter. Total RNA was harvested from 
asynchronous N2 animals and first strand cDNA was generated using 
Superscript III First-Strand Synthesis System (Life Technologies). We amplified a 
1.6 kB PCR product using the following primers: 
ATGCTTTTTCATTTTCTAATCGCTA(S) and TTAACATTTCAAAGCTTTCTT(A). 
This fragment was TA cloned into PCR8/GW/TOPO for further manipulations.   
Rescue constructs that allow for cell autonomous expression of swip-10 
were generated in one of four backbones pRB1106-pRB1109, which contain 
unique restriction sites to allow for subcloning of either promoters, open reading 
frames, or 3’ UTRs. In all cases an unc-54 UTR was used at the end of tagged 
swip-10 cDNA. 
 We fused GFP to the C-Terminus of the swip-10 cDNA and subcloned 
this PCR fragment into pRB1106(dat-1 promoter) using AscI and KpnI as 5’ and 
3’ restriction sites to generate pRB1157. In all cases, insertion of the fragment 
and fidelity of the cassette was confirmed by sequencing. To express swip-10 in 
glia, we amplified a 315 bp fragment of the ptr-10 promoter from OS1917 worm 
lysate and subcloned it into pRB1157 using SphI and AscI as 5’ and 3’ sites to 
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generate pRB1158. To express swip-10 in CEPsh glia, we amplified a 2.6 Kb 
product from phlh-17:GFP (kind gift of Shai Shaham) and subcloned it into 
pRB1106 using FseI and AscI as 5’ and 3’ sites to generate pRB1159. A 1.5 Kb 
fragment of the swip-10 internal promoter was subcloned into pRB1106 using 
FseI and AscI as 5’ and 3’ sites to generate pRB1160. For expression of swip-10 
in the OL/ILso, we amplified a 2.1 Kb fragment of the itx-1 promoter and 
subcloned it into pRB1106 using FseI and AscI as 5’ and 3’ sites. For expression 
of a lactamase dead version of swip-10, His residues at amino acid positions 
351,353, 356, 405, and 470 were mutated to Serine via site-directed 
mutagenesis (Quickchange II XL – Agilent Technologies) in the pRB1158 
backbone to generate pRB1162. These constructs were used to generate the 
following strains: 
 
BY1004-1006(vtEx159-161) – pRB1157 was injected at 80 ng/μl onto swip-
10(vt29) with pelt-2:GFP(10 ng/μl), pdat-1:mCherry(10 ng/μl), and punc-122:RFP(40 
ng/μl). 
BY1076-BY1078 – pRB1158 was injected at 80 ng/μl onto swip-10(vt29) 
with punc-122:RFP(50 ng/μl) to generate vtEx200-vtEx202. 
BY1079-BY1081 – pRB1158 was injected at 80 ng/μl onto swip-10(tm5915) with 
punc-122:RFP(40 ng/μl) to generate vtEx203-vtEx205. 
BY1090-BY1092 – pRB1158 was injected at 80 ng/μl onto swip-10(vt33) with 
punc-122:RFP(40 ng/μl) to generate vtEx206-vtEx208. 
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BY1093-BY1095 – pRB1162 was injected at 80 ng/μl onto swip-10(vt29) with 
punc-122:RFP(50 ng/μl) to generate vtEx209-vtEx211. 
BY1104-BY1106 – pRB1159 was injected at 80 ng/μl onto swip-10(vt29) with 
punc-122:RFP(50 ng/μl) to generate vtEx212-214. 
BY1107-BY1109 – pRB1160 was injected at 80 ng/μl onto swip-10(vt29) with 
punc-122:RFP(50 ng/μl) to generate vtEx215-217. 
 
C. elegans Assay for Swip 
 
In both batch and single worm analyses, we generated synchronous populations 
of these strains by hypochlorite treatment and harvesting arrested L1 animals.  
Early-mid stage L4 animals were identified by characteristic morphology and 
used for behavior as N2 animals show some stochastic Swip and quiescence 
bouts during the last larval molt. For automated analysis, single L4 
hermaphrodites were placed in 20µL water or drug in a single well of a Pyrex 
Spot Plate (Fisher catalog number 13-748B), and 10 minute movies 
(uncompressed AVI format) of their swimming behavior were created and 
analyzed as described previously (Hardaway and Wang et al., under review). For 
testing behavioral responses to elevated osmolarity, 100 mM sucrose was 
dissolved in water immediately prior to testing. 
 
C. elegans assay for Basal Slowing Response 
Assays were performed as described in Chase et al with some modifications 
(Chase, et al., 2004). We prepared food free 35 mm NGM plates and used them 
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for 2-3 days of testing. For the food condition, we spread a thin layer of HB101 in 
a “donut” fashion around the edge of 35 mm plates with the bottom of a glass test 
tube. Bacteria were serially diluted, spread at several different dilutions, and 
incubated o/n at 37 degrees. The next day, food-containing plates were selected 
for BSR assay based on the density of bacterial growth, which was complete (not 
spotty), but also textured and not overgrown. Overgrown bacterial lawns were 
capable of producing non-DA dependent slowing by virtue of imposing a thicker 
matrix for worm locomotion. We picked mid-stage L4 animals and placed them at 
15 degrees o/n to generate young adult hermaphrodites. On the day of testing, 
strains were blinded and experiments picked single young adults, rinsed them 
briefly in M9 (3-4 sec) to remove food, and placed them on either a food-free 
plate or directly adjacent to a bacterial source on a food-containing plate. After 30 
seconds, we counted the number of body bends in a 20 second interval. On each 
day, 5 animals were scored in both conditions for each genotype. Data shown 
represents the cumulative average body bends over at least 3 days of 
experiments for two experimenters. 
 
In vivo Ca2+ Imaging 
Calcium imaging of freely-moving worms was performed on the CARIBN 
(Calcium Ratiometric Imaging of Behaving Nematodes) system as described 
previously (Piggott, Liu, Feng, Wescott, & Xu, 2011). The CARIBN system allows 
for the imaging of freely-behaving worms on the surface of an NGM plate in an 
open environment without any physical constraint. Briefly, 4 spots of freshly-
 116 
grown food (OP50 bacteria) were spotted on the surface of an NGM plate, with 
each one containing 2 μl of OP50 culture spaced 0.5~0.7 mm apart. 
Single young adult animals were picked into a food-free area of the plate. 
Images were acquired at 22Hz with 15 ms of exposure time per frame for 4 min. 
As it has been predicted that the mechanical stimulation of DA neuron dendrites 
produces an increase in DA neuron excitability, we recorded calcium transients 
from CEP soma during this behavior. G-CaMP/DsRed ratio was calculated as 
previously described (Piggott, et al., 2011). 
 
Reversal Analysis and Speed Analysis 
Assays were performed similar to (Zheng, Brockie, Mellem, Madsen, & Maricq, 
1999). Briefly, L4 worms were picked to a fresh plate and incubated at 12-15 
degrees o/n until worms reached the young adult stage. We avoided animals 
that were actively laying eggs in these analyses, preferring the 3-4 hours prior to 
active egg-laying bouts similar to the BSR assays. Food-free NGM plates were 
prepared fresh and used within a week. Plates containing precipitate were not 
used. We did not corral the animals using copper or fructose as these reagents 
can generate reversals that would be captured by the recording. Immediately 
prior to recording, plates containing young adults were placed at room 
temperature and allowed to acclimate to the ambient environment. For 
recordings, individual young adults were picked using an eyelash pick, rinsed 
briefly in a well containing 200 μl of M9 (not water) to remove food from the 
animal, and then placed on the food free NGM plate. Using this rinse method, 
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each worm only swims for <5 seconds. Assays using rinse of an entire plate or 
plate area yielded more inconsistent results. We picked as many animals in this 
way for 2 minutes (normally 10 worms) and then began a recording that lasted 
for seven minutes. For the recordings, the plate was illuminated with an LED 
illuminator passed through a housing unit containing a mirror and a polarizing 
filter beneath a base plate. The illuminator was placed on a camera stand 
beneath video recording components consisting of an AVT Stingray F-504B 
CCD Monochrome Camera and adjustable Nikon Zoom lens with C-mount 
adapter (MBF Biosciences-Williston, VT). Videos were recorded using the 
WormLab Image Capture module (MBF Biosciences-Williston, VT) using the 
native resolution 2456 X 2058 at 7.5 frames per second (fps). On average the 
field size for recording was 1.6 cm X 1.2 cm and the resolution <10 μM/pixel. We 
analyzed these videos using WormLab’s tracking and analytical plugins – most 
notably speed and reversal. Proper head/tail and track assignment was 
validated by hand using available features in Wormlab. 
 
Confocal Microscopy  
Confocal microscopy of transgenic worm promoter fusions were performed 
using either a Zeiss LSM 510 or 710 confocal microscope and LSM or Zen 
capture software. Worms were immobilized using 20 mM Levamisole with 0.1% 
Tricaine in M9 on a fresh 2% agarose pad and sealed with 1 mM cover glass 
and wax. 
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Amino acid level measurements in swip-10  
Worm pellets were homogenized, using a tissue dismembrator, in 100-750 ul of 
0.1M TCA, which contains 10-2 M sodium acetate, 10-4 M EDTA, 5ng/ml 
isoproterenol (as internal standard) and 10.5 % methanol (pH 3.8).  Samples 
were spun in a microcentrifuge at 10000 g for 20 minutes.  The supernatant is 
removed and stored at –80 degrees.  The pellet is saved for protein analysis.  
The supernatant is then thawed and spun for 20 minutes.  Amino Acids are 
determined by the Waters AccQ-Tag system utilizing a Waters 474 Scanning 
Fluorescence Detector.  Ten µl samples of the supernatant are diluted with 70 µl 
of borate buffer to which 20 µl aliquots of 6-Aminoquinol-N-Hydroxysuccinimidyl 
Carbamate and 10 ul 250 pmol/ul alpha-aminobutyric acid (as internal standard) 
are added to form the fluorescent derivatives. After heating the mixture for 10 
minute at 37°, ten µl of derivatized samples are injected into the HPLC system, 
consisting of a Waters 2707 Autosampler, two 510 HPLC pumps, column heater 
(37 degrees C) and the Fluorescence detector.  Separation of the amino acids is 
accomplished by means of a Waters amino acid column and supplied buffers (A 
– 19% sodium acetate, 7% phosphoric acid, 2% triethylamine, 72% water; B – 
60% acetonitrile) using a specific gradient profile. HPLC control and data 
acquisition will be managed by Empower 2 software.  Using this HPLC solvent 
system, the following amino acids elute in the following order: cysteic, 
homocystetic, aspartic, serine, glutamate, glycine, taurine arginine, threonine, 
alanine, proline, GABA, cystine, tyrosine, valine, methionine, lysine, isoleucine, 
leucine, and phenlyalanine. 
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RESULTS 
Analysis of the swip-10 expression pattern 
To determine the relevant site of swip-10 function, we first determined the swip-
10 endogenous expression pattern. Analysis of conserved nucleotides (UCSC 
genome browser) indicated that there existed putative cis elements in the region 
just 5’ of the start site and within the large 5th intron (Figure 26A). We therefore 
generated a series of transgenic strains expressing PCR fusion fragments 
spanning three different regions (A, B + C) of the swip-10 gene fused to a 
flourophore and imaged them during the L4 stage (Hobert, 2002) using confocal 
microscopy. swip-10A, consisting of a 738 bp fragment immediately 5’ of the 
predicted swip-10 translational start site, was sufficient to drive the expression 
of GFP in the hypodermal cells in the head and tail, uterine muscle, and an 
unidentified single cell in the nerve ring (Figure 26B). swip-10B, a 1.4 Kb region 
within the swip-10 large intron, was sufficient to drive expression in multiple cell 
types, most notably glial cells in the head and tail (arrowheads in Figure 26C), 
the hypodermis, the RIA neuron pair (star) and other unidentified head cells. 
swip- 10C, a 3.2 Kb fragment that spans from the A fragment to the end of the B 
fragment, was sufficient to drive expression of GFP in many of the 
aforementioned sites, including a robust expression in glial cells and motor 
neurons along the ventral nerve cord (not shown). However, we also observed 
weak, but detectable, expression of the swip-10 transgene in DA neurons 
including the CEPs and PDEs (Figure 26D).  While it’s possible that some of the 
DA 
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Figure 26 – Analysis of the 
swip-10 expression pattern. 
swip-10 expression is 
controlled by cis elements in 
multiple regions of the swip-10 
gene. A. Diagram of the swip-
10 gene and annotation of 
regions used for generation of 
promoter fusion analysis. B. 
swip-10 promoter A is 
sufficient to drive expression of 
GFP in hypodermal cells in the 
head and tail and uterine 
muscle. C. swip-10 promoter B 
is sufficient to drive expression 
of GFP in many cells in the 
head including glial cells( 
arrowheads) and the RIA 
neuron pair(star), but not in DA 
neurons(marked with mCherry). 
Cross of this swip-10 fusion 
onto a strain expressing a 
stable known marker of glial 
cells(pptr-10:mRFP) confirmed 
that these are indeed glial cells. 
D. Full length swip-10:GFP 
fusion is sufficient to drive 
expression of GFP in many of 
the same cell types seen with 
swip-10B, but also included 
weak expression in DA neurons(CEP and PDE) that we confirmed by coexpression of mCherry in DA neurons.   
vt29(Trp ->stop)
vt33(Gly-> Glu)
1 Kb F53B1.6
A
Ex83-85
B
Ex182-184,191
C
Ex94-96
A B
C D
swip-10/DA neurons
swip-10/glia
swip-10/glia
swip-10/DA neurons
swip-10/DA neurons
ex84
ex184
ex191
ex191
ex94
ex94
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neuron expression may be an artifact of bleedthrough during confocal imaging, 
we believe that our choice of flourophores with very different excitation 
wavelengths precludes such a possibility. To confirm the expression we 
observed in glia, we crossed the swip-10B promoter fusion line to another 
transgenic line expressing an integrated copy of a pan glial fluorescent
transgene (ptr-10:mRFP) (Yoshimura, Murray, Lu, Waterston, & Shaham, 2008). 
Imaging of both flourophores confirmed that swip-10 expression colocalized 
with many ptr-10-expressing glial cells (middle panel in Figure 26C), though 
there are additional swip-10 +/ptr-10 – cells. Additionally, during the generation 
of these transgenic strains, we observed that the expression pattern of swip-10 
was regulated throughout development. We observed a strong swip-10 
expression in worm embryos and during early larval stages (Figure 27). Thus, we 
found that swip-10 is highly expressed in a number of C. elegans tissues, 
including glia and DA neurons, and that this expression is coupled to the 
developmental stage of the animal.
 
Dissection of swip-10 cell autonomy 
With a swip-10 cDNA in hand, we expressed a swip-10 cDNA translationally 
fused to GFP (swip-10(c):GFP) under the control of cell specific promoters 
based on the endogenous expression pattern we observed using GFP promoter 
fusions. As predicted from the promoter fusion experiments,
expression of a swip-10 genomic fragment translationally fused to GFP led to 
expression in multiple cell types inconsistent with the cell specific promoter 
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Pre-hatch L1 L1
 L2 L3
A B
C D
*
Figure 27 – Level of swip-10 expression is regulated throughout development. 
vtex191 progeny were picked at various larval stages and assayed for their swip-10 
expression pattern. A) swip-10 is highly expressed in the developing embryo and the 
pre-hatch larval stage. Transgenic larva is indicated by the asterisk. B) L1 swip-10 
expression pattern. GFP is expressed faintly in the hypodermis and is not yet present in 
neuronal processes as previously shown C) Hypodermal swip-10 expression persists in 
the L2 staged and cell bodies of head cells are more visible D) swip-10 expression in L3 
stage head. Hypodermal expression is lost and expression is restricted to cell bodies 
around the pharynx and nerve ring. Scale bar equal 20 μM in each of the images. 
Whereas the pre-hatch L1 represents a single confocal slice, panels B, C,+ D represent 
compressed z-stacks of the entire worm body or head.
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used (i.e – expression in non-DAergic cells using the dat-1 promoter). Having 
observed a dramatic expression in C. elegans glia, we used the ptr-10 promoter 
to promote expression of swip-10(c):GFP and injected this
transgene onto each of the swip-10 mutant backgrounds. As seen in Figure 22, 
expression of swip-10 in glia via ptr-10 significantly rescued Swip in every allele 
of swip-10. Alternatively, we expressed swip-10(c):GFP specifically in DA 
neurons in swip-10(vt29) and did not observe
rescue. One glial subclass, the CEPsh glia, is known to provide support for CEP 
DA neurons and they express a specific helix-loop-helix transcription factor 
known as hlh-17 (Yoshimura, et al., 2008). Additionally, A recent report 
displayed that strains defective in hlh-17 have altered dopaminergic 
phenotypes, including the basal slowing response (Felton & Johnson, 2011). We 
expressed swip-10(c):GFP under an hlh-17 promoter in the swip-10(vt29) strain, 
but did not observe rescue of Swip. Likewise, we tested hlh-17 and hlh-17, hlh-
31, hlh-32 mutants for Swip to see if they demonstrated Swip (Yoshimura, et al., 
2008), but observed that these mutants did not exhibit a significant Swip 
phenotype (Figure 28). Since we observed that the large 5th intron of swip-10 
was sufficient to drive GFP expression in glia, we used this promoter fragment 
to drive expression of the swip-10(c):GFP cassette. Surprisingly, this construct 
failed to rescue swip-10(vt29).  
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Figure 28 – Basal Swip of hlh-17 and hlh-17, hlh-31, hlh-32 mutants. Strains were 
tested by two experimenters over the course of three weeks. Each column represents 
the average of 48 trials tested over this period. Data were analyzed by one-way ANOVA 
with multiple Bonferroni post tests. No significant differences were observed between 
N2 and hlh-17 or N2 and hlh-17, hlh-31, hlh-32.  
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swip-10 and its predicted metal binding residues 
As we observed nearly complete rescue of the swip-10 mutant strain with 
expression of the swip-10 cDNA in glia, we sought to determine the requirement 
of amino acids within the metallo β-lactamase domain that are
conserved throughout phylogeny.  As the vt29 and vt33 mutations were both 
located proximal to these residues in the metallo β-lactamase domain, we 
hypothesized that these histidines are critical to swip-10 function. We 
mutagenized five conserved histidines to serines in our glial expression 
construct and assayed its ability to rescue the swip-10(vt29). We did observe a 
partial rescue of the vt29 mutant, but the magnitude of this rescue was reduced 
relative to the histidine-containing wildtype gene (Figure 22). These data are 
consistent with the hypothesis that histidine-mediated metal binding is required 
for the activity of the swip-10 gene.  
 
swip-10 and DA neuron excitability 
 
In our previous study we demonstrated that swip-10 does not alter the function 
of dat-1 as measured by uptake of the exogenous neurotoxic agent 6-OHDA 
and the subsequent death of the DA neurons (Hardaway, et al., 2012). With dat-
1 activity intact, we reasoned that swip-10 likely functions in a pathway parallel
of dat-1. We hypothesized that this pathway ultimately controls the amount of 
vesicular DA release. As we had also observed that vt29
mutants display a decreased latency to paralyze and that swip-10 functions in 
glia to regulate Swip, we hypothesized that loss of swip-10 in glia results in an 
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increase in DA neuron excitability and an elevated rate of DA release that 
overwhelms endogenous dat-1 activity present at DA neuron terminals (see 
Figure 53 in Discussion). To test our hypothesis, we performed in vivo Ca2+ 
imaging of CEP neurons expressing the calcium sensitive flourophore GCaMP 
and a calcium-independent flourophore dsRed2 during the BSR using the 
CARIBN (Calcium Ratiometric Imaging of Behaving Nematodes) system (Li, 
Feng, Sternberg, & Xu, 2006; Piggott, et al., 2011; Sawin, et al., 2000). As 
hypothesized by Sawin et al., we observed that the excitability of DA neurons in 
wildtype animals is elevated upon entering a lawn of bacteria. Consistent with 
our hypothesis, we observed that swip-10(tm5915) animals displayed an 
elevated Ca2+ response to food, whereas the response of dat-1 animals was 
similar to wildtype animals (Figure 29).  
 
Characterization of Swip and basal slowing response in glutamate 
signaling gene mutants 
 
Having demonstrated that loss of swip-10 triggers an increase in DA neuron 
excitability and that swip-10 functions in glia regulate Swip, we hypothesized
that alterations in GLU signaling may underlie the increase in DA neuron 
excitability in swip-10 mutants. To begin, we screened a number of strains 
harboring mutations in GLU signaling components including vesicular glutamate 
transporters (vGLUTs), plasma membrane transporters (GLTs), and glutamate 
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Figure 29 – swip-10 mutation results in elevated DA neuron excitability during in 
vivo DA-dependent behavior. A. Schematic of BSR assay and CARIBN recording 
setup. See methods for details. Briefly, animals that were either wildtype , dat-1, or 
swip-10(tm5915) and containing an integrated GCaMP and dsRed2 transgene 
specifically in DA neurons and a mutation in the lite-1 gene were placed on a plate and 
the fluorescence of CEP soma were recording during free movement on the plate. B. 
Average GCaMP/dsRed2 traces for wildtype, dat-1(ok157), and swip-10(tm5915) 
animals(not vt29) during the response to a small lawn of food. C. Magnitude of 
fluorescence at 140 seconds after entering the lawn of food. Data were analyzed using 
a student’s t test. swip-10(tm5915)  animals have a significant elevation in the 
magnitude of their response, while dat-1 animals do not. D. Average speed(μM/sec) of 
wildtype, dat-1(ok157), and swip-10(tm5915)  animals during their response to the lawn 
of food. All three genotypes display a significant slowing in response to the lawn of 
food.   
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receptors (GLURs) using the Swip phenotype. Overall, we determined that the 
loss of glutamate signaling genes does not dramatically impact nematode 
swimming behavior relative to dat-1 or mutations in other genes that we isolated 
in our mutagenesis screen (Hardaway, et al., 2012; P. W McDonald, et al., 2007).  
Amongst the glutamate receptors (GluRs) that we assayed, we observed 
that although loss of glr-2(only tm669 allele), glr-4, and glr-5 signaling does 
result in a significant reduction in swimming behavior relative to N2, these 
mutations do not trigger dramatic Swip phenotypes (Figure 30). Similiarly, 
whereas mgl-2 mutants do demonstrate some significant Swip, the penetrance 
of Swip is very low amongst the population of worms we assayed (Figure 31). 
When we assayed strains harboring mutations in specific GLTs (Mano, 
Straud, & Driscoll, 2007), we found that mutations in glt-1, glt-3, and glt-4 
resulted in a highly significant Swip phenotype relative to N2 (Figure 32). 
Furthermore, when we assayed double mutant strains harboring mutations in 
both glt-1 and glt-3, we observed a more penetrant Swip phenotype. These 
observations are consistent with the hypothesis that specific GLTs function in 
parallel pathways to regulate Swip penetrance. In an attempt to determine if loss 
of all three mutations could trigger Swip with penetrance comparable to dat-1 
and swip-10, we attempted to build the triple mutant strain. Unfortunately, 
recombinant progeny containing homozygous mutations for both glt-1 and glt-4 
were sterile, precluding the possibility of assaying this strain. To determine if the 
Swip that we observed with loss of glt-1,glt-3, and glt-4 was DA-dependent, we  
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Figure 30 – Basal Swip behavior of ionotropic glutamate receptor mutants. glr-2, glr-4, and glr-5 all show a significant 
reduction relative to N2, but not a robust Swip phenotype. Strains were tested by two experimenters over the course of three 
weeks. Each column represents the average of at least 48 trials tested over this period. Data were analyzed by one-way ANOVA 
with multiple Bonferroni post tests. *** indicate p<0.001.   
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Figure 31 – Basal Swip of metabotropic glutamate receptor mutants. mgl-2(tm355) displayed a significant reduction relative to 
N2, but not a robust Swip phenotype overall. Strains were tested by two experimenters over the course of three weeks. Each 
column represents the average of at least 48 trials tested over this period. Data were analyzed by one-way ANOVA with multiple 
Bonferroni post tests. *** indicate p<0.001.  
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Figure 32 – Basal Swip behavior of glutamate transporter mutants. Loss of glt-1, glt-3, glt-4, and glt-6 trigger a significant 
reduction in swimming behavior. Loss of glt-3 and glt-1 together can significantly enhance the amount of Swip. Strains were tested 
by two experimenters over the course of three weeks. Each column represents the average of at least 48 trials tested over this 
period. Data were analyzed by one-way ANOVA with multiple Bonferroni post tests. *** indicate p<0.001. 
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crossed these mutants to cat-2 and assayed double mutant progeny for Swip. 
As seen in Figure 33, the loss of DA biosynthesis via the cat-2 allele, similar to 
dat-1 and swip-10, fully restored swimming behavior in these three lines. To 
further validate the Swip we observed in an unbiased way for glt-1, glt-3, and 
glt-4, we analyzed the kinetics of swimming behavior in these strains using 
SwimR. We observed a robust reduction in average swimming frequency for glt-
1, but the reductions we observed for glt-3 and glt-4 were limited to specific 
times during the recording (Figure 34). These data suggest that Swip penetrant 
animals of these genotypes may have altered swimming kinetics such that in glt-
4 they paralyze and reverse and in glt-3 they paralyze late during the 10 minute 
recording. Thus, loss of glutamate transport through glt-1, glt-3, and glt-4 
triggers a DA-dependent Swip phenotype.  
 To further enhance our understanding of how mutations in glutamate 
signaling pathways might impact DA signaling. We screened these mutants and 
alleles of swip-10 for alterations in the BSR (Allen, et al., 2011; Chase, et al., 
2004; Sawin, et al., 2000). Previously, alterations in BSR had been described as 
an all-or-none effect and as a readout of decreased extrasynaptic DA (Chase, et 
al., 2004; Kindt et al., 2007; Sawin, et al., 2000). Based on the partial penetrance 
and subtle Swip phenotype we observed previously, we hypothesized that 
alterations in DA signaling triggered by loss of glutamate signaling components 
and Swip-causing mutations may have more graded effects on BSR. Therefore, 
we analyzed the BSR phenotype of multiple strains as a percent change from 
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Figure 33 – cat-2  suppression of 
Swip in glutamate transporter 
mutants. Double mutant strains were 
constructed as described in the 
Methods. Strains were tested by two 
experimenters over the course of 
three weeks. Each column represents 
the average of at least 48 trials tested 
over this period. Data were analyzed 
by one-way ANOVA with multiple 
Bonferroni post tests. *** indicate 
p<0.001. 	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Figure 34 - Thrashing 
analysis of glutamate 
transporter mutants glt-1, 
glt-3 and glt-4. A. Loss of 
glt-1 results in a significant 
reduction in average 
swimming frequency with 
points of significance in 
minutes 1-10. B. Loss of 
glt-3 triggers a decrease in 
swimming frequency in the 
final minute of the 
recording. C. Loss of glt-4 
results in a decrease in 
average swimming 
frequency with point of 
significance in the 2nd 
minute. For A, B + C, Single 
worm recordings were 
performed as described in 
the methods. Average 
traces represent at least 30 
individual worm tracks. 
Data were analyzed by two-
way ANOVA with multiple 
Bonferroni post tests at 
each time point. 
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their baseline locomotory on food- free plates.  Consistent with previous reports, 
we observed a significant reduction in the magnitude of BSR with a loss of DA 
signaling (Figure 35). Surprisingly, there was a difference amongst two alleles of 
cat-2 that we tested. While the previously tested cat-2(e1112) allele 
demonstrated virtually no BSR, we found that the unpublished cat-2(tm2261) 
allele exhibited some BSR, albeit at a reduced magnitude relative to N2. This 
BSR persists in spite of the fact that this strain has highly reduced levels of DA 
as measured by HPLC (Hardaway, et al., 2012). Consistent with Chase et al., we 
observed a blunted BSR in the dop-3 mutant strain relative to N2. Interestingly, 
we observed a significantly blunted BSR in the dat-1(ok157)  and swip-
10(vt33)alleles, but not in the swip-10(vt29) alleles. We attribute this difference in 
swip-10(vt29) to a bimodal distribution of responders, where some swip-10(vt29) 
animals demonstrated no apparent BSR and other animals exhibited an 
exaggerated BSR which resulted in a wider standard deviation for this strain. 
Assays of this strain were also confounded by the fact that this strain moved at 
a slower rate on food-free plates relative to N2 (see later results).  
 Assays of BSR in ionotropic GLUR mutants revealed that, as in the Swip 
phenotype, signaling through ionotropic GLURs is largely dispensable for the 
BSR (Figure 36). The exceptions to this were glr-1 and glr-4, that, when lost, 
result in a decrease and increase in the magnitude of the BSR relative to N2 
respectively. Similar to Swip, we observed no alterations in the BSR of 
metabotropic GLU signaling mutants (Figure 37). Assay of BSR in GLT mutants
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Figure 35 – Basal slowing response of swip-10 alleles and dat-1. Assays were performed as described in the methods. Each 
column represents the average locomotory behavior of at least 30 animals tested over the course of three independent test days by 
two experimenters. Data is plotted as the raw counts over a 20 second interval on and off food and as the average percent change 
in body bends/20 sec for each animal tested over this period. Data were analyzed by one way ANOVA with Dunnet’s post tests to 
the N2 strain. Both alleles of cat-2, dop-3(vs106), dat-1(ok157), and swip-10(vt33) demonstrated a significant reduction in the 
amount of slowing relative to N2.
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Figure 36 – Basal slowing response of ionotropic glutamate receptor mutants. Assays were performed as described in the 
methods. Each column represents the average locomotory behavior of at least 30 animals tested over the course of three 
independent test days by two experimenters. Data is plotted as the raw counts over a 20 second interval on and off food and as the 
average percent change in body bends/20 sec for each animal tested over this period. Data were analyzed by one way ANOVA with 
Dunnet’s post tests to the N2 strain. glr-1(n2461) demonstrated a significantly blunted basal slowing response relative to N2 and 
glr-4(tm3239) demonstrated a significantly elevated basal slowing response relative to N2.  
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Figure 37  – Basal slowing response of metabotropic glutamate receptor mutants. Assays were performed as described in the 
methods. Each column represents the average locomotory behavior of at least 30 animals tested over the course of three 
independent test days by two experimenters. Data is plotted as the raw counts over a 20 second interval on and off food and as the 
average percent change in body bends/20 sec for each animal tested over this period. Data were analyzed by one way ANOVA with 
Dunnet’s post tests to the N2 strain. We observed no significant differences for mgl-1(tm1811), mgl-2(tm355) and mgl-3(tm1766) 
relative to N2.
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revealed that loss of glt-1, but not in combination with glt-3, produced a 
significant reduction relative to N2 (Figure 38). Thus alterations in glutamate 
transport, in addition to their impacts on Swip, are capable of producing 
alterations in BSR. We also tested strains possessing a mutation in the primary) 
eat-4/vGlut for defects in BSR. eat-4 mutants displayed a significant BSR 
relative to N2, though there may be alterations in its locomotory rate on food-
free plates (Figure 39). Overall, these results suggested that alterations in GLU 
signaling pathways were capable of producing changes in DA-related behavioral 
phenotypes, but that these effects are graded and that multiple pathways 
function in parallel to mediate these effects. 
 
Analysis of swip-10 Speed using WormLab 
During our analysis of the BSR in the swip-10 lines we noted a decrease in the 
locomotory rate of these strains in plates containing no food. To validate this 
finding, we performed an analysis of their locomotory speed on plates using an 
automated tracking system. Similar to BSR, we calculated the average absolute 
speed value of wildtype, dat-1 and swip-10 mutants. swip-10 demonstrated a 
striking reduction in their average speed, and, similar to Swip, this was 
suppressed by loss of cat-2 (Figure 40). As previously reported, dat-1 animals 
move at a rate similar to wildtype animals on plates. Thus there exist DA-
dependent alterations in locomotion for swip-10 in either water or during 
crawling on plates.  
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Figure 38 - Basal slowing response of glutamate transporter mutants. Assays were performed as described in the methods. 
Each column represents the average locomotory behavior of at least 30 animals tested over the course of three independent test 
days by two experimenters. Data is plotted as the raw counts over a 20 second interval on and off food and as the average percent 
change in body bends/20 sec for each animal tested over this period. Data were analyzed by one way ANOVA with Dunnet’s post 
tests to the N2 strain. We observed a significant reduction in the magnitude of BSR for the glt-1(ok206) strain relative to N2. 
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Figure 39 – Basal slowing response of eat-4(ky5). Assays were performed as described in the methods. Each column represents 
the average locomotory behavior of at least 30 animals tested over the course of three independent test days by two 
experimenters. Data is plotted as the raw counts over a 20 second interval on and off food and as the average percent change in 
body bends/20 sec for each animal tested over this period. Data were analyzed by one-way ANOVA with Dunnet’s post tests to the 
N2 strain. eat-4(ky5) animals demonstrate a normal basal slowing response relative to N2. 
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Figure 40 – Analysis of swip-
10 speed using WormLab. 
Experiments were performed as 
described in the methods and 
the absolute value of worm 
speed calculated during 
movement on a food-free NGM 
plate. Data were analyzed using 
one-way ANOVA with multiple 
Bonferonni post tests. **** 
indicates a p value <0.0001. 
swip-10 is significantly 
suppressed from N2 and this is 
fully restored by loss of cat-2.	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swip-10 interactions with eat-4(vGlut)  
To determine if altered glutamate signaling is required for Swip in the swip-10 
mutants, we crossed the vt29 and vt33 strains to eat-4/vGlut and assayed 
double mutant progeny for their Swip phenotype.  As seen in Figure 41, loss of 
eat-4 alone is dispensible for normal swimming behavior and we observed a 
highly significant, yet incomplete, suppression in the swip-10(vt33) strain but not 
in the swip-10(vt29) strain as measured by manual Swip assays. As previous 
studies indicated that effects of GLU signaling mutations on DAergic 
phenotypes manifest in graded behavioral alterations, we measured the 
swimming behavior of eat-4; swip-10 double mutants using SwimR (Hardaway 
and Wang, under review). Consistent with the manual assays, we did not 
observe a change in the average swimming frequency in the eat-4 strain. 
Analysis of the average swimming frequency of these strains demonstrated that 
loss of eat-4 results in an increased average swimming frequency in both eat-4; 
swip-10(vt29) and eat-4; swip-10(vt33) strains relative to the swip-10(vt29) and 
swip-10(vt33) mutants respectively (Figure 42). These studies establish that 
vesicular GLU signaling through eat-4 contribute to the penetrance and kinetics 
of Swip in both swip-10(vt29) and swip-10(vt33).  
 
swip-10 interactions with egl-3 
Studies using the expression of poly-A binding proteins in specific cell types 
had identified a DA neuron specific transcriptome (Spencer et al., 2011). They 
validated these data by the fact that classical genes necessary for DA
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Figure 41 – eat-4(vGlut) 
significantly suppresses swip-
10(vt33), but not swip-10(vt29) 
as measured by manual Swip 
assays. Double mutant strains 
were constructed as described in 
the Methods. Strains were tested 
by two experimenters over the 
course of three weeks. Each 
column represents the average of 
at least 48 trials tested over this 
period. Data were analyzed by 
one-way ANOVA with multiple 
Bonferroni post tests. **** indicate 
p<0.0001. 
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Figure 42 – eat-4 suppresses swip-10 as measured by kinetic thrashing analysis. Single worm recordings were made as 
described in the methods and videos were analyses as described in the Chapter VII Appendix. Curves represent the average 
thrashing frequency of at least 25 independent animals recorded over the course of several sessions. Data were analyzed by two- 
way ANOVA with multiple Bonferonni post tests at each time point. eat-4; swip-10(vt29) is significantly suppressed from swip-
10(vt29) progeny during minutes 1-3 and eat-4; swip-10(vt33) is significantly suppressed from swip-10(vt33) from minutes 2-10. 
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signaling (cat-1, cat-2, cat-4, bas-1, and dat-1) and ion channels known to be 
enriched in DA neurons (trp-4 and asic-1) were highly enriched relative to a pan-
neuronal data set. In this data set, several neuropeptides were highly enriched. 
As neuropeptides have been shown to modulate the excitability of other neurons 
(Chalasani et al., 2010), we crossed the swip-10(vt29) and swip-10
(tm5915) alleles to a strain harboring a mutation in egl-3 (Kass, Jacob, Kim, & 
Kaplan, 2001), the C. elegans preprotein convertase necessary for the 
production of most neuropeptides. Surprisingly, loss of egl-3 fully suppressed 
the Swip phenotype present in swip-10(vt29) and swip-10(tm5915)(Figure 43). 
Thus, neuropeptide signaling through egl-3 activity is required for Swip in swip-
10 mutants.    
 
swip-10 interactions with glutamate receptors
Having observed that vesicular GLU signaling is required for Swip in swip-10 
mutants and that loss of GLURs does not drastically impair normal swimming 
behavior, we crossed swip-10 into strains harboring mutations in distinct 
GLURs. In most cases we used the swip-10(vt29) allele, but for X-linked genes 
we recombined the glutamate receptor alleles with swip-10(tm5915). Despite its 
requirement for normal BSR, we found that loss of glr-1 did not affect the Swip 
phenotype of swip-10 as measured by hand (Figure 44). Likewise, glr-2, glr-5, 
nmr-1, nmr-2, mgl-2, and mgl-3 were all dispensable and had no effect on the 
amount of Swip we observed in swip-10(vt29). Loss of the ionotropic GLURs glr-
4 and glr-6 and the metabotropic GluR mgl-1  
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Figure 43 – Loss of egl-3 
fully restore the Swip 
phenotype swip-10(vt29) 
and swip-10(vt33). 
Double mutant strains 
were constructed as 
described in the Methods. 
Strains were tested by two 
experimenters over the 
course of three weeks. 
Each column represents 
the average of at least 48 
trials tested over this 
period. Data were 
analyzed by one-way 
ANOVA with multiple 
Bonferroni post tests. **** 
indicate p<0.0001. 	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significantly, yet incompletely suppressed the Swip phenotype in swip-10 
mutants (Figure 44). To confirm what we observed by hand, we used automated 
analysis of their swimming behavior in the single and double mutants and 
compared their average swimming frequency. As seen in Figure 45, we 
observed that the glr-4; swip-10(vt29), swip-10(tm5915) glr-6(tm2729), and swip-
10(tm5915) mgl-1(tm1811) strains all displayed a significantly elevated average 
swimming frequency relative to their single allele swip-10 controls(Figure 45). To 
understand how these GLURs function in parallel to mediate Swip in the swip-
10 mutant, we constructed strains bearing mutations in each of these GLURs in 
combination. As in Figure 44, we observed that loss of two or more of these 
GLURs in combination could enhance the suppression of swip-10, though not 
completely restore it to wildtype levels. Importantly, loss of glr-4, glr-6, and mgl-
1 alone did not alter basal swimming behavior similar to the individual alleles 
(see Figure 30). In these analyses, we observed that loss of glr-6 had the most 
significant effect on swip-10 Swip either alone or paired with mutations in either 
glr-4 or mgl-1. Thus, GLUR signaling through glr-4, glr-6, and mgl-1 is required 
for the Swip in swip-10 mutants and these receptors function in parallel to 
regulate the penetrance of the Swip phenotype. 
We hypothesized that loss swip-10 function in glia may impact the 
magnitude of excitatory signaling through glr-4, glr-6, and mgl-1 and that the 
contribution of these receptors is specific. Additional studies in the lab studying 
the contribution of known ion channels such as trp-4 and asic-1 suggested that 
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Figure 44 – Loss of 
specific GluRs 
significantly suppresses 
swip-10 Swip. Double 
mutant strains were 
constructed as described 
in the Methods. Strains 
were tested by two 
experimenters over the 
course of at least three 
weeks. Each column 
represents the average of 
at least 48 trials tested 
over this period. Data from 
these test days were 
analyzed by one-way ANOVA 
with selected Bonferroni post 
tests. **** indicate p<0.0001.  
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Figure 45 – swip-10 is 
suppressed by loss of glr-4, 
glr-6, and mgl-1. A. Loss of 
glr-4 significantly suppresses 
swip-10(vt29). swip-10  is 
significantly elevated from 
swip-10(vt29) starting in the 1st 
minute. B. Loss of glr-6 
significantly suppresses swip-
10(tm5915) with points of 
significance in minutes 4-10. C. 
Loss of mgl-1 significantly 
suppresses swip-10(tm5915) 
with points of significance in 
minutes 3-10. For A, B, + C, 
single worm recordings were 
performed as described in the 
methods and analyzed with 
SwimR. Data were analyzed by 
two-way ANOVA with multiple 
Bonferroni post tests at each 
time point.   
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these channels are dispensable for swip-10 Swip, but required for dat-1 Swip. 
Therefore, we tested the impact of glr-4, glr-6, and mgl-1 on the Swip 
phenotype in dat-1 mutants. As we hypothesized, loss of glr-4 and glr-6 had no 
impact on the dat-1 Swip phenotype. Surprisingly, however, we observed a near
complete restoration of swimming behavior in dat-1; mgl-1 mutants (Figure 46). 
During the performance of these assays, we noticed that this strain did paralyze, 
but often transited between paralysis, swimming, and crawl-like motion. To gain 
a fuller picture of the impact of mgl-1 on dat-1 Swip, we analyzed the swimming 
behavior of this strain using SwimR. Loss of mgl-1, as in the hand assays, 
almost completely restored the average swimming frequency of the dat-1 
mutant (Figure 47). Inspection of individual worm tracks revealed a population of 
worms that exhibit only sporadic bouts of paralysis. 
 
swip-10 interactions with glutamate transporters 
 
As our behavioral analyses of glt-1, glt-3, and glt-4 demonstrated a DA-
dependent Swip phenotype, we hypothesized that swip-10 may function in glia 
to regulate glutamate transporters. To test this hypothesis, we used a previously 
established epistatic paradigm to assay the swip-10 Swip phenotype in 
combination with glt-1, glt-3, and glt-4 (Hardaway, et al., 2012). As glt-1 and glt-
4 are X-linked, we used the swip-10(tm5915) deletion allele for these studies. 
dat-1 and swip-10 both demonstrate a highly penetrant Swip phenotype that is 
suppressed by graded increases in the swimming media osmolarity such that a 
slight increase in osmolarity(100 mOsm) is sufficient to suppress these alleles
 152 
Figure 46 – glr-6, glr-4, and mgl-1 
interaction with dat-1 Swip. Loss of 
mgl-1 significantly restores the Swip of 
the dat-1 strain. Double mutant strains 
were constructed as described in the 
Methods. Strains were tested by two 
experimenters over the course of three 
weeks. Each column represents the 
average of at least 48 trials tested over 
this period. Data were analyzed by one-
way ANOVA with multiple Bonferroni post 
tests. **** indicate p<0.0001 for the post 
test to dat-1.  	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Figure 47 – Loss of mgl-1 significantly suppresses dat-1. Single worm recordings 
were performed as described in the methods. Data were analyzed by two-way ANOVA 
with multiple Bonferonni post tests at each time point. dat-1; mgl-1 thrashing frequency 
is significantly elevated from dat-1 throughout the 10 minute period. 
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(Hardaway, et al., 2012). As we demonstrated in our previous report using the 
swip-10(vt29) allele, an increase in osmolarity reveals that loss of swip-10 
significantly enhances Swip in the dat-1 strain (Hardaway, et al., 2012). This is 
consistent with our hypothesis that dat-1 and swip-10 function in parallel 
independent pathways to regulate DA signaling. As seen in Figures 48, 49, and 
50, an increase in the osmolarity is sufficient to suppress the Swip phenotype of 
glt-1, glt-3, and glt-4. In keeping with our previous findings of cat-2 suppression 
and osmolarity induced suppression of dat-1 and swip-10, these findings add 
further evidence to our hypothesis that loss of glt-1, glt-3, and glt-4 triggers DA-
dependent Swip. Swip assays of double mutant strains containing either dat-1 
or swip-10 and glt-1 demonstrated that loss of glt-1 significantly enhances swip-
10 Swip at intermediate osmolarity (Figure 49). Surprisingly, loss of glt-1 did not 
enhance the dat-1 allele. Therefore glt-1 may function in a pathway shared with 
dat-1, but not with swip-10. glt-4, on the other hand, significantly enhanced 
Swip in the dat-1 strain at 100 mOsm, but did not enhance swip-10 (Figure 48). 
Assay of glt-3’s interaction with swip-10 revealed that the loss of glt-3 
significantly, albeit partially, suppressed swip-10 at basal or intermediate 
osmolarity (Figure 50). The impact of glt-3 on dat-1 Swip is still unknown at this 
time. Therefore, swip-10 may function in a pathway containing glt-4 and not glt-
1, and that glt-3 is required for the fully penetrant Swip phenotype of swip-10.  
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Figure 48 – dat-1 and 
swip-10 interactions 
with glt-4. A) Swip 
phenotype in water alone 
and in 100 mOsm-
buffered water. Swip in 
each of these strains is 
significantly suppressed 
by elevated osmolarity. 
Data were analyzed by 
two-way ANOVA with 
Sidak’s multiple 
comparison test 
comparing the osmolarity 
effect for each genotype. 
B) Swip behavior at 100 
mOsm. dat-1 Swip is 
significantly enhanced by 
loss of swip-10  and glt-4,  
whereas swip-10 is not 
enhanced by loss of glt-4. 
Data were analyzed by 
one-way ANOVA with 
selected Holm-Sidak’s 
post tests.   For both A 
and B, assays were 
performed and double 
mutant strains 
constructed as described 
in the methods. Strains 
were tested by two 
experimenters over the 
course of three weeks. 
Each column represents 
the average of at least 48 
trials tested over this 
period. Data were 
analyzed by one-way 
ANOVA with multiple 
Bonferroni post tests. * 
and **** indicate p<0.05 
and 0.0001 for the post 
tests. 
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Figure 49 – dat-1 and 
swip-10 interactions 
with glt-1. A) Swip 
phenotype in water 
alone and in 100 
mOsm-buffered water. 
Swip in each of these 
strains is significantly 
suppressed by 
elevated osmolarity. 
Data were analyzed by 
two-way ANOVA with 
Sidak’s multiple 
comparison test 
comparing the 
osmolarity effect for 
each genotype. B) 
Swip behavior at 100 
mOsm. dat-1 Swip is 
significantly enhanced 
by loss of swip-10, but 
not glt-1, whereas 
swip-10 is enhanced by 
loss of glt-1. Data were 
analyzed by one-way 
ANOVA with selected 
Holm-Sidak’s post 
tests.   For both A and 
B, assays were 
performed and double 
mutant strains 
constructed as 
described in the 
methods. Strains were 
tested by two 
experimenters over the 
course of three weeks. 
Each column 
represents the average 
of at least 48 trials 
tested over this period. 
Data were analyzed by 
one-way ANOVA with 
multiple Bonferroni 
post tests. *, **, and **** 
indicate p<0.05, 0.01 
and 0.0001 for the post 
tests. 
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Figure 50 – swip-10 
interactions with glt-3. A) 
Swip phenotype in water alone 
and in 100 mOsm-buffered 
water. Swip in each of these 
strains is significantly 
suppressed by elevated 
osmolarity. Data were 
analyzed by two-way ANOVA 
with Sidak’s multiple 
comparison test comparing 
the osmolarity effect for each 
genotype. B) Swip behavior at 
100 mOsm. dat-1 Swip is 
significantly enhanced by loss 
of swip-10. swip-10 is 
significantly suppressed by 
loss of glt-3. Data were 
analyzed by one-way ANOVA 
with selected Holm-Sidak’s 
post tests.   For both A and B, 
assays were performed and 
double mutant strains 
constructed as described in 
the methods. Strains were 
tested by two experimenters 
over the course of three 
weeks. Each column 
represents the average of at 
least 48 trials tested over this 
period. Data were analyzed by 
one-way ANOVA with multiple 
Bonferroni post tests. * and 
**** indicate p<0.05 and 
0.0001 for the post tests. 
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swip-10 and GLT amino acid level measurements 
Based on our previous data that swip-10 requires GLUR signaling and that it 
may function in a pathway with glt-4, we hypothesized that the Swip phenotype 
may derive from gross alterations in the changes of excitatory or inhibitory 
signaling amino acids. Excitatory signaling at GluRs can occur through the ionic 
form of glutamic acid, GLU, and N-methyl-D-aspartic acid, whose precursor is 
aspartic acid. Additionally, extracellular GLU can also be passively affected 
through changes in extracellular 158ysteine and the export of GLU through the 
158ysteine-glutamate exchanger (xC-). Lastly, the increase in excitability of DA 
neurons in swip-10 might also derive from a loss of inhibitory GABAergic 
signaling. To determine if loss of swip-10 results in gross changes of these 
essential molecules, we performed HPLC on synchronized L4 tissue from 
wildtype, dat-1, swip-10 and glutamate transporter mutants and determined the 
amount of these amino acids present.  We did not observe any significant 
changes in the overall amino acid composition (Figure 51), including aspartic 
acid (Figure 52A), glutamic acid (Figure 52B), GABA (Figure 52C), and cysteine 
(Figure 52D). Thus loss of swip-10 does not result in a gross change in the 
tissue composition of excitatory or inhibitory signaling molecules. 	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Figure 51 – Tissue amino acid composition of N2, dat-1, swip-10, glt-1, glt-3, and glt-4. Amino acid levels were determined by 
HPLC of synchronized L4 worm tissue as described in the methods. Data were analyzed by one-way ANOVA within each amino 
acid with Dunnet’s post tests to N2. Overall, we observed no differences across the different amino acids measured.  	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Figure 52 – Enlarged 
view of the HPLC 
measurement of 
Aspartic Acid, 
Glutamatic Acid, GABA, 
and Cystine for N2, dat-
1, swip-10, glt-1, glt-3 
and glt-4. Amino acid 
level measurements were 
performed as described 
in the methods. Data 
were analyzed by one-
way ANOVA with 
Dunnett’s post tests to 
N2. We did not observed 
any significant changes.	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DISCUSSION 
Decades of research of CNS circuits have revealed that the brain is composed 
of neurons with genetic and developmentally defined patterns of gene 
expression and specific connectivity patterns (Arenkiel & Ehlers, 2009). It is 
embedded within a matrix of glia that perform a variety of complex functions 
including neuronal development, development and regulation of the brain’s 
vasculature, and synaptic transmission (Clarke & Barres, 2013; Haydon, 2001; 
Lemke, 2001; Seifert, Schilling, & Steinhäuser, 2006). Despite their abundance in 
the brain, the role of glia in regulating behavior and ultimately neurological 
disease has long been overlooked. In the previous chapter we established that 
swip-10 encodes a novel metallo β-lactamase regulator of DA signaling and that 
its loss results in a dat-1 like Swip that is rescued by reserpine pretreatment, 
loss of cat-2/TH, and loss of dop-3/D2. In these studies, we describe the 
mechanism for how swip-10 functions to regulate DA signaling.  
To understand how the swip-10 gene impacts the regulation of DA 
signaling, we began with determining its pattern of gene expression. The 
organization of swip-10 required that we screen specific gene fragments for the 
presence of transcriptional cis elements. Using this transgenic approach, we 
observed that the regulation of swip-10 gene expression is regulated by the 
presence of transcriptional elements immediately 5’ of the predicted 
translational start site and within the large 5th intron situated between two 
groups of exons (Hobert, 2002). The 5’ fragment was sufficient to drive GFP 
expression in mostly non-neuronal tissues like the hypodermis and vulval 
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muscle, whereas the intronic fragment was sufficient to express GFP in the 
hypodermis, but also in glia and some neurons. We compared the swip-10 5th 
intron GFP reporter to a known pan-glial marker and confirmed that swip-10 is 
highly expressed in glia surrounding the anterior pharyngeal bulb. Interestingly, a 
fragment containing both 5’ and intronic cis elements was sufficient for weak, 
but detectable GFP expression in DA neurons. We also observed that the 
expression of swip-10 using any of these fragments, especially the intronic 
fragment, is detectable in the early embryo and persists with a more restricted 
expression pattern into adulthood. Considering the developmental profile of 
swip-10, its function in coordinating DA homeostasis may derive from its activity 
during the development of these tissues. Further experiments expressing swip-
10 under inducible promoters within certain cell types may help determine the 
temporal requirement for its function. Through additional experiments of the dat-
1 Swip temporal window, we have determined that the penetrance of Swip is 
highly dependent on the developmental stage of the animal. Though the 
biological mechanism of this regulation is unknown, the penetrance of Swip in 
dat-1 and other mutants may derive from alterations in the connectivity and 
synaptic transmission of upstream neurons and glia. Alternatively, the 
penetrance of Swip in these strains may simply derive from the developmental 
trajectory of DAergic synapses that is not complete until L3-L4 (Sulston, et al., 
1975). 
 To understand the precise site of swip-10 function in regulating DA 
homeostasis, we transgenically overexpressed swip-10 in specific cell types. 
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Our initial efforts using GFP-tagged genomic fragments under the expression 
different cell specific promoters demonstrated expression of GFP in off-target 
cells (data not shown). Consistent with our analysis of swip-10 cis elements, we 
hypothesize that the presence of the swip-10 5th intron precluded cell specific 
expression using a genomic fragment. Therefore we isolated a full length swip-
10 cDNA to use for investigation of swip-10 cell autonomous function.  
   Having isolated the swip-10 cDNA, we transgenically expressed it under 
the control of cell specific promoters on the swip-10 backgrounds and tested 
transgenic progeny for rescue of Swip. Although we observed detectable 
expression of swip-10 in DA neurons, expression of either tagged or untagged 
swip-10 cDNA in these neurons did not rescue Swip. Consistent with the glial 
expression we observed using the swip-10 promoter fusions, expression of the 
swip-10 cDNA under the pan-glial promoter ptr-10 significantly rescued the 
Swip in all alleles of swip-10. Thus, swip-10 functions in glia to regulate DA 
signaling. CEPsh glia envelop and regulate the function and development of 
CEP DA neurons (Oikonomou & Shaham, 2010). Expression of swip-10 in these 
cells (via the hlh-17 promoter), however, did not rescue swip-10 Swip. Likewise 
loss of the mammalian glial transcription factor Olig2 homolog hlh-17, whose 
expression is enriched in CEPsh, had been reported to generate dopaminergic 
phenotypes (Felton & Johnson, 2011). In our own assays of these lines, 
however, we did not observe any significant reductions in swimming behavior in 
hlh-17 or hlh-17 hlh-31 hlh-32 mutants. Importantly, whereas the swip-10 5th 
intron was sufficient to drive the expression of GFP, we could not rescue Swip 
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using this swip-10 internal promoter to drive expression of the swip-10 cDNA. 
Therefore, while the 5th intron of swip-10 contains cis elements that are sufficient 
to drive expression of GFP in glia, they are not sufficient to permit function of 
the swip-10 protein and rescue of Swip in a mutant allele. ptr-10 is expressed in 
multiple glial cell classes: including sheath and socket cells of the inner/outer 
labial sensilla (OL/ILsh, OL/ILso, OLQsh, and OLQso cells), CEPsh glia, and 
sheath and socket cells of the deirid (ADE/PDEsh and ADE/PDEso cells). 
Unfortunately, cell specific promoters for many of these glial cell classes have 
not been described. Based on the robust expression that we observed in the 
promoter fusion experiments, we hypothesize that swip-10 functions in sheath 
or socket cells of the inner and outer labial sensilla. The function of swip-10 in 
the OL/ILso cells may be tested by use of the itx-1 promoter (Haklai-Topper et 
al., 2011), but a cell specific promoter for the sheath cells has not been 
identified. The OL/ILsh and OL/ILso glia make supporting contacts with many 
neurons of the inner and outer labial sensilla, including the OLL neurons. 
Interestingly, the OLL mechanosensory neuron pair makes multiple synapses 
onto CEP neurons (wormatlas.org). Therefore swip-10 may function in the OL	  
sheath or socket cells to buffer the unknown chemical output of the OLL 
neurons onto CEP DA neurons. Mosaic analysis of using the ptr-10 expression 
construct in combination with an SL2-mCherry cassette or by coinjection with a 
ptr-10:RFP plasmid will be necessary to precisely isolate the relevant glial cell 
type for swip-10’s role in regulating DA signaling.  
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 Our previous study using the application of the DAT-dependent 
neurotoxin 6-OHDA had indicated that dat-1 activity was intact in the swip-10 
mutant strain (Hardaway, et al., 2012). We hypothesized that loss of swip-10 
results in an increase in DA neuron excitability that results in elevated DA release 
that overwhelms the activity of endogenous dat-1 that clears DA following 
release. Using in vivo Ca2+ imaging during BSR, we demonstrated that an 
encounter with a lawn of food is sufficient to drive CEP DA neuron excitability 
and that loss of swip-10 results in an increase in excitability during this DA-
dependent behavior. The rescue of this behavior using glial specific swip-10 will 
be important to link the function of swip-10 in glia in regulating Swip with swip-
10’s role in regulating DA neuron excitability.  
 Having described the cell autonomous function of swip-10 in glia and its 
impact on DA neuron excitability, we hypothesized that the increase in DA 
neuron excitability in swip-10 may derive from an increase in GLU signaling. 
Although a previous study had illustrated that DA and GLU function in parallel to 
promote area-restricted search behavior in the worm (Hills, Brockie, & Maricq, 
2004), no study to date has systematically assayed the impact of GLU signaling 
mutations on dopaminergic behaviors. Using Swip and the BSR assays, we 
screened through available mutant alleles in genes necessary for GLU signaling 
including both ionotropic and metabotropic GLURs and vesicular and plasma 
membrane transporters (P J Brockie, Madsen, Zheng, Mellem, & Maricq, 2001; 
P. J. Brockie & Maricq, 2006; Penelope J Brockie & Maricq, 2003; Dillon, 
Hopper, Holden-Dye, & O'Connor, 2006; C. Kang & Avery, 2009; R. Y. Lee, 
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Sawin, Chalfie, Horvitz, & Avery, 1999; Mano, et al., 2007). We did not observe 
major changes in the Swip phenotype of strains containing mutations in GLURs, 
but we did observe a loss of normal BSR with a loss of glr-1 and an elevated 
BSR with a loss of glr-4. Allen et al. observed that the function of glr-1 at 
command interneurons is necessary for modulating cholinergic output of motor 
neurons, thus we hypothesize that this loss of BSR is likely due to its function in 
the interneurons rather than its role in DA neurons (Allen, et al., 2011). glr-4 
expression is enriched in wide variety of neurons in the nerve ring, DB motor 
neurons, and analysis of DA neuron transcriptomes revealed the presence of glr-
4 transcript in these cells. Further work will be necessary to determine how glr-4 
contributes to normal BSR. Our assays of Swip in lines containing mutations in 
the glutamate transporters glt-1, glt-3, and glt-4 revealed that loss of these 
transporters triggers an incomplete, yet highly significant, Swip phenotype. 
Furthermore, assays of strains containing mutations in multiple GLTs revealed 
that these GLTs likely function in parallel pathways to mediate the Swip 
phenotype. Unfortunately, it was impossible to assay a line containing a loss of 
all three GLTs, as glt-1 glt-4 double mutants were not viable. To validate that the 
Swip in these strains was DA-dependent, we crossed these alleles to cat-2 and 
observed that loss of cat-2 fully restored the Swip phenotype of all three GLT 
alleles. Similarly, we observed that the Swip of these three alleles was 
suppressed by an increase in the swimming media osmolarity. Similar to Swip, 
we observed that loss of glt-1 significantly impaired the magnitude of BSR 
relative to N2. Thus altered GLU signaling through loss of specific GLURs and 
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GLTs can evoke changes in DAergic behaviors and that loss of glt-1, glt-3, and 
glt-4 can trigger DA-dependent Swip.  
During our analyses of BSR in glutamate signaling mutants, we also 
tested the BSR of Swip-harboring strains including dat-1 and swip-10 as the 
effect of presynaptic or upstream mutations had not been described elsewhere. 
Surprisingly, loss of dat-1 impaired normal BSR. We observed a loss of BSR in 
the swip-10(vt33) allele, but not in the swip-10(vt29) allele. Analysis of the latter 
allele was confounded two factors: 1) the presence of a bimodal distribution of 
animals that do not exhibit BSR and those that exhibit exaggerated BSR and 2) 
a decrease in their basal locomotory rate on food-free plates. We confirmed the 
latter finding and its DA dependence by use of an automated platform, 
WormLab, which provides for a more systematic analysis of locomotory kinetics 
on plates. In combination with the changes in DA neuron excitability, we 
hypothesize that that loss of swip-10 results in an increase in extrasynaptic DA 
that is context-independent. While DA-dependent locomotory alterations for 
dat-1 are only revealed when these animals are placed in water, an environment 
that we believe is capable of evoking dramatic increases in DA neuron 
excitability, swip-10 mutants are hyperdopaminergic due to a persistent change 
in DA neuron activity. Simply put, DA neurons in the swip-10 mutant are firing all 
the time, resulting in constitutive DA release. Initially, we hypothesized that 
strains that we suppose to be hyperdopaminergic (i.e. – dat-1 and swip-10) 
would all demonstrate an exaggerated BSR through elevated DAergic tone on 
postsynaptic dop-3 receptors. Due to the complexity of dop-1/dop-3 
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antagonism (Allen, et al., 2011; Chase, et al., 2004) or due to compensatory 
changes in tissue DA levels in Swip-harboring mutants (Hardaway, et al., 2012), 
we have revised our hypothesis. We hypothesize that BSR requires that the 
worm possess a wide dynamic range in the amount of extrasynaptic DA to 
control the amount of ligand available to act on postsynaptic dop-1 and dop-3. 
In this model, a loss of the ligand or a gain in the amount of DA would be 
predicted to alter the amount of postsynaptic signaling and eventually behavior. 
Thus, strains that are hyperdopaminergic or hypodopaminergic have a narrower 
dynamic range of DA available for postsynaptic signaling than wildtype animals. 
Furthermore, it is unknown how chronic elevations in DA signaling in the dat-1 
and swip-10 mutants impact the desensitization of pre and postsynaptic DA 
receptors and whether this contributes to the alterations in BSR that we 
observe. Based on changes in DA receptor expression levels in the DAT-/- 
mouse, we hypothesize that there are changes in DA receptor levels in the dat-1 
and swip-10 strains (Giros, et al., 1996).          
As a primary test of GLU signaling requirements on swip-10, we crossed 
swip-10 to lines containing mutations in the only characterized vGLUT in C. 
elegans: eat-4. Loss of eat-4 significantly suppressed Swip in the swip-10 alleles 
vt29 and vt33. Importantly, the suppression that we observed was incomplete. 
We hypothesize that loss of eat-4 may decrease the overall extrasynaptic GLU 
content of the worm, but that Swip in the swip-10 strain may derive from either 
1) global changes that effect the overall extrasynaptic GLU content or 2) local 
changes in synaptic GLU that do not all use eat-4. A search of the worm gene 
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databases revealed that two other vGLUT orthologs exist (named vglu-2 and 
vglu-3). Alleles of these vGLUTs are available, but their expression patterns have 
not been thoroughly characterized. Enrichment of their expression in neurons 
presynaptic to DA neurons may indicate that multiple vGLUTs contribute to 
elevated GLU release onto DA neurons in the swip-10 mutant.  
In combination with our analysis of DA neuron excitability, we 
hypothesized that swip-10 hyperdopaminergia may require contribution of 
GLURs either in DA neurons or other neurons known to project to DA neurons. 
As loss of these GLURs by themselves did not evoke highly penetrant Swip 
phenotypes, we could assess the impact of these GLURs on swip-10 through 
genetic analysis of GLUR loss on the swip-10 background. We constructed 
double mutant strains of swip-10 in combination with different GLUR alleles and 
assayed them for suppression of Swip. We observed that the majority of the 
GLURs that we tested including glr-1, glr-2, glr-5, nmr-1, nmr-2, mgl-2, and mgl-
3 did not affect the penetrance of Swip in the swip-10 strain. We did find that 
loss of glr-4, glr-6, and mgl-1 all produced a significant, yet incomplete, 
suppression of swip-10. Assays of triple mutant strains containing loss of two of 
these three GLURs on the swip-10 background demonstrated that these 
receptors function in parallel to promote Swip in the swip-10 mutant and a loss 
of all three receptors generated the most robust suppression of swip-10, though 
not to N2 levels. Importantly, we have not yet assayed the contribution of glr-7 
to swip-10, and there are no alleles available to test the contribution of glr-3 and 
glr-8. However incomplete the suppression of swip-10 Swip, these experiments 
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clearly demonstrate that swip-10 hyperdopaminergia requires the function of 
two ionotropic and one metabotropic GLURs. To determine the specificity of 
these GLURs for swip-10 Swip, we crossed them to the dat-1 mutant and 
assayed their suppression of Swip in the dat-1 mutant. Loss of glr-4 and glr-6 
on the dat-1 strain had no effect dat-1 Swip penetrance. Loss of mgl-1, 
however, led to a nearly complete suppression of dat-1 Swip. Moreover, we 
determined that the loss of mgl-1 on the dat-1 background promoted more 
frequent Swip reversal and crawling behavior. Future studies of rescue of the 
mgl-1 gene and its expression within specific cell types will be necessary to 
determine the site of mgl-1 function and the mechanism of dat-1 Swip 
suppression. These studies establish that swip-10 Swip, relative to dat-1 Swip, 
is mediated by a host of GLURs as opposed to just mgl-1. We hypothesize that 
this shift in the GLUR contribution can be accounted for by a change in the 
amount of extrasynaptic GLU around these GLURs either in DA neurons or 
upstream neurons (Figure 53 and 54).  
As we had demonstrated that swip-10 requires the function of GLURs 
and that loss of GLTs can also generate Swip, we sought to determine whether 
swip-10 functions in a pathway with either glt-1, glt-3, and glt-4 using genetic 
epistasis experiments. We used a previously established paradigm, whereby an  
 171 
Figure 53 – Schematic of 
glr-4, glr-6, and mgl-1 
contributions to dat-1 and 
swip-10. N2 animals 
maintain normal 
extrasynaptic DA levels 
through the uptake of DA 
through dat-1 and the 
buffering of DA neuron 
excitability that is regulated 
by the amount of glutamate 
levels and excitatory 
signaling. Swip in the dat-1 
mutant is triggered by the 
loss of DA clearance but 
requires signaling of mgl-1, 
but not glr-4 and glr-6. Swip 
in the swip-10 mutant 
persists despite the normal 
function of dat-1 and 
requires the contribution of 
mgl-1, glr-4, and glr-6 
mediated by an increase in 
tonic glutamate levels. 
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Figure 54 – Circuit level diagram of glutamate and dopamine contributions to Swip in the dat-1 and swip-10 strains. An 
increase in extrasynaptic DA in both strains is sufficient to trigger Swip, but the increase in extrasynaptic DA in the swip-10 mutant 
is due to an increase in glutamate-mediated excitation-driven DA release as opposed to a loss of DA clearance through dat-1.
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increase in osmolarity is sufficient to suppress the Swip in dat-1 or swip-10, and 
that this suppression can reveal when two genes function in parallel, 
independent pathways to regulate the penetrance of Swip. Using this approach 
and a combination of dat-1 and swip-10 GLT double mutant strains, we found 
that, although loss of glt-1 is capable of generating DA-dependent Swip, it 
significantly enhances Swip in the swip-10 mutant and likely functions in 
pathways parallel and independent of swip-10. Surprisingly, loss of glt-1 did not 
enhance the Swip of the dat-1 mutant. Thus, glt-1 and dat-1 may cooperate 
through a shared pathway to regulate Swip. Analysis of glt-4 revealed that it 
significantly enhances dat-1, but does not significantly enhance swip-10. Thus 
we conclude that swip-10 functions in a genetic pathway containing glt-4. We 
have yet to construct the dat-1; glt-3 strain, but we observed that loss of glt-3 
significantly rescued the swip-10 strain at either osmolarity. Contrary to the 
presence of Swip in the glt-3 mutant strain, we hypothesize that glt-3 activity 
may also be required for the recycling of GLU and its rerelease in addition to its 
predicted role in sodium dependent GLU clearance. Loss of glt-3 function, in 
this case however, does not result in a global change in tissue GLU or aspartate 
levels as we did not observe any change in these amino acids, or cystine and 
GABA, in the glt-1, glt-3, or glt-4 mutant lines using HPLC. Therefore, we 
hypothesize that changes in GLU signaling may be localized to synapses that 
are regulated by glt-4. Mano et al. observed that glt-1, by adulthood, is 
expressed mainly in the head muscle cells, but is enriched in hypodermal cells 
early in development (Mano, et al., 2007). Though our Swip analysis at the L4 
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stage of swip-10 glt-1 double mutants suggest that these genes function in 
parallel, it is possible that swip-10 may regulate glt-1 function at an earlier larval 
stage. glt-3’s expression is pronounced in the excretory cell, a structure 
dedicated to excretion and electrolyte balance, and weakly in the pharynx. We 
predict that glt-3 may function to regulate overall extrasynaptic GLU levels in the 
nerve ring thereby elevated extrasynaptic GLU may be capable of driving DA 
neuron excitation and DA release. The mechanism by which glt-3 suppresses 
swip-10 is more elusive. As these deletions are constitutive, compensatory 
changes in GLU neurotransmission such as reduced release or receptor 
desensitization are a possible mechanism for this effect. glt-4 expression is 
enriched within neurons in the surrounding the nerve ring. In the description of 
its expression pattern the authors noted that glt-4 expression colocalized with 
neurons also expressing eat-4. Therefore, they consider glt-4 a presynaptic GLT, 
though a number of cells expressing glt-4 were unidentified. In the description of 
the expression pattern of all C. elegans GLTs, they did not note any expression 
in worm glia. Therefore the actions of swip-10 in a GLT pathway would have to 
function non cell- autonomously. We noted that the swip-10 protein contains a 
nonconserved signal peptide sequence that may mediate secretion of the 
protein and hypothesize that swip-10 may be secreted by glia to act on its 
substrate at distant sites in a glt-4 pathway. In our review of the C. elegans glia 
literature there is no mention of glia’s importance in regulating GLU 
neurotransmission in the worm. Considering the importance of glia like 
astrocytes in regulating synaptic and extrasynaptic GLU levels in mammals and 
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other invertebrates like Drosophila through the actions of GLTs, (Danjo, 
Kawasaki, & Ordway, 2011; Freeman & Doherty, 2006; Grosjean, Grillet, 
Augustin, Ferveur, & Featherstone, 2007; Stacey et al., 2010) (Nave & Trapp, 
2008), we consider it highly unlikely that C. elegans glia do not harbor regulatory 
proteins necessary for GLU clearance. Rather, we suggest that the importance 
of glia in regulating GLU signaling derives from an evolutionarily ancient species 
and that its role has been previously unappreciated in C. elegans. Further 
studies of cell ablations of specific glia and measurements and their impact on 
synaptic GLU levels and GLU-regulated behaviors will be necessary to answer 
this question.  
In summary, we identified a highly conserved gene in C. elegans that, 
when lost, triggers a hyperdopaminergic phenotype through an increase in DA 
neuron excitability. This gene is highly expressed and functions in worm glia to 
regulate the amount of excitatory signaling through 3 independent GLURs likely 
through the activity of glt-4, a neuronal GLT that, by itself, is necessary for 
maintenance of DA signaling.   
 
FUTURE DIRECTIONS 
The precise cell autonomous role of swip-10 is still unknown. Our studies 
establish that swip-10 functions in glia, but we do not yet know which glia are 
important for the regulation of Swip. The use of mosaic analysis using an 
expression plasmid containing an SL2-mCherry cassette or by coinjection of the 
ptr-10:RFP marker plasmid in tandem with the previously established functional 
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ptr-10: swip-10 cDNA:GFP construct and the generation of transgenic lines with 
mosaic transmission would allow for this type of analysis. Animals harboring 
expression of RFP or mCherry in specific glia could be tested separately by 
manual or automated Swip to determine which glia must express swip-10 to 
rescue Swip.  
Although we have established that DA neuron specific ion channels 
function cell autonomously to regulate Swip in a dat-1 animal (see Chapter X), 
these ion channels exert only modest effects on swip-10. Therefore Swip in the 
swip-10, consistent with our previous data, derives from a polyneuronal and 
glial-interacting circuit. In keeping with our hypothesis of the importance of the 
OL/IL glia and the OLL mechanosensory neuron pair, in vivo Ca2+ imaging of the 
OLL neuron using a ser-2prom3:GCaMP transgene during BSR and/or 
photostimulation of these neurons using  ser-2prom3:ChR2 during swimming and 
BSR, and ablation of these neurons on the swip-10 and dat-1 backgrounds will 
be important experiments to consider in illustrating how swip-10 functions within 
the Swip-interacting native circuit to regulate DA homeostasis.  
In our previous study, we noted that 6-OHDA exerts normal neurotoxic 
effect on swip-10 animals. Although we measured this effect over an acute time 
scale, we did not, however, assay the integrity of DA neurons throughout the 
worm lifespan. The effects of many Parkinson’s Disease associated genes on 
DA neuron viability has been thoroughly studied (Caldwell & Caldwell, 2008; 
Cao, et al., 2005; Hamamichi, et al., 2008; Iwatsubo, 2007; Kuwahara et al., 
2006; Lakso et al., 2003), therefore a longitudinal measurement of DA neuron 
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morphology on the swip-10 or GLT mutant background should be possible. We 
hypothesize that because swip-10 animals contain a persistent elevation in DA 
neuron excitability that requires GLURs, these animals will demonstrate age-
dependent neurodegeneration relative to the N2 strain.  
We observed that loss of egl-3 completely suppressed the swip-10 strain. 
At this time, we have no further data to support an explanation for this result. 
We hypothesize, however, that neuropeptide signaling through egl-3 may be 
required postsynaptically at the motor circuit to mediate DA’s effects. A cross of 
egl-3 into the dat-1 mutant would be sufficient to demonstrate if egl-3’s function 
generalizes to other hyperdopaminergic strains. We hypothesize that egl-3 
would suppress this strain and other Swip-harboring strains. Finally, assay of 
egl-3’s response to exogenous DA would be sufficient to determine its 
requirement for DA modulation of the postsynaptic motor circuit. We 
hypothesize that egl-3 and neuropeptides are necessary for DA signaling onto 
DA receptors expressed by motor neurons. 
In these studies, we screened through a number of strains harboring 
mutations in GLU signaling genes. There are a number of strains that we might 
still screen or repeat to complete our analysis of the entire GLU signaling 
network. vglu-2 and vglu-3 are other vGLUT homologs in the worm and mutant 
alleles are available to screen for Swip and BSR. Though we did observe 
suppression of swip-10 with loss of eat-4, we may observe a more dramatic 
suppression of Swip with a loss of vglu-2 or vglu-3. We screened swip-10’s 
interaction with all GLURs with an available allele except for glr-7. We 
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hypothesize that, based on the expression pattern and level of glr-7 transcript in 
DA and other neurons, that glr-7 is not required. Similarly, there are no current 
alleles available for the AMPA receptors glr-3 and glr-8 which precludes an 
analysis of their contribution to swip-10. Through these genetic analyses we 
observed that loss of glr-4, glr-6, and mgl-1 in parallel generates a robust 
suppression of swip-10. Analysis of BSR in the triple glr-4; glr-6 mgl-1 strain 
may reveal a reduction in this behavior, consistent with the hypothesis that 
these GLURs function in parallel to mediate changes in DA neuron excitability. 
Similarly, at the time of performing the BSR assays on GLU signaling 
components, the swip-10(tm5915) allele was not yet available. Assay of this 
strain would provide parallel evidence to the phenotypes we observed using 
vt29 and vt33 that include the reduction in overall locomotory rate on food-free 
plate. Using Wormlab and the swip-10(tm5915) allele in combination with cat-2, 
dop-3 and GLUR alleles, there is a need to establish that the reduction in speed 
in the swip-10 mutant is not allele specific and that this reduction is mediated by 
DA, dop-3, and the same GLURs that are mediating Swip. 
The contribution of GLUR signaling to dat-1 and swip-10 is a compelling 
line of research. Future analyses using transgenic restoration of these GLURs on 
the glr-4; swip-10 glr-6 mgl-1 and dat-1; mgl-1 backgrounds will help augment 
our understanding of the cell autonomous function of these GLURs and how 
swip-10 mutations alter a network of GLU signaling genes. 
Our analysis of swip-10 genetic interactions with GLTs establish that 
swip-10, unlike dat-1, likely functions in a pathway with glt-4 to mediate Swip. 
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glt-1, on the other hand, functions in a parallel pathway to swip-10 and may 
interact genetically with dat-1. Our analysis of glt-3 and its interaction with dat-1 
is still incomplete however.  
Lastly, our epistasis experiments clearly establish genetic interactions 
between swip-10 and GLU signaling components, but we do not yet understand 
the molecular mechanism by which swip-10 alters GLU signaling. Future studies 
investigating swip-10’s contribution to glutamatergic behaviors such as 
spontaneous reversal would provide parallel evidence for our hypothesis that 
swip-10 are hyperglutamatergic (P J Brockie, Mellem, Hills, Madsen, & Maricq, 
2001; Mellem, Brockie, Zheng, Madsen, & Maricq, 2002; Zheng, et al., 1999). 
Additionally, the molecular mechanism by which glt-4 is regulated by swip-10 is 
still unknown. Analysis of glt-4 transcription by use of the available glt-4:GFP 
reporter may reveal swip-10’s contribution to glt-4 transcription.  
Recently, a group reported the development and in vivo analysis in C. 
elegans of a GFP-based glutamate sensor called iGluSnFr (Marvin et al., 2013).  
The expression of this sensor has already been tested in DA neurons 
(Snarrenberg and Hardaway, unpublished) and the relative baseline fluorescence 
of this sensor or the imaging of this sensor on the dat-1 and swip-10 
background using fluorescence recovery after photobleaching (FRAP) may serve 
as an effective proxy for synaptic GLU levels. Similarly, measurement of 
synaptic release using FRAP of a pasic-1:: snb-1:pHlourin transgene in DA neurons 
have already been established and implemented in the lab (Bermingham and 
Baas, unpublished)(Voglis & Tavernarakis, 2008). A line containing the swip-10 
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mutation in combination with the pasic-1:: snb-1:pHlourin transgene has been 
generated and archived for these experiments.  
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Chapter VI 
IDENTIFICATION AND CHARACTERIZATION OF Mblac1 
 
INTRODUCTION 
In the previous chapter, we described the identification and characterization of 
swip-10 in the nematode C. elegans. In this chapter, we analyze the expression 
pattern of Mblac1 RNA and protein in the mouse brain and in cultured cells, 
begin our efforts to identify the endogenous Mblac1 substrate, and describe 
how this protein fails to interact with β-lactam containing substrates.  
 
MATERIALS AND METHODS 
Isolation of RNA 
Total RNA was isolated from either whole brain, distinct brain regions or 
peripheral tissues in 14-16 week old C57/BL6 male mice. An appropriate 
amount of Trizol (Sigma) was added to the tissue and Total RNA was isolated 
according to the manufacturer’s instructions. We repeated the Trizol extraction 
to ensure that gDNA was not present in our samples. 
 
RT-PCR 
To generate first-strand cDNA, we used 500 ng of total RNA as input in a 
reverse transcriptase reaction using Superscript III RNA Polymerase (Life 
Technologies). cDNAs were diluted to 100 ng/μl and used as template for 
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polymerase chain reaction. PCR reactions were performed using Platinum PCR 
Supermix (Life Technologies) according to the manufacturer’s instructions. PCR 
products were sequenced with the sense primer to validate their identity. The 
primers used were: 
Mblac1: 
RB4442(For) – CCTGGGGCTGTTTCCCGAGGCAG 
RB4393(Rev) -  TGCCTTCACATATCAAATCCTC  
Mblac2:  
RB4394(For) - ACCTCTACTCCTCTGGCCTCTT 
RB4443(Rev) – GCCCAGGAAGCACCTTCTCCACAAG 
Lactb2: 
RB4396(For) – GGAATCCCCAGAGAGAAGAAAT 
RB4444(Rev) – GGATGACTGGGCCATGTCCTGG 
Gapdh: 
RB4495(For) – GCACAGTCAAGGCCGAGAAT 
RB4496(For) – GGCCTTCTCCATGGTGGTGAA 
 
In situ hybridization of Mblac1 and Mblac2 
Experiments were performed as described in Wu et al. with some modifications 
(Wu et al., 2009; Wu & Levitt, 2013). Prior to probe generation 564 bp Mblac1 
and 524 bp Mblac2 cDNA fragments at the 3’ end of each gene were subcloned 
into pBSKII(-) using 5’ BamHI and 3’ XbaI sites to generate pRB1165 and 
pRB1166 respectively. Digoxigenin cRNA probes for Mblac1 and Mblac2 were 
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generated by in vitro transcription from these vectors using a DIG RNA labeling 
kit (Roche) and T3 RNA polymerase (Roche). Brains were dissected and frozen 
fresh with liquid N2 cooled isopentane and stored at -80°. Brains were 
embedded in TFM tissue freezing media (Triangle Biomedical Sciences) and 
sectioned at a thickness of 20 µM using a cryostat. Slides were fixed in 4% 
paraformaldehyde (PFA)/PBS for 20 min. at RT, washed with PBS, and 
incubated in Proteinase K(1 µg/ml) solution for 15 min. at RT. Slides were 
acetylated by incubating with triethanolamine (TEA-HCl, pH 8.0) for 10 min. after 
drop additions of acetic anhydrate(0.25% TEA volume). We prehybridized the 
slides for 2 hr at 60° in hybridization solution (50% deionized formamide, 5X 
SSC, pH 7.0, 1X Denhardt’s solution, 0.1% Tween-20, 0.1% CHAPS, 5 mM 
EDTA, pH 8.0, 100 µg/ml heparin, 300 µg/ml yeast tRNA in DEPC-H2O). 
Hybridization of slides with cRNA probes was carried out in hybridization 
solution at 60° for 16-18 hrs. Slides were first washed three times for 45 min at 
65° in washing solution (2X SSC, pH 4.0, 50% formamide, 1% SDS in distilled 
H2O) and then three times for 15 min in TBST (25 mM Tris-HCl, pH7.5, 136 mM 
NaCl, 2.68 mM KCl, 1% Tween-20 in distilled H2O) with light agitation at RT. We 
blocked the slides for 1 hr at RT with blocking solution (100 mM Tris-HCl, pH7.5, 
150 mM NaCl, containing 1.5% blocking agent – Roche) and then incubated 
them o/n with alkaline-phosphotase conjugated anti-DIG Fab fragments 
(1:2,000, Roche). To color the sections, we incubated them in NTMT solution 
(100 mM NaCl, 100 mM Tris- HCl, pH 9.5, 25 mM MgCl2, 1% Tween-20, 2 mM 
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levamisole) with 0.2 mM 5-bromo-4-choloro-3-indolyl phosphate (BCIP) and 0.2 
mM nitroblue tetrazolium (NBT; Roche) until color was evident.  
 
Development of an Mblac1 Polyclonal Antibody 
Mblac1 cDNA (ThermoFisher) was amplified and subcloned in frame to 
glutathione S-transferase (GST) within pGEX2T using BamHI and EcoRI sites at 
the 5’ and 3’ ends respectively to generate pRB1163. pRB1163 was 
transformed into BL21 competent cells. Expression of a full length GST-Mblac1 
protein was induced via IPTG addition and purified from crude bacterial cell 
lysates via GST affinity chromatography. GST-Mblac1 with adjuvant was 
injected into two rabbits (#4979 + 4980) over the course of several months to 
produce GST-Mblac1 antiserum. Antiserum from both rabbits was tested at 
several dilutions via western blotting against GST-Mblac1 protein and Mblac1 
transfected cells. Specificity of Mblac1 immunoreactivity was confirmed by 
preadsorption of the antiserum with GST-Mblac1 protein. For purification of the 
Mblac1 antiserum, we cloned Mblac1 cDNA in frame to maltose binding protein 
(MBP) within pMal-cR1 using EcoRI and BamHI sites at the 5’ and 3’ ends 
respectively to generate pRB1164. Full length MBP-Mblac1 protein was 
generated as previously described with addition of 100 uM ZnSO4 (Sigma-
Aldrich) to the culture media during induction. The protein was purified via 
amylose affinity chromatography (New England Biolabs) and concentrated for 
further use. MBP-Mblac1 protein was conjugated to amylose resin, and 4980 
serum was passed over the column multiple times, washed with column buffer, 
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and eluted with 150 mM Glycine pH 2.0. 400 µl fractions were collected and 
immediately neutralized in 2 M Tris-HCl pH 8.0. Fractions were pooled and 
dialyzed in excess 1X PBS containing additional 150 mM NaCl at 4 degrees 
overnight. Dialysate was then concentrated for further experiments and testing. 
For these experiments, we used several affinity-purified lots from Rabbit #4980 
serum. 
 
Immunohistochemistry 
WT C57/BL6 males aged 10-15 weeks were anesthetized with Nembutal and 
cardiac perfused with 4% paraformaldehyde. Brains were removed and post-
fixed for up to one week in 4% paraformaldehyde. The tissue was cryoprotected 
overnight in 20% sucrose at 4 degrees and sliced at 40 μM using a freezing 
microtome. Sections were collected in cryoprotectant and stored at -20 degrees 
until experiments were performed. For peroxidase staining, sections were 
washed 3X in TBS to remove cryoprotectant and endogenous peroxidase 
activity was quenched with 0.5% hydrogen peroxide and 10% methanol in TBS. 
Sections were blocked for 1 hour at RT using 3% normal goat serum (Jackson 
Research Labs) in TBS containing 0.1% Triton X-100 (TBST) and incubated with 
Mblac1 primary antibody (100-1000 ng/ml) at 4 degrees overnight. The following 
day, the sections they were washed 3X with TBS and incubated with 
biotinylated Goat anti-Rabbit (1:1,000) secondary antibody for 1 hour at RT. 
Following 3X washes with TBS, Mblac1 immunoreactivity was detected by 
applying avidin/horseradish peroxidase conjugate and 3,3’-diaminobenzodine 
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(3-7 min.). High resolution images of peroxidase based IHC were capture at 5-
20X on an upright AxioImager 2 microscope and then stitched using AxioVision 
software. For immunofluorescence, sections were washed 3X in TBS and 
blocked in 10% normal goat or donkey serum in TBST for 1 hour at RT. Sections 
were then incubated in primary antibody cocktails for two days at 4 degrees. 
Antibodies used in these studies were Rabbit α Mblac1(5 ug/ml), GFAP(mAb360 
- Millipore) at 1:1,000, S100β(SAB1402349 - Sigma) at 1:200, MAP2(M4403 – 
Sigma) at 1:100, vGlut2(ab2251 – Millipore) at 1:1,000, GLT-1(courtesy Robinson 
lab) at 1:100, Doublecortin(ab2253 – Millipore) at 1:1,000 and GAD67(mAb5406) 
at 1:500. Sections were then washed 3X with TBS and incubated with host 
appropriate AlexaFlour488 or 546 conjugated secondary antibodies at 1:1,000 
for 1 hour at RT in the dark. Sections were washed 3X with TBS and incubated 
with 4',6-diamidino-2-phenylindole (DAPI) at 1:1,000. Sections were mounted on 
glass slides and sealed for imaging. All images were captured on an Zeiss LSM 
710 confocal microscope and processed offline in ImageJ. 
 
Mammalian Cell Culture 
Human embryonic kidney cells containing a stable integrated SV40 large antigen 
(HEK293T) cells were cultured in DMEM containing 10% fetal bovine serum 
(FBS) containing L-glutamine and 1 mM L-glutamine. Note that antibiotic was 
not included for β-lactamase activity assays. Immortalized mouse fibroblast 3T3 
cells were cultured in DMEM containing 4.5 g/L glucose and 1.5 g/L sodium 
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bicarbonate supplemented with 10% bovine calf serum. All cell lines were 
maintained in incubators at 37° with 5% CO2. 
 
Western Blot and Immunoprecipitation Analyses 
For western blot analyses in 3T3 cells, cells were trypsinized for 5 min. at 37°, 
harvested with phosphate-buffered saline (PBS) and transferred to a 1.5 ml 
microfuge tube. Protein was solubilized from the cell pellet by incubation with 
RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% 
sodium deoxycholate, 0.1% SDS, 1 mM EDTA) at 4 degrees for 1 hour with 
gentle agitation. Following solubilization, insoluble material was removed from 
the extracts by centrifugation at 13,000 rpm for 15 minutes. The protein 
concentration of the supernatant was determined by use of the colorometric 
bicinchoninic acid (BCA) method and absorption at 562 nM using an Omega 
Series plate reader (BMG Labtech). Total protein was denatured by incubation 
with 2X Laemli buffer at 95° for 5 min. Insoluble material was removed from the 
samples by centrifugation at 13,000 rpm for 15 min at RT.  15-25 µg of total cell 
protein were separated using SDS-PAGE and then transferred to an immobilon 
PVDF membrane (Millipore). Membranes were then baked at 37° and reactivated 
by methanol application. We blocked the membranes using PBS containing 
0.1% Triton X-100 (PBST) and 5% bovine serum albumin (BSA). To detect 
Mblac1 we incubated the membranes overnight with the previously described 
Mblac1 affinity purified antibody at a concentration of 1 µg/ml diluted in 5% 
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BSA/PBST.  For expression of human and mouse cDNAs, we cloned full length 
cDNAs using BamHI and EcoRI sites at the 5’ and 3’ ends to generate 
pRB1167(Mouse Mblac1), pRB1168(Human MBLAC1), pRB1169(Mouse 
Mblac2), and pRB1170(Human MBLAC2). Original cDNAs were obtained from 
Thermo-Fisher. 
 
Measurement of β-lactamase Activity  
We used the mammalian heterologous expression vectors described above in 
parallalel with a construct expressing a truncated non-secreted version of the 
TEM-1 β-lactamase (Bla)(Hasegawa, Jackson, Tsien, & Rao, 2003). We 
transfected HEK293T cells in six-well plate using TransIT-LT1 (Mirus Bio, 
Madison, WI), grew them for 48-72 hours, cells were harvested by rinse with 
PBS containing 100 µM ZnSO4. We washed the cell pellets twice using the same 
buffer. Cell lysates were generated by four repeated freeze thaw cycles for 10 
min. in liquid nitrogen and in a 37 degree water bath. Following cell lysis, we 
spun the lysates at 13,000 rpm to remove insoluble material and transferred the 
supernatant to a fresh tube. 90 µl of cell lysate was transferred on ice to a 
microtiter plate in quadruplicate and the substrate was added just prior to 
recording the absorbance on a Omega microplate reader (BMG Labtech) at 486 
nM for Nitrocefin (de Seny et al., 2002) and both 346 and 405 nM for CENTA (C 
Bebrone et al., 2001). For nitrocefin (Millipore), we dissolved the compound in 
dimethyl sulfoxide (DMSO) according to the manufacturers instructions and then 
diluted this to a working stock of 1 mM with phosphate buffer (100 mM, pH 7.0). 
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For CENTA, we dissolved the substrate in 50 mM phosphate buffer (pH 7.0)  to a 
final concentration of 1 mM. For both substrates, we added them to the cell 
lysates at a final concentration of 100 µM.  
 
Confocal Microscopy 
Confocal microscopy of immunofluorescent staining of mouse brain sections 
was performed using Zeiss LSM710 and the Zen software. 
 
RESULTS 
Expression of Mammalian Mblac1 and Mblac2  
As we had observed robust expression of swip-10 in glia and some neurons in 
C. elegans, we hypothesized that Mblac1 is expressed in the mammalian brain. 
During our identification of Mblac1 and analyses of functional domains using 
secondary structure prediction, we noted the existence of other genes 
containing metallo-β-lactamase domains. Preliminary experiments of Mblac1 
and another metallo-β-lactamase, Mblac2, using in situ hybridization by the 
Allen Brain Institute supported our hypothesis that these metallo-β-lactamase 
domain-containing genes were expressed in the brain (Mblac1 -	  
http://mouse.brain-map.org/experiment/show/68920662, Mblac2 - 
http://mouse.brain-map.org/experiment/show/72283390). To validate these 
experimental results we performed reverse transcriptase polymerase chain 
reaction (RT-PCR) on these three genes in parallel with a loading control RNA 
isolated from peripheral tissues such as the liver, lung, and the heart, whole 
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brain, and several distinct brain regions like the olfactory bulb, striatum, 
hippocampus, cerebellum, and the cortex. Similar to the available experiments 
at Allen, we observed that Mblac1 and Mblac2 were expressed throughout the 
brain including each of the regions we assayed (Figure 55). We also found that 
these two genes were expressed in each of the peripheral tissues we assayed. 
  
Distribution of Mblac1 and Mblac2 RNA in mouse brain
To determine the distribution of Mblac1 transcript, we performed in situ 
hybridization on coronal sections. We observed high levels of Mblac1 RNA in 
the same brain regions that we tested with RT-PCR including the cerebellum 
(Figure 56A), the cingulate cortex (Figure 56B), the medial habenula (Figure 56C), 
the hippocampus (Figure 56D), and in cells lining the lateral ventricle (Figure 
56E). Together with our RT-PCR experiments, these experiments establish that 
Mblac1 RNA is expressed in several areas of the mammalian brain. 
	  
Development and Affinity Purification of Mblac1 Antiserum 
To probe for the expression of Mblac1 protein, we developed antiserum against 
a full-length GST-Mblac1 protein and tested its ability to detect Mblac1 
expression in transfected cells. We found that antiserum (Rabbit #4980) could 
detect a protein of the predicted molecular weight in HEK293T cells 
overexpressing mouse Mblac1, but not human MBLAC1 (Figure 57A). To 
remove any potential contaminants, we affinity purified the antiserum and tested 
it as before in mouse Mblac1 transfected cells. Again, we found that our Mblac1 
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Figure 55 – RT-PCR of Mblac1 and Mblac2 from Mouse brain and peripheral tissues. Experiment, including RNA isolation, 
reverse transcription, and PCR was performed as described in the Methods. Significant Mblac1 and Mblac2 transcript was 
detected in each of the tissues we isolated, but not in whole brain libraries treated minus the reverse transcriptase enzyme. 	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Figure 56 – In situ hybridization of Mblac1 in various mouse brain regions. Mblac1 RNA is present in the granular layer of the 
Cerebellum(A), cingulate cortex(B), medial habenula(C), the cellular layer of the hippocampus(D), and cells lining the lateral 
ventricle(E). Scale bar equals 50 μM in each image. Abbreviations are GrL – granular layer, ML – molecular layer, LV – lateral 
ventricle, cc – corpus callosum, MHb – medial habenula, LHb – lateral habenula, h – hilus, gcl – granule cell layer, DG – dentate 
gyrus, Str – striatum
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Figure 57 – Development and Purification of Mblac1 antiserum. A. Western blot of 
transfected cell lysates using 4980 antiserum(1:30,000). We detect a band of the 
predicted molecular weight in cells expressing mouse Mblac1. We do not detect human 
MBLAC1 protein with this antiserum. B. Western blot of transfected cell lysates using 
affinity purified Mblac1 antibody(1 µg/ml). We detect a band of the predicted molecular 
weight in cells expressing mouse Mblac1 but not human MBLAC1. For both A and B, 
we transfected HEK293T cells with pCDNA3 alone or pCDNA3 containing 
mouse(Mblac1) or human(MBLAC1). Cell lines and western blots were performed as 
described in the methods.  
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polyclonal antibody could reliably detect transfected Mblac1 at the predicted 
molecular weight. 
 
Identification of Immortalized Cell Line expressing Mblac1 
To gain a better understanding of Mblac1’s subcellular expression pattern, we 
screened a number of immortalized cell lines for the expression of endogenous 
Mblac1. Our previous experiments using HEK293T cells transiently transfected 
with Mblac1 had already demonstrated that these cells do not express Mblac1 
endogenously. Based on the expression of Mblac1 in peripheral tissues we 
observed with RT-PCR and the expression of swip-10 in hypodermal cells, we 
screened NIH 3T3 cells and observed a band of the predicted molecular weight 
(28 kD) that was blocked by preadsorption of the Mblac1 antibody with a full 
length Mblac1 protein (data not shown).  
  
Mblac1 Subcellular Expression Pattern in 3T3 cells 
Having identified a cell line that expresses Mblac1 endogenously, we used 3T3 
cells and crude subcellular fractionation to determine the subcellular expression 
pattern of Mblac1 (Holden & Horton, 2009). Using additional proteins to validate 
our fractionation protocol, we observed that Mblac1, like Gapdh, was expressed 
in the cytosol. Calnexin and Lamin B1 were enriched in the organellar and 
nuclear fractions respectively (Figure 58). Importantly, although we detected 
significant Lamin B1 protein in our cytosolic fraction, but we never observed any 
Mblac1 expression in the nuclear fraction. Along with our studies of Mblac1  
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Figure 58 – Western blot analysis of Mblac1 in fractionated 3T3 cells. Crude 
subcellular fractionation were performed as described in the methods with 200 ug/ml 
digitonin for the cytosolic fraction and we probed three cellular fractions for the 
expression of known subcellular markers and Mblac1. We detected Mblac1 expression 
solely in the cytosolic fractions similar to Gapdh. 
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expression in native brain tissue sections (see next section), these data suggest 
that Mblac1 is a cytoplasmic protein. 
 
Expression of Mblac1 Protein in mouse brain 
To determine if Mblac1 protein is expressed in native tissue, we harvested 
protein from striatum, midbrain, cerebellum, hippocampus, and cortex and
probed for its expression using western blots. As shown in Figure 59, we 
detected a band of the predicted molecular weight (28 kD) in all of these brain 
regions. Importantly, using this antibody we also detected a doublet just below 
50 kD and a single band ~70 kD, but only the 28 kD band was blocked by 
preadsorption of the primary antibody with Mblac1 protein. We hypothesize that 
these bands are proteins with similar antigenicity to Mblac1, but that 
endogenous Mblac1 is expressed at the predicted molecular weight of 28 kD.   
 
Distribution of Mblac1 expression in the mouse brain 
To determine how Mblac1 expression is distributed in the mammalian brain, we 
used peroxidase-based immunohistochemistry using our Mblac1 antibody. We 
detected a high level of Mblac1 expression throughout all regions of the brain, 
but with a very consistent pattern of staining in certain areas (Figure 60). Mblac1 
protein was enriched in areas that we had observed in analyses of Mblac1 
transcript including the anterior cingulate cortex (Figure 61A), medial habenula 
(Figure 61D), hippocampus (Figure 61E), and the subventricular zone (Figure  
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Figure 59 – Mblac1 protein is expressed throughout the mammalian brain. A) Representative blot of Mblac1 and loading 
control(β-actin) from native brain tissue B) Quantification of Mblac1/β-actin band density from 6 mice. Experiments were performed 
as described in the Methods and band density was determined using NIH ImageJ. Normalized values were analyzed by one-way 
ANOVA with multiple Bonferonni post tests.
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Figure 60 – Immohistochemical staining of Mblac1 in the wildtype mouse brain. Representative rostral and caudal coronal 
sections display that Mblac1 is expressed in multiple regions of the brain. Experiments were performed and sections were imaged  
as described in the methods section. Scale bar equals 500 μM in bottom right hand corner of each section. 
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Figure 61 – High resolution images of Mblac1 immunohistochemistry. in A) Anterior Cingulate Cortex, B) Lateral Septal nucleus, 
C) Amygdala, D) Medial Habenula, E) Dentate Gyrus, and F) Subventricular Zone. Experiments were performed and sections were 
imaged  as described in the methods section. Scale bar equals 50 μM in A and B and 20 μM in C-F.  
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61F). We also observed significant staining in throughout portions of the lateral 
septal nucleus (Figure 61B) and in other portions of the limbic system including  
the nucleus accumbens (see top right sections in Figure 60) and the amygdala 
(Figure 61C).  
 
Immunofluorescent Characterization of Mblac1 Expression  
To gain an understanding of how the Mblac1 expression pattern is defined at a 
molecular and genetic level, we performed immunofluorescence of Mblac1 in 
parallel with markers of specific neuronal and glial markers. We used association 
of the swip-10 phenotypes and the distribution of known CNS molecules as our 
guide focusing on specific regions of robust Mblac1 staining including the 
medial habenula (MHb), dentate gyrus (DG), lateral septal nucleus (LS), dorsal 
peduncular cortex (DPC), subventricular zone (SVZ), lateral cerebellar nucleus 
(LCN), and the trapezoidal body nucleus (TB). 
 As we had observed robust expression of swip-10 in C. elegans glia, we 
performed immunofluorescent staining for Mblac1 and known glial markers glial 
fibrillary acidic protein (GFAP), S100β, and glutamine synthetase (GS). 
Suprisingly, we did not observe colocalization of Mblac1 with any of these 
markers in the MHb, DG, DPC, or LS (Figures 62, 63, and 64).  We did observe 
an enrichment of GS immunoreactivity in the DPC (Figure 64A), but analysis of 
both proteins at high resolution demonstrated that they display non-overlapping 
patterns of expression.  As our characterization of swip-10 suggested a 
connection to glutamate transporters (GLTs), we performed immunofluorescent 
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Figure 62 – Mblac1 and GFAP expression are not colocalized. A-D) 63X image of Mblac1 and GFAP in the MHb. GFAP+ fibers 
do not colocalize with Mblac1. E-F) 63X image of Mblac1 and GFAP staining in the DG. GFAP+ fibers do not colocalize with 
Mblac1. Scale bar indicates 10 μM for all panels. Dorsal is up for all confocal images. 
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Figure 63 - Mblac1 and S100β 
expression are not colocalized. A-
D)10X image of Mblac1 and S100β in 
the MHb. E-H) 10X image of Mblac1 
and S100β in the DPC. I-L)63X image 
of Mblac1 and S100β in the MHb. 
Mblac1 and S100β do not colocalize. 
M-P)63X image of Mblac1 and S100β 
in the DPC. Mblac1 and S100β do not 
colocalize. Scale bar indicates 20 μM 
for A-H and 10 μM for I-P.  
A B C
E F G H
I J K L
M N O P
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Figure 64 - Mblac1 and GS 
expression are not 
colocalized. A-D)10X image of 
Mblac1 and GS in the DPC. E-
H)10X image of Mblac1 and GS 
in the Medial Habenula. I-L)63X 
image of Mblac1 and GS in the 
DPC. Mblac1 and S100β do 
not colocalize. M-P) 63X image 
of Mblac1 and GS in the MHb. 
Mblac1 and S100β do not 
colocalize. Scale bar indicates 
20 μM for A-H and 10 μM for I-
P.
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Figure 65 – Mblac1 is expressed in 
EAAT2/GLT-1 containing fibers. A-D) 
10X image of Mblac1 and GLT-1 in the 
DPC. E-H)63X image of Mblac1 and 
GLT-1 staining in the DPC. I-L)63X 
image of Mblac1 and GLT-1 at the 
midline between rostralmost dorsal 
hippocampi. Arrowhead denotes an 
Mblac1 positive fiber expressing GLT-
1. M-P) 63X image of Mblac1 and GLT-
1 staining in the TB. Arrowhead 
indicates an Mblac1+ fiber surrounded 
by GLT-1 immunoreactivity. Scale bar 
indicates 20 μM for A-D and 10 μM for 
E-P.   
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Figure 66 – Mblac1 apposes 
the dendritic marker MAP2 
except for in the SVZ. A-
D)63X image of Mblac1 and 
MAP2 expression in the DG. 
Arrowhead denotes a site of 
MAP2 and Mblac1 apposition. 
E-H)63X image of Mblac1 in 
the DPC. Arrowhead denotes 
a MAP2+ dendrite surrounded 
by Mblac1+ puncta. I-L)63X 
image of Mblac1 and MAP2 in 
the MHb. Mblac1 and MAP2 
show non-overlapping, yet 
adjacent patterns of 
expression in the MHb. M-P) 
Mblac1 and MAP2 colocalize 
in the SVZ. 	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staining for Mblac1 and the dominant astrocytic glutamate transporter 
EAAT2/GLT-1. We observed a striking enrichment of GLT-1 in areas of intense 
Mblac1 staining like the DPC (Figure 65A-D) and the TB (Figure 65M-P) but not 
in the MHb. At high resolution in the DPC and hippocampal midline, we 
detected a high # of Mblac1+ cross sections (Figure 65E-L) surrounded by GLT-
1 immunoreactivity. Thus Mblac1 is expressed in GLT-1 expressing fibers, but 
does not colocalize with known astrocytic filament proteins.    
 To determine if Mblac1 was expressed in neurons we stained for Mblac1 
in parallel with the neuronal dendritic marker MAP2. We found Mblac1 was often 
expressed apposed to MAP2 fibers in the DG (Figure 66A-D), DPC (Figure 66E-
H), and the MHb (Figure 66I-L). Surprisingly, we noticed that MAP2 colocalizes 
with Mblac1+ cells in the SVZ. As Mblac1 was expressed opposite dendrites, 
we reviewed the literature for patterns of expression that resembled Mblac1. 
The neuronal vesicular glutamate transporter 2(vGlut2) has a very robust 
expression pattern in the MHb (Qin & Luo, 2009) which we were able to 
replicate. We observed a striking gross overlapping pattern of expression with 
vGlut2 and Mblac1 in the MHb and LCN (Figure 67A-D and not shown). At high 
resolution, we found that Mblac1 is expressed immediately adjacent to vGlut2 in 
the MHb and colocalizes with vGlut2 in the LCN (Figure 67E-L). Conversely, we 
did not observe any consistent colocalization with the GABAergic neuronal 
marker GAD67 (Figure 68). Therefore Mblac1 is expressed in or near 
glutamatergic axon terminals in addition to being expressed in GLT-1 containing 
fibers.
 207 
   
Figure 67 – Mblac1 is 
expressed adjacent to the 
glutamatergic axon 
terminal marker vGlut2. 
Immunoflourescence and 
confocal microscopy was 
performed as described in 
the methods  A-D) 20X 
image of MHb. E-H) 63X 
image of MHb. Arrowheads 
indicate example areas 
where Mblac1 and vGlut2 
are expressed in at a high 
density adjacent to one 
another. I-L) 63X image of 
LCN. Arrowheads indicate 
colocalized Mblac1 and 
vGlut2. Scale bar indicates 
10 μM for all images. Dorsal 
is up for all confocal images.  	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Figure 68 – Mblac1 and GAD67 
expression are not colocalized. 
A-D) 10X image of Mblac1 and 
GAD67 expression in the MHb. E-
H) 63X image of Mblac1 and 
GAD67 expression in the MHb. 
Mblac1 and and GAD67 
expression do not overlap. I-L) 
63X image of Mblac1 and GAD67 
in the DG. Mblac1 and GAD67 
expression do not overlap. M-P) 
63X image of Mblac1 and GAD67 
in the LS. Mblac1 and GAD67 are 
expressed near one another but 
do not colocalize or share fibers. 
Scale bar indicates 20 μM for A-D 
and 10 μM for E-P.
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To characterize the expression that we observed in the SVZ, we 
performed immunofluorescence for both Mblac1 and the neural stem cell marker 
doublecortin (DCX) (Seri, Garc a-Verdugo, Collado-Morente, McEwen, & 
Álvarez-Buylla, 2004). We observed complete colocalization of Mblac1 with DCX 
in the SVZ that did not differ dorsoventrally (Fig. 69A-H) (Ihrie et al., 2011). To 
our surprise, we observed that Mblac1 is also colocalized with DCX+ cells in the 
subgranular zone of the DG (Fig. 69I-L). Although we observed that there are 
additional areas of Mblac1 staining in the DG, these are consistent with the 
hypothesis that one of the population of cells expressing Mblac1 in the DG are 
neural stem cells. 
 
Evaluation of β-lactamase activity using chromogenic β-lactamase 
substrates  
β-lactamases make up a very broad family of enzymatic molecules amongst 
prokaryotes and can be segregated into Classes A-D. Classes A, C, + D all 
utilize a serine residue in the active site to hydrolyze β-lactam rings, a cyclic 
amide that is present in many types of β-lactam antibiotics like penicillin and 
ampicillin. Class B β-lactamases include the metallo β-lactamases that require 
the presence of metal ions in the active site to mediate hydrolytic activity (Carine 
Bebrone, 2007). The emergence of antibiotic resistant bacteria by the 
expression of novel metallo β-lactamases is a growing problem (Yong et al., 
2009). To aid in the clinical diagnosis of antibiotic resistant infections, multiple β-
lactam containing chromogenic substrates have been developed that can be 
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Figure 69 – Mblac1 
colocalizes with the 
neural stem cell marker 
Doublecortin (DCX). 
Immunoflourescence and 
confocal microscopy was 
performed as described in 
the methods  A-D) 10X 
images of the 
subventricular zone(SVZ). 
Dotted line box indicates 
magnified image in E-H. 
E-H) 63X images of dorsal 
SVZ. Mblac1 and DCX 
expression completely 
overlaps in the SVZ  I-L) 
63X image of subgranular 
zone(SGZ). Mblac1 is 
expressed in DCX+ cells. 
Scale bar indicates 20 μM 
for A-D and 10 μM for E-
L. 
DAPI DCX Mblac1 merge
DCX Mblac1 merge
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used as a readout of β-lactamase activity (C Bebrone, et al., 2001; O'Callaghan, 
Morris, Kirby, & Shingler, 1972). To determine if Mblac1 can cleave β-lactams, 
we expressed Mblac1 in HEK293T cells as before and assayed β-lactamase 
activity by two chromogenic substrates: Nitrocefin and CENTA. While we were 
able to detect a significant β-lactamase activity of the E. coli β-lactamase TEM-1 
using this method, we did not detect any significant β-lactamase activity of 
Mblac1 using this method (Figure 70). These data suggest that Mblac1 does not 
cleave β-lactam rings and that its endogenous substrate is not likely to contain 
this chemical group. 
 
DISCUSSION 
In this chapter we describe our initial efforts to characterize the expression 
pattern of the swip-10 homolog, Mblac1. To date, there are no reports 
describing the Mblac1 gene.  
Using a combination of RT-PCR and in situ hybridization, we show that 
Mblac1 RNA is present throughout the brain yet is enriched in particular brain 
regions. Of these regions we note a high density of Mblac1 RNA in the cingulate 
and entorhinal cortices, the hippocampus, the MHb, and the SVZ.  
We then developed and purified an Mblac1 antibody and used it to probe 
the expression of Mblac1 in transfected cells and in native brain tissue via 
Western blots. Though our primary antibody exhibits a high level of specificity in 
western blots of Mblac1 transfected cells, this antibody does not recognize 
human MBLAC1. Using antiserum from another host (#4979), we were able to
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Figure 70 – Measurement of Mblac1 β-lactamase activity using chromogenic substrates. Cell lysates from HEK293T cells 
transfected with the indicated gene were treated with one of two β-lactamase substrates to measure β-lactamase activity as 
described in the methods. Data were analyzed by one-way ANOVA with multiple Bonferroni post tests. Whereas the E. coli protein 
TEM-1(Bla) can cleave these substrates, Mblac1 and Mblac2 do not exhibit any specific cleavage of either A) Nitrocefin or B) 
CENTA.    
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detect the expression of transfected human MBLAC1 in this way. Thus 
antiserum from another rabbit may prove a vital tool in elucidating the 
expression of human MBLAC1 in post mortem brain tissue.  
To understand how Mblac1 expression is distributed in the cell, we 
screened immortalized cell lines for the expression of endogenous Mblac1. We 
identified the 3T3 embryonic fibroblast cell line as expressing endogenous 
Mblac1 that could be blocked by peptide preincubation. Based on the 
expression of swip-10 in glia, we screened C6 glioma cells for Mblac1 
expression. Surprisingly, we did not observed a specific Mblac1 band of the 
predicted molecular weight. Using 3T3 cells, we carried out crude subcellular 
fractionation to determine which cellular compartment is enriched for Mblac1 
expression. With this approach, we determined that Mblac1 is expressed in the 
cytosol and not in organelles or the nucleus. 
Next, we used our custom antibody to probe the expression of Mblac1 in 
mouse brain tissue via western blots and immunohistochemistry. We detected 
bands of the predicted molecular weight (28 kD) that could be blocked by 
peptide preadsorption of the primary antibody in cortex, striatum, midbrain, 
hippocampus, and cerebellum. These studies did not reveal any significant 
differences in the relative amount of Mblac1 in these brain regions so we moved 
to immunohistochemistry to get a more precise view of how Mblac1 expression 
is distributed throughout the brain. In multiple experiments using either 
antiserum or affinity purified antibody, we observed a very consistent pattern in 
areas proximal to the areas we observed in the in situ hybridization experiments. 
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Importantly, whereas Mblac1 RNA was enriched in neuronal layers of nuclei like 
the hippocampus and the cingulate cortex, we observed the majority of Mblac1 
protein in the molecular layer of the HIPP or surrounding the neuronal layer of 
the cingulate. As in the in situ we observed a striking expression in the MHb and 
in cells that make up the SVZ. In terms of the intensity of staining that we 
observe in these areas, the cells in the SVZ have the most pronounced level of 
staining. In immunohistochemistry experiments titrating the amount of Mblac1 
primary antibody, we observed staining of these cells at relatively low amounts 
of primary where staining in other known nuclei was limited.   
We have established that swip-10 hyperdopaminergia may derive from 
alterations in GLU signaling that drive the excitability of DA neurons and that its 
function is required in glia. In mammals, astrocytes are critical for the 
termination of synaptic and extrasynaptic GLU. We were therefore surprised to 
find that Mblac1 did not colocalize with known astrocyte markers like GFAP, 
S100β, or GS. Not deterred, we used immunofluorescence to determine if GLT-
1 and Mblac1 were coexpressed. In certain areas of the brain like the HIPP and 
the TB, we observed that Mblac1 and GLT-1 are expressed in shared fibers. 
Other areas of the brain such as the MHb are not rich in GLT-1 expression, so 
their coexpression in this area is unlikely. The MHb is rich in the expression of 
another GLT called GLAST, so immunofluorescence for both Mblac1 and 
GLAST may be an important step in determining if Mblac1 might have a broader 
role in its coexpression near GLTs (Gampe, Hammer, Kittel, & Zimmermann, 
2012). 
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Based on the pattern of expression we observed in the MHb, another 
candidate that shared a similar glomerular pattern of expression was vGlut2 (E 
Herzog et al., 2004; Etienne Herzog, Takamori, Jahn, Brose, & Wojcik, 2006). We 
observed that Mblac1 and vGlut2 were grossly expressed in shared terminal 
fields of the MHb and appear to colocalize in deep cerebellar nuclei. 3D 
reconstruction of MHb Z-stacks in these experiments did not suggest that 
Mblac1 expression is along vGlut2 containing axons, but a costain for 
acetylated tubulin and Mblac1 would be more informative.  These studies 
suggest that robust Mblac1 expression exists in areas of dense glutamatergic 
innervation. Importantly, we demonstrated that Mblac1 does not colocalize with 
the known dendrite marker MAP2.  
Lastly, based on our literature review, we hypothesized that the striking 
staining pattern that we observed in the SVZ cells were neural stem cells. We 
observed that Mblac1 colocalizes with the neural stem cell marker DCX in the 
SVZ and in the SGZ of the dentate gyrus. Therefore, in addition to its expression 
near vGlut2 and in GLT-1 containing fibers, Mblac1 expression is highly 
enriched in neural stem cells.    
 Using chromogenic β-lactamase substrates, we sought to probe the 
activity of Mblac1. Unlike TEM-1, however, Mblac1 nor Mblac2, was able to 
specifically cleave these β-lactam containing compounds. Similary, other β-
lactamase containing genes in humans like CPSF-73 and Artemis have been 
cloned and characterized that do not cleave β-lactams (Dominski, Yang, & 
Marzluff, 2005; Ma, Pannicke, Schwarz, & Lieber, 2002; Mandel et al., 2006; 
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Moshous et al., 2001; RYAN, 2004). We hypothesize that Mblac1 has an 
alternative substrate that does not contain this core chemical group.
FUTURE DIRECTIONS 
Mblac1 Expression Pattern 
To enhance our understanding of the pattern of Mblac1 expression in the brain, 
there are a few immunofluorescent stains that might inform about its localization 
including GLAST, NeuN, and acetylated tubulin to determine if it localizes in 
fibers with another known GLT and whether Mblac1 is expressed in neurons. To 
determine the exact site of expression in areas of dense Mblac1 expression like 
the MHb, immunoelectron microscopy of Mblac1 will reveal how Mblac1 is 
expressed around synapses. A collaboration to facilitate these efforts is 
currently underway. 
 
Impact of Mblac1 on Neuronal Physiology 
Our studies of swip-10 revealed that its loss results in an increase in DA neuron 
excitability. To test if Mblac1 has a conserved role as a regulator of neuronal 
physiology, we have begun efforts to understand the impact of viral Mblac1 
overexpression or knockdown in astrocytes on neuronal cocultures. Our 
preliminary studies have established that 1) Mblac1 is expressed in astrocytic 
cultures 2) The expression of Mblac1 is upregulated when neurons are 
cocultured with these glia 3) Neuron-induced upregulation of Mblac1 is more 
exaggerated when Mblac1 is virally overexpressed in astrocytes and 4) Whole 
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cell patch clamp recordings of spontaneous excitatory postsynaptic currents 
(sEPSCs) in neurons cocultured with and without astrocytic Mblac1 
overexpression suggest that Mblac1 overexpresssion in astrocytes increases 
the frequency, yet reduces the amplitude of sEPSCs. These data are consistent 
with the hypothesis that alterations in Mblac1 gene dosage in astrocytes 
impacts postsynaptic excitatory signaling. The detailed mechanism of Mblac1’s 
role in regulating GLU clearance or release is still unknown at this time.  
 
Identification of the Mblac1 substrate  
Our studies demonstrate that Mblac1 contains a metallo β-lactamase domain 
and that, in the case of swip-10, this domain is required for its function. It does 
not, however, appear to function as known prokaryotic metallo β-lactamases by 
cleavage of β-lactam bonds that can inactivate cephalosporin antibiotics. To 
discover the endogenous substrate, we are currently utilizing mass 
spectroscopy of Mblac1 protein incubated with and without mouse whole brain 
extract. We hope that these analyses may reveal a mass peak that is sensitive to 
Mblac1 expression.        
 
Mblac2/MBLAC2 
We identified a second metallo β-lactamase that is of similar length to Mblac1 
and contains some sequence similarity to swip-10 and Mblac1 (Figure 71). 
Analysis of the sequence similarity between swip-10 and mouse and human 
Mblac1/2 demonstrated that swip-10 is most similar to Mblac1 (39%) and that 
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Mblac1 is more closely related to swip-10 than Mblac2 (29%). During our 
previous RT-PCR experiments we also confirmed that demonstrated that 
Mblac2 and another metallo β-lactamase, Lactb2, were expressed throughout 
the brain. Importantly, analysis of the Mblac2 RNA expression pattern using in 
situ hybridization revealed some overlapping and nonoverlapping areas of 
expression with Mblac1 (data not shown). Mblac2 transcript is present in areas 
of the hypothalamus where there is no Mblac1 transcript. Analysis of Mblac2 
protein expression in brain sections via a recently generated commercial 
antibody revealed that this protein, though it is expressed in some overlapping 
areas of Mblac1 like the medial habenula, SVZ, hippocampus, and cerebellum, 
has a different cellular pattern within these nuclei. In the SVZ, for example, 
Mblac2 is likely expressed in a less dense and particular cell type known as 
tanacytes, whereas Mblac1 is expressed in a large swath of neural stem cells. 
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Figure 71 – 
Alignment of swip-
10 with Mblac1 and 
Mblac2. Black 
shading indicate 
residues that match 
swip-10. Blue 
shading indicates 
conserved histidine 
residues necessary 
for metal binding. 
Multiple Sequence 
alignment was 
performed using 
ClustalW in DNAStar.	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Chapter VII 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
INTRODUCTION 
These studies have demonstrated that the nematode C. elegans remains a 
powerful force in the identification of novel, conserved genes. With its rapid 
lifespan, the ability to carry out forward and reverse genetic screens, a 
transparent cuticle, and the availability of molecular biological tools to carry out 
rapid transgenesis, C. elegans’ holds promise to open new avenues of research 
that might be impractical or impossible using other model systems. Futhermore, 
more advanced neurophysiological approaches such as calcium imaging and 
optogenetics provide direct real time control or measurement of neural activity 
during behavior. Our forward genetic screen, though small in scale, has resulted 
in the isolation of a novel gene that regulates DA signaling through a novel 
pathway and whose mammalian homolog is expressed in the brain. In addition 
to the characterization we have already performed, these studies have 
stimulated a new line of research as to the function of mammalian metallo β-
lactamases in the CNS including Mblac1 and Mblac2. Though future studies will 
be necessary to fully describe their mechanism of action, the impact of swip-10 
on DA neuronal excitability and DA-regulated behaviors suggests that one or 
both of these genes may be important in regulating the physiology of neurons in 
the brain.  
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SWIP-10/MBLAC1 AND ITS CONNECTION TO β-LACTAM ANTIBIOTIC 
EFFECTS ON THE CNS 
In addition to their role in regulating neuronal excitability, we propose a 
hypothesis that Mblac1, possibly Mblac2, represent important potentially 
druggable targets for neuropsychiatric and neurological disorders. We 
hypothesize that manipulation of these proteins with pharmacological agents 
may have a dramatic impact on CNS neurocircuitry through alterations in the 
amount of extrasynaptic GLU. In the following section I describe the current 
state of knowledge about the impact of β-lactam antibioitics on brain disorders, 
why we hypothesize that Mblac1 may represent its target, the data that is 
consistent or inconsistent with this hypothesis, and what we propose to test our 
hypothesis.  
 In 2005, researchers at Johns Hopkins and Columbia University made an 
important discovery that we believe represents the key link to understanding 
Mblac1’s function in the CNS. Previous work had shown that either inhibition of 
GLTs in organotypic slices or genetic loss of the astroglial GLTs GLAST and 
GLT-1 in a mouse was sufficient to produce excitotoxicity (Rothstein et al., 
1996; Rothstein, Jin, Dykes Hoberg, & Kuncl, 1993). They postulated that loss of 
GLT-1 protein and GLU transport activity was a valid model of amyotrophic 
lateral sclerosis (ALS) as studies of post mortem tissue in ALS patients 
demonstrated a highly significant reduction in GLT-1 protein (Rothstein, Martin, 
& Kuncl, 1992). Thus they hypothesized that compounds that increased the 
amount of GLT-1 protein might be neuroprotective. In this study, the authors 
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screened a library of 1,040 FDA-approved compounds for their protective 
effects on organotypic rat spinal cord slices bathed in glutamate (Rothstein et 
al., 2005). The overwhelming majority of compounds that they screened had no 
effect on the amount of toxicity, but they observed that compounds of the β-
lactam antibiotic class consistently protected the slices and elevated the 
amount of GLT-1 protein. These compounds were sufficient to activate the 
human GLT-1 promoter in vitro and increase transcription and protein 
expression of GLT-1 in vivo in a mouse brain. To validate the relevance of these 
compounds in a disease model of ALS, they treated G93A superoxide 
dismutase 1 (SOD1) mice with one particular β-lactam compound: ceftriaxone 
(CEF). They found that CEF treatment significantly increased the lifespan, body 
weight, grip strength relative to saline treated animals. Moreover, treatment with 
CEF increased the amount of GLT-1 protein in these animals and prevented the 
death of motor neurons in the SOD1 G93A. These studies established a clear 
link between the effects of β-lactam antibiotics on the CNS, the regulation of 
GLT-1 activity, and identified a novel compound class to pursue in the treatment 
of ALS. Future studies have shown that β-lactams like CEF may have broader 
effects in the treatment of brain disorders. 
     One of the hallmarks of addictive psychoactive drugs like cocaine is 
that their acute use results in an increase in the amount of DA release in the 
NAc, but the neuroadaptive changes that result in chronic use of these drugs 
and behavioral hallmarks of addiction like tolerance, withdrawal, and relapse are 
still unclear. Work over the past decade has established that these aspects of 
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addiction are the result of alterations in the connectivity, morphology, and 
neurotransmission in pathways that ultimately converge on the NAc (S E Hyman 
& Malenka, 2001). One of the hypotheses postulated to account for these effects 
is that chronic exposure to cocaine or other drugs of abuse is that they alter the 
amount of extrasynaptic GLU that produces enduring changes in the physiology 
of NAc medium spiny neurons and ultimately behavioral elements of the phases 
of addiction (Kalivas, 2009). Baker and colleagues showed that animals that 
have undergone cocaine self-administration and 3-week withdrawal have a 
specific decrease in the amount of extrasynaptic GLU in the NAc as measured 
by no-net flux microdialysis (Baker et al., 2003).  They found that restoration of 
the GLU levels could be accomplished by application of a drug called N-
acetylcysteine (NAC) that acts on xC- to promote passive exchange of cysteine 
into the cell for GLU out of the cell. Later work by Knackstedt et al. showed that 
that this same self-administration and extinction paradigm was capable of 
reducing the amount of GLT-1 and xC- protein expression and a reduction in the 
amount of glutamate uptake (Knackstedt et al., 2009). As ceftriaxone 
upregulates the amount of GLT-1 expression, they treated the drug self-
administered animals and drug naive animals with NAC and CEF and found that 
both of these compounds restored the amount of xC- and GLT-1 in the drug-
treated animals with no effect on drug-naïve animals. To determine if CEF had 
effects in a behaviorally relevant addiction model, they challenged the drug 
withdrawn saline and CEF-treated animals with a cue previously paired with 
drug administration. Whereas the saline treated animals reinstated drug-seeking 
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behavior (lever presses), the CEF treated animals exhibited a significant 
reduction in cue-induced reinstatement. Another lab has also validated these 
results using a similar self-administration and withdrawal paradigm (Sari, Smith, 
Ali, & Rebec, 2009). Recently, Knackstedt and colleagues validated their 
previous results and demonstrated that cocaine self-administration results in an 
increase in sEPSC or ePCSC frequency and amplitude on MSNs in the NAc that 
were normalized by CEF (Trantham-Davidson, LaLumiere, Reissner, Kalivas, & 
Knackstedt, 2012). What is unclear in these studies is why loss of these of these 
GLTs (GLT-1 and xC-) results in a decrease in extracellular GLU and an increase 
in excitatory neurotransmission. A model that has been proposed is that the 
amount of extracellular glutamate exerts drive on presynaptic GLURs mGluR2/3 
and mGluR5 and that this drive is necessary for the development of plasticity 
that alters GLU release (Bellesi & Conti, 2010; Moussawi et al., 2009; Moussawi 
et al., 2011). Thus elevation of extracellular GLU via NAC or CEF treatment 
restores cocaine-induced metaplasticity, that is the loss of drug or behaviorally 
induced plasticity after chronic cocaine treatment. The effects of CEF on drug-
induced behavior may be more complicated as Ward et al. demonstrated that 
CEF reduces cocaine self-administration on a fixed ratio schedule without 
affecting the acquisition of sweet food reinforcement (Ward et al., 2011). 
Additionally, Rasmussen and colleagues showed that chronic CEF treatment 
inhibited acute AMPH-induced hyperactivity and acute and sensitized AMPH-
induced stereotypies (Rasmussen, Unterwald, & Rawls, 2011; Sondheimer & 
Knackstedt, 2011). Nonetheless, although an exact understanding of how NAC 
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and CEF alter drug-induced plasticity, neurotransmission, and behavior is not 
yet available, these studies establish that drugs like CEF may have broader 
activity in multiple brain disorders like addiction in addition to ALS. 
 The breadth of behavioral or disease paradigms that are ameliorated by 
CEF are on the rise, which suggests that alterations in GLU signaling may 
underlie the etiology of multiple CNS disorders. Considering the ubiquity of the 
GLU in the CNS, this is perhaps not surprising. Following the identification of 
CEF, another lab determined that CEF administration exerts antidepressant 
effects in mice (Mineur, Picciotto, & Sanacora, 2007). Similar to traditional 
antidepressants and serotonin selective reuptake inhibitors (SSRIs), ceftriaxone 
decreased the immobility time in the tail suspension and forced swim tests and 
decreased the latency to feed in the novelty-suppressed feeding paradigm. The 
authors therefore determined that ceftriaxone has antidepressant effects in 
mice. Further work by Lipski et al. determined that, similar to Rothstein et al., 
ceftriaxone was neuroprotective in oxygen glucose deprivation model of stroke 
(Lipski et al., 2007). Perhaps the best illustration of the broad neuroprotective 
role of CEF is a recent study that demonstrates that CEF protects against the 
neurochemical and behavioral effects of 6-OHDA (Leung et al., 2011). Together 
these studies demonstrate that CEF and the upregulation of GLT-1 (and perhaps 
xC-) has broad role in CNS disorders and prompts two important questions 1) 
where does CEF bind and accumulate in the brain and 2) What is the molecular 
target of this drug? 
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 We hypothesize that Mblac1 is the target of β-lactam compounds like 
CEF, and that CEF accumulates in Mblac1 expressing cells in the brain. Based 
on our studies in worms, we found that swip-10 acts in glia cells and may 
function in a pathway containing a GLT. Additionally, in collaboration with Jens 
Meiler’s group, we determined a predicted structural model for the swip-10 
metallo β-lactamase that had 27% sequence similarity to di-Zn metallo β-
lactamase VIM-4 from P. aeruginosa (Loktis, Sheehan, and Combs). We used 
this model to determine if the catalytic binding site could accomodate 
macromolecules like DNA or RNA or small molecules like CEF. Unlike other 
mammalian β-lactamases like Artemis or CPSF-73, these molecules are likely 
too large to dock in the predicted model of swip-10. The docking of CEF or 
penicillin within the binding site, on the other hand, was more likely. Thus it is 
structurally plausible that β-lactams can bind within the catalytic site of swip-10. 
Whether swip-10/Mblac1 acts on an endogenous β-lactam-containing 
compound is still unknown, but these analyses imply that swip-10 is not likely to 
act on a nucleic acid and that its molecular target is most likely a peptide or a 
small molecule. Currently, we are carrying out similar computational analyses 
with Mblac1 to validate that these same principles can be applied to the 
mammalian homolog. 
 Our studies of Mblac1 expression in vivo are consistent with our 
hypothesis that it functions in a pathway that is regulated by β-lactams and 
contains GLT-1. We demonstrated that it is expressed directly adjacent to 
vGlut2 and in GLT-1 containing fibers. Our GLT-1 colocalization and 
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fractionation experiments both demonstrate that Mblac1 is expressed in the 
cytosol. We hypothesize that β-lactams are likely to accumulate in overlapping 
GLT-1/Mblac1-containing fibers. Currently, we are using CEF-crosslinked resin 
to pull down potential binding partners from whole brain protein lysates and 
using matrix associated laser desorption ionization (MALDI) imaging of CEF-
treated brain sections to determine the areas where this compound accumulates 
in the brain. Unfortunately, we were not able to detect significant β-lactamase 
activity using prokaryotic chromogenic substrates. This does not preclude the 
possibility that CEF acts on Mblac1, rather it suggests that we must use the 
endogenous substrate and its modified product as a way to assay CEF’s effect 
on this enzyme. We are currently using mass spectroscopy of Mblac1-treated 
brain lysate with and without CEF as a way to identify the Mblac1 substrate and 
whether this interaction is sensitive to CEF. We hypothesize that the Mblac1 
target will be sensitive to CEF and will provide us with a novel mechanism to 
understand the regulation of GLU signaling and GLT-1. 
 Lastly, Mblac1’s expression in neural stem cells may hold the key to 
understanding CEF’s actions. It has been established that stem cells have an 
inherently glial nature, and Mblac1 may have a critical role in the differentiation 
or function of glial precursors in these stem cells (Kriegstein & Álvarez-Buylla, 
2009). One potential way to explain the breadth of literature on the effect of β-
lactams on CNS disorders is that CEF effects on Mblac1 and the production of 
its product ultimate control the production of new glia or neurons. In all of the 
previously mentioned studies, there have been no controls to rule out this 
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possibility such as western blotting for GFAP (in addition to GLT-1) or BrdU 
labeling to label newly generated cells. Another reason this hypothesis deserves 
a more critical examination is that CEF has been shown to produce 
antidepressant like effects (Mineur, et al., 2007). In the past 10 years, there is a 
growing body of evidence that the effects of antidepressants on CNS circuitry 
ultimately require that they increase hippocampal neurogenesis in the SGZ of 
the DG. As we observe Mblac1 expression in these cells, we hypothesize that 
Mblac1 may function in a pathway with antidepressants to regulate the 
production or maintenance of new neurons and/or glia. 
 
GENETIC MANIPULATION OF MBLAC1 
We have begun to gauge the impact of Mblac1 gene dosage alteration via 
lentiviral overexpression of this gene in mouse astrocytes and neuron 
cocultures. Our preliminary evidence suggests that Mblac1 overexpression 
increases the frequency and decreases the amplitude of spontaneous excitatory 
postsynaptic currents in postsynaptic neurons. These data suggest that Mblac1 
overexpression in astrocytes may increase glutamate release probability, but 
decrease the number of postsynaptic AMPA receptors available for glutamate. 
Future studies repeating these experiments with Mblac1 overexpression and 
using viral knockdown of Mblac1 will be informative in connecting Mblac1 to the 
regulation of neuronal physiology similar to swip-10. 
In in vitro preparations of astrocytes cultured in isolation the expression 
of the astrocytic glutamate transporter EAAT2/GLT-1 is limited. Similar to Yang 
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et al., GLT-1 expression is upregulation by the overlay of neurons on astrocytes 
(Yang et al., 2009). Over several experiments, we have observed that Mblac1 
expression is linked to neuronal coculture such that the amount of Mblac1 
expression relative to a loading control is increased when neurons are applied. 
These studies suggest that Mblac1 expression is dynamic in astrocytes or that 
Mblac1 may be partially expressed by neurons. Importantly, the neuron induced 
increase of Mblac1 expression is magnified in astrocytes that are virally 
overexpressing Mblac1. Thus these data are consistent with the expression of 
Mblac1 being linked to neuronal induction similar to GLT-1. Current efforts to 
develop a lentivirus to knockdown Mblac1 expression via Mblac1-specific 
shRNAs in these preparations are underway. The previously described 
connection to β-lactam antibiotics have led us to hypothesize that antagonism 
or binding of these compounds to endogenous Mblac1 may be required for the 
upregulation of GLT-1 that occurs during chronic CEF administration.  
In addition to developing a knockdown virus for manipulation, we are 
interested in developing genetic tools to determine the physiological role of 
Mblac1 in vivo. The International Knockout Mouse Consortium is currently using 
traditional homologous recombination to generate a Mblac1 knockout mouse 
(http://www.knockoutmouse.org/genedetails/MGI:2679717) and the Texas 
Institute for Genomic Medicine has screened positive ES cells containing a 
GeneTrap that is inserted in the 5’ UTR of Mblac1. More work will be needed to 
characterize the functional impact of either of these mutations and validate 
these genetic mouse models. As Mblac1 is expressed in a number of peripheral 
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tissues and we believe it impacts the function of GLT-1, viral knockdown 
approaches using ICV or nuclei specific injection of adeno associated viruses 
containing Mblac1 siRNA may be an important tool to assay the function of this 
gene in a tissue and temporal specific with minimal cost and time associated 
with generating a knockout mouse model.   
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Appendix A 
DEVELOPMENT OF A NOVEL, ANALYTICAL PLATFORM FOR KINETIC 
ANALYSIS OF C. ELEGANS SWIMMING INDUCED PARALYSIS2 
 
INTRODUCTION 
Since the completion of the human genome project and the growing annotation of 
several model organism genomes, neuroscientists have exploited these systems 
to identify novel conserved genes that directly impact behavior. In the nematode 
Caenhorhabditis elegans, there exist a repertoire of simple, reproducible 
behaviors that are easily implemented in the lab to link genotype to phenotype. In 
particular, modulation of these behaviors are highly conserved across families of 
signaling molecules that include fast-acting neurotransmitters such as 
acetylcholine, gamma-aminobutyric acid, and glutamate as well as slower acting 
neuromodulators including dopamine (DA), serotonin (5-HT), and neuropeptides 
(Jorgensen 2005; Brockie and Maricq 2006; Chase 2007).  DA was among the 
first neurotransmitters demonstrated to modulate locomotion in the worm 
(Schafer and Kenyon 1995). Since that time, genes necessary for DA synthesis, 
packaging, release, reuptake, and signaling at pre- and postsynaptic receptors 
have been cloned and their impact on worm behavior studied (Mcdonald et al. 
2006).  
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  Adapted from Hardaway and Wang et al. Journal of Neuroscience Methods 
(under review) 
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In our previous report, we demonstrated that worms lacking activity of the 
presynaptic dopamine transporter (DAT) demonstrate DA and dop-3 dependent 
Swimming Induced Paralysis (Swip) (Mcdonald et al. 2007). These efforts and 
others have revealed a clear need for a simple, open source analytical platform 
to quantify C. elegans swimming behavior and paralysis. In this study, we 
describe the development and implementation of a system for quantification of 
Swip. We demonstrate the capabilities of our tools by analyzing the highly 
penetrant Swip behavior of dat-1 animals and the Swip behavior observed after 
treatment of animals with the tricyclic antidepressant and dat-1 antagonist 
imipramine (IMI). We demonstrate that SwimR can reveal novel kinetic 
alterations in swimming produced by these manipulations that can be of use in 
dissecting the differential control of swimming behavior by converging signaling 
pathways.   
 
MATERIALS AND METHODS 
C. elegans Strains and Husbandry 
C. elegans strains were cultured on bacterial lawns of OP50 and maintained at 
12 to 20°C using standard methods unless otherwise noted (Brenner 1974). The 
wild-type strain is N2 Bristol. The dat-1(ok157)III strain was obtained from J. 
Duerr and J. Rand (Oklahoma Medical Research Foundation, Oklahoma City), 
and is a complete loss of function mutation that eliminates the majority of the 
DAT-1 coding sequence. A strain producing a loss of function disruption of DOP-
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3 (dop-3(vs106)X) was obtained from the Caenorhabditis Genetics Center 
(University of Minnesota, Minneapolis) and cat-2(tm2261) from Shohei Mitani at 
the National Bioresource Project at Tokyo Women’s Medical University.  
 
Assessment of Swip Behavior 
In both batch and automated analyses, we generated synchronous populations of 
these strains by hypochlorite treatment and harvesting arrested L1 animals. L1s 
were plated at a moderate density on fresh NGM/OP50 plates and incubated at 
temperatures ranging from 12 to 20 degrees. On test days, middle stage L4 
animals were identified by characteristic morphological features and used for 
behavior as N2 animals show some stochastic Swip and quiescence bouts prior 
to and during the last larval molt. We placed worm test plates at room 
temperature for 15 min to acclimate to room temperature before testing. A stock 
of IMI (Sigma – Cat No. I7379) was dissolved in water to 100 mM on test days 
and serially diluted in water to the desired concentrations. For batch analyses, 
100 μL of water or drug were dispensed in multiple wells of a Pyrex Spot Plate 
(Fisher catalog number 13-748B) and 10-15 L4 animals were gently transferred 
using an eyelash pick. After 10 min., we recorded the number of paralyzed 
worms/total worms. Two independent observers performed assays over several 
weeks using multiple worm preparations, blind to genotype or drug manipulation.  
For automated video analysis, single L4 hermaphrodites were placed in 20 µL of 
water or drug in a single well of a Pyrex Spot Plate, and 10 min. movies 
(uncompressed AVI format) of their swimming behavior were captured as 
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described in the supplementary materials. Every worm line was recorded 
sequentially and in parallel over several days to ensure that strains were identical 
in age. 
 
SwimR Tools 
Individual worm videos were tracked in open source morphometric tracking 
program (Tracker 2.0), and output files were analyzed in SwimR according to the 
Supplementary Materials. 
 
Statistical Analysis 
SwimR generates several output images and text files of the raw data used to 
generate them (see Supplementary Materials). Raw data from SwimR was input 
into Prism 6.0a (Graphpad, La Jolla,CA) and subsequent analyses performed as 
described in the text or figure legends. 
 
RESULTS AND DISCUSSION 
Development of a Single Worm Swimming Tracker and an R-based 
Analytical Platform (SwimR) 
In our initial efforts to quantify thrashing behavior, we developed a tool (Tracker) 
that can analyze the swimming frequency of individual nematodes (Matthies et al. 
2006; Mcdonald et al. 2007). This software provides an output of the worm 
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Figure 72	   – Paralytic effects of IMI on C. elegans N2 animals as determined by 
manual and automated assays. A) Diagram of the workflow for C. elegans swimming 
analysis. B) Response of N2 (filled circles), cat-2 (open triangles), and dat-1 (open 
squares) to increasing concentrations of IMI. Dose Responses to IMI were fit using non-
linear regression. Using these analyses we determined the IC50 of N2 and cat-2 to be 10 
μM (+/-1.5 μM) and 99 μM (+/-12 μM) respectively. Dose-response data points for dat-1 
were connected with a line between data points.   C) Effect of IMI on N2 swimming 
frequency. Average frequency values were analyzed by 2-way ANOVA with with 
Dunnet’s post tests of each time point in the drug condition to the corresponding basal 
time point. Shaded areas represent SEM. 3 μM IMI triggered a significant (P<.05) 
decrease in the average frequency beginning at the 4th minute (P<.05). 10 μM IMI 
induced a significant decrease in average frequency (P<.05) with individual time points 
reaching significance in the 2nd minute. D) Distribution of N2 swimming frequency 
values with and without IMI. IMI treatment induces a shift to lower frequency values. E) 
Heat map representations of N2 swimming frequency with or without 10 μM IMI.  
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positional coordinates during swimming (Figure 72A). Since C. elegans swim by 
the propagation of C-shaped bends on their dorsal and ventral sides, Tracker 2.0 
uses a particle filter to assign a 3-point spine to a worm difference image. Within 
this program, parameters related to spine length, the number of particles, the 
maximum angle between two points along the spine, and the allowable 
displacement of the spine between frames can be altered to maximize tracking 
fidelity (See Supplementary Materials). To analyze subcomponents of worm 
swimming, we developed an open source analytical suite using R (http://www.r-
project.org/).  Our suite, SwimR, analyzes Tracker 2.0 files and uses several 
counting methods to determine the spine movement frequency. The frequency 
values, as determined using these methods, are provided in output directories to 
allow the user to tailor the counting method to the desired analysis. After the 
analysis of each worm track, SwimR constructs a matrix of frequency vs. time for 
each worm in the data set that is used for subsequent calculations and graphical 
output. SwimR analyzes the frequency matrix to extract kinetic parameters 
related to swimming frequency, paralysis probability and duration, and reversion 
characteristics.  
 
Manual Analysis of IMI-Triggered Paralysis and Dose Selection 
Previously we implemented Tracker and SwimR to demonstrate the power of our 
tools for characterizing and distinguishing the Swip behavior of multiple genetic 
models (Hardaway et al. 2012).   Here, we analyze the paralysis of animals as 
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triggered by the dat-1 antagonist IMI to understand whether SwimR is also 
capable of discerning patterns produced by pharmacological manipulations. IMI 
was first described as a potent inhibitor of dat-1 mediated DA uptake following 
heterologous expression of the cloned transporter (Jayanthi et al. 1998). In vivo 
studies with IMI on behavior with the drug were not pursued as a null dat-1 allele 
was not available at the time to test for dat-1 specificity of IMI actions. With the 
null dat-1(ok157) allele now available, we returned to this question and utilized 
SwimR to determine the program’s utility for dissection of acute, drug-induced 
Swip.  
 
We first tested the effects of IMI using manual Swip assays, counting the number 
of animals that paralyze within a 10 minute time frame post application of IMI. We 
observed a robust loss of Swip in cat-2 animals that lack expression of tyrosine 
hydroxylase, the rate limiting step in DA synthesis (Figure 72B), amounting to a 
9-fold shift in the IMI IC50. Thus, whereas at 50 µM IMI, N2 animals become 
nearly fully paralyzed, cat-2 animals exhibit only modest (~20%) paralysis. 
Consistent with a DA dependence of IMI actions, we also observed a reduction in 
IMI potency with dop-3 animals (Figure 74A), though the shift was more 
moderate (~5 fold). When IMI was tested on dat-1 animals, we saw the expected 
inability of IMI to augment paralysis, consistent with the drug and mutation acting 
through a common pathway (Figure 74D). Interestingly, at 33 and 50 µM IMI, we 
observed a reversal of paralysis in dat-1 animals, followed by a decline to 
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complete paralysis as the concentration was raised further. Although we have not 
explored the mechanism(s) for these effects, we note that IMI has been reported 
to inhibit the 5-HT transporter mod-5 (Ranganathan et al. 2001), and may act at 
ion channels like egl-2 (Weinshenker et al. 1999) to regulate egg-laying. Given 
the importance of 5HT’s role in crawl-swim transitions (Vidal-Gadea et al. 2011), 
we hypothesize that mod-5 plays a role in one or more of the components seen 
at concentrations above 33 µM. In order to explore the Swip of IMI with SwimR 
in relation to Swip of dat-1, we used 3 and 10 μM IMI in all further studies. 
 
Automated Analysis of IMI-induced Swip Behavior 
In the next set of studies, we generated single worm tracking files from videos 
using Tracker 2.0 and analyzed tracks by genotype and drug using SwimR. We 
compared individual frequency plots for each worm to its corresponding movie 
by eye to validate tracking fidelity. Some false tracking was observed, but this 
was usually due to a low-quality video containing poor contrast and/or debris in 
the well (See Supplementary Materials). Using SwimR, we generated data 
matrices for each genotype by drug combination containing properly tracked 
files for further analysis. We then used SwimR to analyze IMI’s effects on each 
genotype.  
IMI produced a robust, dose-dependent decrease in average thrashing 
frequency with the N2 strain. As shown in Figure 72C, 3 μM IMI produced a 
significant decrease in the N2 thrashing frequency that was more prominent with 
10 μM IMI. In addition, IMI, irrespective of dose, reduced the average maximal 
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Table 2 – Swimming and Paralytic Measurements for IMI-induced Swip 	  	  	   Maximal  Frequency 
(Hz) 
Latency to  
Paralyze 
(sec) 
Reversion  
IncidenceA 
Reversion 
Frequency 
(events/ animal) 
Reversion  
ProbabilityB 
Time to 1st  
Reversion 
(sec) 
Average 
Reversion Event 
Length (sec) 
N2(n=63) 1.82+/-0.141 305+/-165 0.455 3.80 +/-1.93 1070+/-693 93.9+/-132 17.5+/-24.0 
N2 + 3 μM IMI(46) 1.60+/-0.262*** 274+/-141 0.25 3.33+/-3.21 432+/-584 147+/-89.8 20.0+/-31.5 
N2 + 10 μM IMI(38) 1.65+/-0.137*** 297+/-169 0.2 1.25+/-0.50 42.7+/-52.3* 175+/-97.0 7.62+/-8.79 
 
dat-1(ok157)(117) 1.46+/-0.436 206+/-124 0.366 0.336+/-2.63 394+/-500 140+/-127 13.4+/-26.6 
dat-1 + 3 μM IMI(31) 1.61+/-0.193 261+/-109 0.308 1.38+/-0.744 237+/-417 171+/-121 5.36+/-6.20 
dat-1 + 10 μM IMI(27) 1.56+/-0.260 260+/-141 0.273 0.273+/-2.33 162+/-264 235+/-84.2 6.40+/-3.19 
 
cat-2(tm2261)(38) 1.75+/-0.091 N/A N/A N/A N/A N/A N/A 
cat-2 + 3 μM IMI(23) 1.82+/-0.097 438+/-138 0.333 0.333+/-3.5 0.333+/-3.50 177+/-44.3 1.15+/-0.54 
cat-2 + 10 μM IMI(27) 1.53+/-0.183*** 140+/68.3**C 0.25 9 715 98.2 5.87 
 
dop-3(vs106)(22) 1.88+/-0.034 223+/-206 1 2.67+/-1.15 1500+/-1550 157+/-139 15.89+/-10.0 
dop-3 + 3 μM IMI(27) 1.81+/-0.050 379+/-165 0.333 0.333+/-2.00 986+/-1380 50.1+/-3.15 9.08+/-12.8 
dop-3 + 10 μM IMI(34) 1.50+/-0.278*** 188+/-144 0D* N/A N/A N/A N/A 	  
A Reversion Probability = total time spent in reversion/ total time after paralysis onset 
B Reversion Incidence = fraction of animals that reverse from paralysis 
Asterisks(*) indicate a significant difference to control genotype as determined by one-way ANOVA with Dunnet’s multiple comparision test where  
* = p < 0.05, ** = p < 0.01, and *** = p < 0.001. 
C – unpaired student’s t test to cat-2 + 3 μM IMI  
D Chi-square test  
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Figure 73 – Equipment setup for C. elegans swimming analyses and sample video 
recordings A) C. elegans swimming was assayed on a system containing stereo 
dissecting scope (2) on a mounted stage coupled to a ThorLabs DCC1545M camera (3) 
illuminated by a Fostec Fiber Optic Illuminator (1). Uncompressed .avi videos were 
acquired in VirtualDub (Avery Lee) on a PC WorkStation running either Windows XP or 
Windows 7 (4). B) Ancillary equipment necessary for swimming assays. Single worms 
were assay in 9-well Pyrex dishes (1) containing 20 μL of water or drug dissolved in 
water. Media was transferred using a fixed volume 20 μL pipette (2). A single worm was 
transferred from an NGM/OP50 plate into solution using an eyelash pick (3). 
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frequency of swimming across the entire recording (Figure 72D, Table 2, + Sup 
Fig 76A). As we observed a reduction in maximal swimming frequency in dat-1 
and DA-dependent Swip lines isolated in our forward genetic screen, we 
suspected that the reduction in maximal frequency after IMI treatment was due 
to the presence of paralyzers in this population limiting the time frame over 
which high swimming frequencies could be reached. To determine whether the 
decrease in average thrashing frequency was due to an increase in Swip latency 
or in penetrance, we used SwimR to plot a heat map of each worm’s swimming 
frequency over time (Figure 72E and Figure 75A). In these plots, each track is 
placed in a single row, one above the other, and its thrashing frequency is 
scaled according to color where black/yellow represents its highest swimming 
frequency and white/blue represents paralysis. SwimR orders the maps so that 
the strongest paralyzers are placed at the bottom. As we observed a small 
amount paralysis in N2 animals without drug treatment, we could assess the 
properties of this paralysis for comparison with IMI treatment. Inspection of IMI 
treated animals revealed a higher incidence of Swip with 10 μM IMI relative to 
N2 animals without drug treatment with no change in Swip latency (Table 2). The 
increased penetrance of Swip was also evident in an increased density of low 
frequency values with 10 μM IMI treatment relative to no drug (Figure 72D and 
Figure 76A). Whereas N2 paralyzers without drug treatment displayed a high 
level of reversion from paralysis, paralysis triggered by IMI displayed a lower 
incidence of reversion, though this parameter did not reach statistical 
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Figure 74 – IMI effects on swimming of dat-1, cat-2 and dop-3 animals A) Dose 
response effects of IMI on dop-3(vs106) as measured manually. Assays and statistical 
analyses were performed as described in Fig. 1 and in the methods. r2 of fitted curves 
for N2 and dop-3 were 0.9086 and 0.8265 and the IC50 values for N2 and dop-3 were 10 
μM (+/-1.5 μM) and 56 μM (+/- 7 μM) respectively. B) Automated recordings and 
analysis using Tracker 2.0. Average frequency of cat-2(tm2261) without drug, 3 μM IMI, 
and 10 μM IMI. Data were analyzed by 2-way ANOVA with Dunnet’s post tests of each 
time point in the drug condition to the corresponding basal time point. Shaded area 
around the no drug condition represents the standard error. For illustrative purposes, 
the standard error is not shown for the drug conditions. Significant changes (P<.05) in 
average frequency for 3 μM IMI were observed, reaching significance at the 1st and 9th 
minute. The increase in frequency with 10 μM IMI during the 1st minute did not reach 
significance.  C) Average frequency of dop-3(vs106) without drug, 3 μM IMI, and 10 μM 
IMI. Data were analyzed as above. We observed significant changes in average 
frequency for 3 μM IMI during the 9th minute. 10 μM IMI decreased the average 
frequency of dop-3 during minutes 2-4 and 6-10. D) Average frequency of dat-1(ok157) 
without drug, 3 μM IMI, and 10 μM IMI. 3 μM IMI increased the average frequency of 
dat-1 during several points in the first 4 minutes. 10 μM IMI increased the average 
frequency of dat-1 during time points in the first four and last five minutes. 
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Figure 75 – Heat map representations of IMI effects on N2, dat-1, cat-2, and dop-3 
animals. Each row represents the frequency of swimming of an individual animal with 
thrashing frequency values represented as a color where yellow represents a high 
thrashing frequency and blue represents paralysis. We smoothed the raw frequency 
values in a 10 second moving window before plotting. For representative purposes, the 
top 5% of the thrashing frequency values are not used in this scale. Plots are ordered b 
ottom to top according to the latency to paralyze. A) IMI increases the incidence of 
paralysis of N2 animals in a dose dependent manner. B) IMI has limited, but detectable 
paralytic effects on cat-2 worms at 3 μM and 10 μM. C) IMI has subtle immobilizing 
effects on dop-3 worms at 3 μM and 10 μM. D) IMI alters the kinetic paralytic profile of 
dat-1 worms.  
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significance (Table 2).  However, we observed that paralyzed worms treated with 
10 μM IMI displayed a statistically significant reduction in reversion probability, 
with no change in the time to 1st reversion or reversion event length. Thus, IMI 
dose dependently increases the amount of paralysis evident in the population 
assayed and decreases the likelihood that the animals reverse. 
Unlike our manual assays, using SwimR we detected cat-2 and dop-3 
independent effects of IMI. Surprisingly, 3 μM IMI increased the average 
thrashing frequency of cat-2 animals during the first two minutes and decreased 
thrashing frequency during the final minute. For dop-3 animals, 3 µM IMI 
triggered a significant reduction in thrashing frequency in the final minute of 
recording whereas this behavior started in the third minute for 10 μM IMI. Unlike 
N2, only 10 μM had a significant effect on the maximal frequency reached by 
cat-2 and dop-3 worms. Inspection of the population plots for cat-2 and dop-3 
revealed a higher incidence of paralytic worms at both doses and an increase in 
Swip latency for cat-2 paralyzers treated with 10 μM IMI relative to 3 μM IMI 
(Figure 74B and Table 2). Consistent with the significant reduction in average 
thrashing frequency evident in the final minute, 3 μM IMI triggered paralysis at 
the end of several worm tracks (asterisks in Figure 75). Inspection of the 
frequency distribution for cat-2 and dop-3 treated with IMI revealed that the 
increase in average thrashing frequency during the first two minutes was 
reflected in a shift in the density of higher frequency value bins (Figure 76). As  
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Figure 76 – Frequency distribution of IMI effects on N2, dat-1, cat-2, and dop-3 
animals. Frequency values were binned (0.1 Hz) and plotted as a fraction of the total # 
of values recorded. A) IMI increases the fraction of animals of low frequency bins and 
decreases the fraction of high frequency bins of N2 animals in a dose dependent 
manner. B) IMI dose dependently decreases the density of low frequency bins and 
increases the fraction of intermediate and high frequency bins in a dat-1 strain. C) IMI 
increases the quotient of low frequency bins and increases the fraction of high 
frequency bins in cat-2 animals. D) IMI causes only subtle alterations to low and high 
frequency bins in a dop-3 strain.   
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we only detected a few paralyzers in either dose, we were underpowered to 
make any significant observations regarding IMI’s effects on cat-2 or dop-3 
paralytic reversion. Nonetheless, analysis with SwimR revealed that IMI alters 
swimming behavior in strains lacking cat-2 or dop-3, though IMI effects on cat-2 
and dop-3 are not as robust in reducing the average thrashing frequency.  
IMI treatment of dat-1 animals at 3 μM and 10 μM triggered a dose-
dependent increase in average thrashing frequency across all time points, with 
10 μM producing a more sustained significant increase across the recording 
time (Sup. Figure 74D). Unlike cat-2 and dop-3, IMI did not alter the maximal 
frequency reached at either dose. Consistent with our manual assays, 
inspection of the heat maps (Figure 75), frequency distributions (Figure 76B), 
and analysis of Swip latency and reversion (Table 2) in dat-1 animals treated 
with 3 μM and 10 μM IMI revealed that this increase in average thrashing 
frequency is due to a decrease in Swip penetrance. These observations 
represent the first identification of an acute pharmacological agent that rescues 
dat-1 Swip. The apparent affinities of IMI for dat-1 and mod-5 suggest that IMI 
is more likely to act on dat-1 (Jayanthi et al. 1998; Ranganathan et al. 2001). In 
dat-1’s absence however, IMI may have a higher bioavailability for targets like 
mod-5 or egl-2 (Weinshenker et al. 1995). Considering the classical antagonistic 
roles for DA and serotonin in behaviors like egg-laying and movement on plates, 
it seems plausible that dat-1 and mod-5 function in parallel to regulate the 
extrasynaptic tone of both neurotransmitters during worm swimming. Further 
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studies exploring these genetic interactions in context with IMI application may 
inform how these pathways converge to regulate swimming behavior.  
These studies demonstrate the utility of SwimR for the analysis of both 
genetic and pharmacologically induced patterns of C. elegans swimming. In 
manual assays, we demonstrated that IMI induces paralysis consistent with DA 
and dat-1 dependence. Analysis of IMI effects using SwimR revealed that 
whereas the behavioral effects of IMI clearly require endogenous DA signaling, 
additional pathways are likely to regulate responses even at low concentrations 
of the drug. Importantly, SwimR enabled us to depict and quantify 
subcomponents of IMI effects not detected with manual assays. For example, 
time-dependent changes in drug-modulated swimming behavior are missed in 
end-point, “yes-no” manual paralysis assays. We conclude that SwimR is a 
useful tool for exploring the differential impact of mutations and drugs on 
distinct signaling networks, one that, due to its freely available, open-platform 
nature, can be tailored to the specific interests of C. elegans researchers. 
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Appendix B 
CANDIDATE-BASED ANALYSIS OF ION CHANNEL AND AUTORECEPTOR 
CONTRIBUTIONS TO DAT-1 SWIMMING INDUCED PARALYSIS. 
  
 
 
INTRODUCTION 
Our previous studies of the identification of Swip in the dat-1 strain established 
that this strain demonstrates a paralytic phenotype that requires the presence of 
DA and the dop-3 receptor (P. W McDonald, et al., 2007). The identification of 
the Swip phenotype, the absence of dat-1 mediate locomotory alterations on 
solid substrate, and the subsequent demonstration that Swip is osmosensitive 
suggest that there exist context-specific mechanisms that trigger excitation of 
DA neurons when worms are placed in water.  In this study, we aim to describe 
the upstream mechanisms via a host of genetic and behavioral assays. We 
demonstrate that a network of presynaptic genes including the ion channels trp-
4 and asic-1 and DA receptor dop-2 function in DA neurons to control the 
penetrance of Swip in the dat-1 mutant. 
  
MATERIALS AND METHODS 
C. elegans Strains and Husbandry 
C. elegans strains were cultured on bacterial lawns of OP50 and maintained at 
12 to 20°C using standard methods (Brenner, 1974) unless otherwise noted. The 
wild-type strain is N2 Bristol. 
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We used the following strains for this study: 
dat-1(ok157) 
dat-1(v21) 
dat-1(vt22) 
dop-2(vs105) 
cat-2(tm2261) 
asic-1(ok415) 
trp-4(ok1605) 
trp-4(sy695) 
swip-10(vt29) 
swip-10(vt33) 
 
Genetic Crosses 
Crosses were performed using publically available integrated fluorescent 
reporter strains to mark chromosomes in trans. Single worm PCR were 
performed to confirm the presence of the indicated mutation. For all deletions, 
we used a three primer multiplex strategy that produces PCR amplicons with 
100-200 bp difference between N2 and mutant. This was highly effective in 
eliminating preferential amplification of a lower molecular weight species. In all 
cases, a synthetic heterozygous control was utilized to ensure that heterozygous 
clones could be identified within that experiment. All PCR reactions were 
performed with Platinum PCR Supermix (Life Technologies). 
 
We generated the following strains by cross. Primers for genotyping are only 
listed once: 
 
BY822 trp-4(ok1605); dat-1(vt21) 
PCR genotyping of trp-4(ok1605) was performed using the following primers 
5’ sense – AAGACTCCGGTACACGTTGC 
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3’ antisense – AGAAGCATCCGCACAAGACT 
inner antisense – acagtaaccttggtcctggt 
Genotyping of dat-1(vt21) was determined by sequencing of PCR products 
using the following primers: 
5’ sense – tcctgcaaatctggaaaacc(sequencing primer) 
3’ antisense – agctccagcaaaacttccaa 
BY823 trp-4(ok1605); dat-1(vt22) 
Genotyping of dat-1(vt22) was determined by sequencing of PCR products 
using the following primers: 
5’ sense – acagcaatgtgtcgaagtgc(sequencing primer) 
3’ antisense – ggttttccagatttgcagga 
BY830 dat-1(ok157); dop-2(vs105) 
PCR genotyping of dat-1(ok157) was performed using the following primers: 
5’ sense – gcaatcacaacttggggaag 
3’ antisense –aaagtggaagacacctatgttcatagc 
inner antisense -  ggttttccagatttgcagga 
PCR genotyping of dop-2(vs105) was performed using the following primers 
5’ sense – tttgtgcctcagttcgtctgac 
3’ antisense – aacctcggtttcccttgttaggca 
inner sense – cgagcactgcaatcagccatcaat  
BY831 trp-4(ok1605); dat-1(ok157) 
BY839 asic-1(ok415) trp-4(sy695) 
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asic-1(ok415) and trp-4(sy695) were crossed together to generate double 
heterozygote animals and recombinant progeny were identified by screening 
individual clones using the following primers: 
asic-1(ok415): 
5’ sense – gccgtgctctagccgtaatacag 
3’ antisense – GCCCAGCTTCTGGCCATATGTA 
inner antisense – gcctggatgcaaattagaattggctc 
trp-4(sy695): 
5’ sense – gtactgaaaaaaaactcgattccccc 
3’ antisense – TGGTTCGCCCGTCTGTAAGCT 
inner sense – CTACCAGCCTGTCGACGAGGAC 
BY840 asic-1(ok415) trp-4(sy695); dat-1(ok157) 
We crossed BY839 to dat-1(ok157).  
BY885 asic-1(ok415) trp-4(sy695); swip-10(vt29) 
We crossed BY839 to swip-10(vt29). swip-10(vt29) genotype was determined by 
Sanger sequencing of PCR amplicons generated using the following primers: 
Sense – ccagAACGATACGATGAACC(Sequencing primer) 
Antisense – GCAACCATAGCGCCTTCTAG 
BY886 asic-1(ok415) trp-4(sy695); swip-10(vt33) 
We crossed BY839 to swip-10(vt33). swip-10(vt33) genotype was determined by  
Sanger sequencing of PCR products using the same primers for swip-10(vt29). 
BY892 asic-1(ok415); dat-1(ok157) 
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C. elegans assay for Swip 
In both batch and single worm analyses, we generated synchronous populations 
of these strains by hypochlorite treatment and harvesting arrested L1 animals.  
Early-mid stage L4 animals were identified by characteristic morphology and 
used for behavior as N2 animals show some stochastic Swip and quiescence 
bouts during the last larval molt. For automated analysis, single L4 
hermaphrodites were placed in 20µL water or drug in a single well of a Pyrex 
Spot Plate (Fisher catalog number 13-748B), and 10 minute movies 
(uncompressed AVI format) of their swimming behavior were created and 
analyzed as described previously (Hardaway and Wang et al.). 
 
C. elegans assay for Basal Slowing Response 
Assays were performed as described in Chase et al. with some modifications. 
We prepared food free 35 mm NGM plates and used them for 2-3 days of testing. 
For the food condition, we spread a thin layer of HB101 in a “donut” fashion 
around the edge of 35 mm plates with the bottom of a glass test tube. Bacteria 
were serially diluted, spread at several different dilutions, and incubated o/n at 37 
degrees. The next day, food-containing plates were selected for BSR assay 
based on the density of bacterial growth which was complete (not spotty), but 
also textured and not overgrown. Overgrown bacterial lawns were capable of 
producing non-DA dependent slowing by virtue of imposing a thicker matrix for 
worm locomotion. We picked mid-stage L4 animals and placed them at 15 
degrees o/n to generate young adult hermaphrodites. On the day of testing, 
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strains were blinded and experiments picked single young adults, rinsed them 
briefly in M9 (3-4 sec) to remove food, and placed them on either a food-free 
plate or directly adjacent to a bacterial source on a food-containing plate. After 30 
seconds, we counted the number of body bends in a 20 second interval. On each 
day, 5 animals were scored in both conditions for each genotype. Data shown 
represents the cumulative average body bends over at least 3 days of 
experiments for two experimenters. 
 
Isolation of mRNA 
An asynchronous population of BY200 and dat-1(vt22) worms were harvested 
from a 10 cM 8p/NA22 plate by rinsing with M9. These worms were washed 5X 
with 15 mls of M9 and the pellet was frozen at -80° o/n. On the next day we 
ground up the pellet using a ceramic mortar and pestle that had been prefrozen 
with liquid nitrogen. RNA from 100 μl aliquots of the frozen powder was 
extracted in 1 ml of TRIzol (Life Technologies) according to the manufacturer’s 
instructions. Precipitated RNA was suspended in RNAse and DNAse free water 
(Life Technologies). We purified mRNA from these total RNA preps using 
MicroPoly(A)Purist kit (Life Technologies) according to the manufacturers 
instructions. mRNA and Total RNA were run on an 1% agarose gel to confirm 
the purity and that rRNA was not present in our samples.  
 
Whole Transcriptome Sequencing of BY200 and dat-1(vt22) 
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We used 100 ng of mRNA for cDNA library synthesis and used this library to 
construct a sequencing library for next-generation sequencing using single end 
36mers on an Illumina Genome Analyzer Iia. The reads were trimmed to facilitate 
mapping and then mapped to a reference transcriptome (WS180). Average 
nucleotide coverage depth was ~5X. We normalized the # of reads at each 
particular gene by the number of total reads from that sample and the length of 
the gene (in Kb)(Mortazavi, Williams, McCue, Schaeffer, & Wold, 2008) and 
compared the fold enrichment of reads in BY200 and dat-1(vt22). We then 
compared lists of genes that were either up or downregulated in dat-1(vt22) with 
a list of genes whose expression is known to be enriched in DA neurons to 
extract genes that are more likely to function presynaptically within DA neurons 
(Spencer, et al., 2011).       
 
Transgenic rescue of asic-1 and trp-4 
To determine the cell autonomous role of asic-1 and trp-4, we constructed 
vectors or used available vectors that drive their expression solely in DA 
neurons. We obtained a pdat-1:trp-4(cDNA):SL2-YFP courtesy of the Schafer lab 
and a pore dead version of trp-4 in the same backbone via the Xu lab (L. Kang, 
Gao, Schafer, Xie, & Xu, 2010; Kindt, et al., 2007). To express asic-1 cell 
autonomously, we cloned an asic-1 genomic fragment into a pdat-1 expression 
vector. The asic-1 fragment was amplified from a pasic-1:asic-1(genomic):GFP 
construct obtained from the Tavernarakis lab.  
The following strains were generated by germline transformation: 
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BY1017-BY1019 – We injected pdat-1: asic-1 onto BY840(asic-1(ok415) trp-
4(sy695); dat-1(ok157)) to generate vtEx169-vtEx171 
BY1027-BY1029 – We injected pdat-1: trp-4	  (EPK1739-41KPK):SL2-YFP onto BY840 
to generate vtEx177-179 
BY1035-BY1036 – We injected pdat-1: trp-4:SL2-YFP onto BY840 to generate 
vtEx180-vtEx181. 
 
For Swip analyses, transgenic and non-transgenic progeny were picked onto 
separate plates, allowed to acclimate for at least three hours and then assay for 
Swip. 
 
RESULTS 
RNAseq of dat-1 reveals compensatory changes in ion channels 
We hypothesized that genes important for normal DA neuron physiology, DA 
biosynthesis, vesicular release, or postsynaptic signaling would be revealed by a 
loss of DA clearance through dat-1. To understand how dat-1 functions in a 
network of DA neuron cell autonomous genes, we performed whole 
transcriptome sequencing on mRNA from wild type and dat-1 strains and 
identified all of the genes whose expression was altered by at least 25% (Figure 
77A). As we observed an inordinate number of genes whose expression was 
upregulated in dat-1 (skewed right distribution in Fig. 77B), we focused on 
genes with downregulated expression in the dat-1 mutant. Importantly, we 
compared our list of genes with altered expression levels to lists of genes 
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identified to be highly enriched in DA neurons identified by tiling arrays 
(Spencer, et al., 2011). Importantly, these analyses identified a number of genes 
whose expression is known to be enriched in DA neurons and are 
downregulated in the dat-1 mutant, including dat-1 itself (Figure 77C). These 
experiments revealed a high enrichment of genes associated with neuropeptide 
signaling including egl-3, the primary worm preprotein convertase, and a 
number of specific neuropeptide genes including npsb–(7-11), flp-(2,4,7,8,10, 
25) and nlp-29 (Figure 77D). We also detected several ion channels including 
trp-4, osm-9, lgc-49, lgc-53, aqp-6, unc-2, acr-5, and asic-1 and G-protein 
coupled receptors including dop-2, dop-3, tyra-2, and tyra-3. To validate the 
importance of DA neuron specific network, we focused our mechanistic 
analyses on genes whose actions have been studied and for which there are 
publically available alleles.  
 
Loss of asic-1 and trp-4 mediates parallel suppression of dat-1 Swip 
Based on the downregulation of trp-4 and asic-1 and the literature describing 
their function, we hypothesized that these genes were required for normal dat-1 
Swip by evoking an increase in DA neuron excitability through swimming evoked 
mechanical stretch of trp-4 containing DA neuron dendrites and enhancement of 
vesicular release through asic-1 activity. We generated a series of strains  
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Figure 77 – Analysis of altered gene expression in the dat-1 strain via RNAseq. A. Relative expression level plot for all genes in 
dat-1(SWIP3) vs the parental strain(BY200). B. Frequency distribution of ratio of expression in parental vs dat-1. We noted a large 
proportion of genes with elevated expression in dat-1 (non Gaussian bump in genes with low parental/ dat-1 RPKM ratio). C. Genes 
in A that are known to be enriched gene in DA neurons. D. Selected genes and the magnitude of their downregulation in the dat-1 
strain. 
 259 
containing mutations in either or both of asic-1 and trp4 and dat-1 and tested 
them for Swip. For asic-1, we did not observe any significant paralysis with its 
loss alone (Figure 78A), and in combination with dat-1 we observed a significant 
incomplete suppression of dat-1 that was most apparent at 100 mOsm (Figure 
78B). For trp-4, we observed a highly significant basal paralysis that was not 
suppressed by an increase in osmolarity. We also observed more paralysis 
using the trp-4(ok1605) allele (data not shown) and they also have altered 
movement on plates. As we were concerned with this broader movement 
phenotype masking genetic interactions with dat-1, we pursued our analysis 
with the sy695 allele in these studies. Surprisingly, loss of trp-4(sy695) did not 
suppress dat-1 Swip (Figure 79). Rather, trp-4 loss alone enhanced the 
penetrance of dat-1 Swip and this enhancement was revealed only during basal 
Swip assays. To determine if asic-1 and trp-4 function redundantly to mediate 
dat-1 Swip, we generated a triple mutant strain containing mutations in both 
asic-1 and trp-4 on the dat-1 mutant background. We observed a highly 
significant suppression of dat-1 Swip that restored their swimming levels to near 
that of the wildtype strain (Figure 80A).	   
 
Thrashing analysis of asic-1 and trp-4’s contribution to dat-1 Swip 
To confirm asic-1 and trp-4 contributions to dat-1 Swip, we analyzed the 
swimming behavior of the previously described lines using automated thrashing 
analysis (Hardaway and Wang, under review). Surprisingly, these analyses 
revealed a highly significant reduction in the thrashing frequency in the asic-1 
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Figure 78 – asic-1 
incompletely 
suppresses Swip in 
the dat-1 strain. A) 
Swip phenotype in 
water alone and in 
100 mOsm-buffered 
water. Swip in either 
dat-1 or asic-1; dat-1 
is significantly 
suppressed by 
elevated osmolarity. 
Data were analyzed 
by two-way ANOVA 
with Sidak’s multiple 
comparison test 
comparing the 
osmolarity effect for 
each genotype and 
comparing 
genotypes at either 
osmolarity. B) Swip 
behavior at 100 
mOsm only. asic-1 
incompletely 
suppresses Swip in 
dat-1. For both A and 
B, assays were 
performed and 
double mutant strains 
constructed as 
described in the 
methods. Two 
experimenters tested 
strains over the 
course of three 
weeks. Each column 
represents the 
average of at least 40 
trials tested over this 
period.**** indicate 
p<0.0001 for the post 
tests. 
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Figure 79 – trp-4 
demonstrates a 
basal paralysis that 
is not suppressed by 
elevated osmolarity 
and operates in 
parallel with dat-1 at 
low osmolarity only. 
A) Swip phenotype in 
water alone and in 
100 mOsm-buffered 
water. Swip in either 
dat-1 or trp-4; dat-1 is 
significantly 
suppressed by 
elevated osmolarity. 
Data were analyzed 
by two-way ANOVA 
with Sidak’s multiple 
comparison test 
comparing the 
osmolarity effect for 
each genotype and 
comparing genotypes 
at either osmolarity. 
B) Swip behavior at 
100 mOsm only. trp-4 
demonstrates 
paralysis at 100 
mOsm that did not 
reach statistical 
significance. trp-4 
does not alter the 
penetrance of dat-1 
Swip at 100 mOsm. 
For both A and B, 
assays were 
performed and double 
mutant strains 
constructed as 
described in the 
methods. Two 
experimenters tested 
strains over the 
course of three 
weeks. Each column 
represents the 
average of at least 40 trials tested over this period.**** indicate p<0.0001 for the post 
tests.
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Figure 80 – trp-4 loss 
enhances asic-1 
suppression of dat-1 
Swip. A) Swip phenotype in 
water alone. Loss of trp-4  
significantly enhances asic-
1 suppression of dat-1. 
Data were analyzed by one-
way ANOVA with multiple 
Bonferonni’s post tests. B) 
Loss of asic-1 and trp-4 
together has a reduced 
effect on Swip penetrance 
in the swip-10(vt29) or 
swip-10(vt33) mutant. For 
both A and B, assays were 
performed and double 
mutant strains constructed 
as described in the 
methods. Two 
experimenters tested 
strains over the course of 
three weeks. Each column 
represents the average of at 
least 40 trials tested over 
this period.* and **** 
indicate p<0.05 and 0.0001 
for the post tests. 
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strain relative to the N2 (Figure 81A). Unlike our manual assays, we were not 
able to detect a significant suppression of dat-1 Swip with loss of asic-1 (Figure 
81A). Therefore loss of asic-1 results in a reduction in swimming frequency 
without causing paralysis(see Figure 78A) and the subtle suppression in dat-1 
Swip penetrance is only detectable in bulk population assays. Consistent with 
what we observed by hand, we detected a significant reduction in the average 
swimming frequency of trp-4 (Figure 81B) or in the asic-1 trp-4 strains (Figure 
81C). We also observed a highly significant suppression of Swip in the asic-1 
trp-4; dat-1 strain with a significantly elevated thrashing frequency relative to 
dat-1 throughout the 10 min. recording (Figure 81C). Thus our automated 
analyses confirm a more robust suppression of dat-1 Swip with loss of both 
asic-1 and trp-4 than either alone.   
 
asic-1 and trp-4 function cell autonomously in DA neurons for Swip 
To determine if asic-1 and trp-4 function cell autonomously in DA neurons to 
mediate dat-1 Swip, we expressed these ion channels specifically in DA neurons 
on the asic-1 trp-4; dat-1 background and tested transgenic and non-transgenic 
animals for Swip. Expression of wildtype asic-1 or trp-4 in DA neurons was 
sufficient to restore significant Swip in asic-1 trp-4; dat-1 strain (Figure 82). To 
determine if channel activity was required in the trp-4 gene, we expressed a 
previously validated pore dead version of trp-4(EPK1739-41KPK). We did not 
observe significant restoration of Swip by expression of this version of trp-4.  
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Figure 81 – Automated 
thrashing analysis of asic-1, 
trp-4, and asic-1 trp-4 in 
context with dat-1. 
Recordings of individual L4 
worms were performed as 
described in the methods and 
in Chapter VIII. A) asic-1 
average thrashing frequency is 
significantly reduced from 
N2(significant points in 
minutes 0-2, 4-5, 6, and 8-9). 
asic-1; dat-1 does not show 
any significant difference from 
dat-1 alone. B) trp-4 is 
significantly reduced from 
N2(significant points in 
minutes 1-3 and 5-10). trp-4; 
dat-1 is significantly reduced 
from dat-1(significant points in 
minutes 1-6). C) asic-1 trp-4 
thrashing frequency is 
significantly reduced from 
N2(minutes 7,8, + 10). asic-1 
trp-4; dat-1 thrashing 
frequency is significantly 
elevated over dat-1(minutes 1-
10). For A, B, and C, data were 
analyzed by two-way ANOVA 
with multiple Bonferonni’s post 
tests at each time point and 
the shaded areas represent 
the SEM of the average values.  	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Figure 82 – asic-1 and trp-4 function cell autonomously in DA neurons to promote 
dat-1 Swip and trp-4 channel activity is required. Restoration of asic-1 and trp-4 
specifically in DA neurons significantly restores Swip in the asic-1 trp-4; dat-1 strain. 
Significant restoration is not seen when using a pore dead version of trp-4(right hand 
column). Transgenic strains were generated and tested as describe in the methods. 
Each transgene’s effect was analyzed by an unpaired student’s t test to non transgenic 
progeny assayed in parallel. The left hand empty column is representative of the 
penetrance of Swip that we observed in these experiments. * and **** indicate p<0.05 
and 0.0001 respectively. 
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Therefore asic-1 and trp-4 function cell autonomously in DA neurons and 
channel activity of trp-4 is required to promote Swip in the dat-1 strain. 
 
Loss of asic-1 and trp-4 disrupts BSR 
Previous studies had indicated that trp-4, but not asic-1, were critical for 
promoting the excitability of DA neurons during BSR. Our studies with dat-1 
Swip were consistent with the hypothesis that asic-1, rather than trp-4, was the 
more important ion channel. Therefore we conducted our own assays of BSR in 
the asic-1, trp-4, and asic-1 trp-4 strains. We independently validated that the 
cat-2 and dop-3 strains have a reduced magnitude of BSR relative to the N2 
strain (Figure 83). Consistent with Li et al. and Kindt et al. and contrary to Voglis 
et al.; the trp-4, asic-1, and the asic-1 trp-4 strains all demonstrated a reduced 
magnitude of BSR relative to the N2 strain (Kindt, et al., 2007; Li, et al., 2006; 
Voglis & Tavernarakis, 2008). 
 
asic-1 and trp-4 are not fully required for swip-10 Swip 
To determine if asic-1 and trp-4 activity are required more broadly for all 
hyperdopaminergic mutants, we crossed the asic-1 trp-4 strain to a recently 
isolated strain that demonstrates Swip, but harbors normal dat-1 
activity(Hardaway, et al., 2012). Swip analyses of two asic-1 trp-4; swip-10 
strains revealed that asic-1 and trp-4 have a minimal contribution to this mutant 
(Figure 80B).
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Figure 83 – Basal Slowing response of asic-1 and trp-4. Loss of either asic-1 or trp-4 results in a reduction in the magnitude of 
BSR relative to the N2 strain. Assays were performed as described in the methods. Each column represents the average 
locomotory behavior of at least 28 animals tested over the course of three independent test days by two experimenters. Data is 
plotted as the raw counts over a 20 second interval on and off food and as the average percent change in body bends/20 sec for 
each animal tested over this period. Percent change data were analyzed by one way ANOVA with Dunnet’s post tests to the N2 
strain.
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Loss of dop-2 functions in parallel and enhances dat-1 Swip 
In our previous experiment of identifying genes downregulated in the dat-1 
mutant strain we identified the dopamine receptor dop-2. In the initial cloning of 
this receptor, the authors described robust expression in DA neurons and 
speculated in its role in presynaptic maintenance of DA signaling. To understand 
how dop-2 interacts with dat-1 in the regulation of extrasynaptic DAergic tone
we crossed this mutant to the dat-1 mutant and investigated its impact on dat-1 
Swip. We observed that the dat-1; dop-2 strain exhibits Swip with elevated 
penetrance relative to the dat-1 strain alone such that addition of 100 mOsm 
sucrose doesn’t even trigger a significant suppression of Swip as it does in the 
dat-1 strain (Figure 84A). Moreover, the penetrance of Swip at 100 mOsm was 
enhanced relative to the dat-1 strain (Figure 84B).  
Thrashing analysis of dop-2 contribution to dat-1 Swip 
 
Our manual assays of dop-2 and dat-1; dop-2 in water and 100 mOsm buffer 
suggest that loss of dop-2 enhances the penetrance of Swip in the dat-1 strain. 
To determine if loss of dop-2 alters the kinetic profile of dat-1 Swip, we 
performed single worm thrashing analysis on dop-2 and dat-1; dop-2. As we 
had observed in manual assays, the dop-2 strain demonstrated a reduction in its 
average swimming frequency relative to N2 (Figure 85). In agreement with our 
previous data, we observed a significant reduction in the average swimming 
frequency of dat-1; dop-2 relative to dat-1. These data are consistent with the 
hypothesis that the activity of dop-2 promotes swimming in the dat-1 strain.  
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Figure 84 – dop-2 
demonstrates a basal 
paralysis that is not 
suppressed by 
elevated osmolarity 
and operates in parallel 
with dat-1 A) Swip 
phenotype in water 
alone and in 100 mOsm-
buffered water.dop-2 
exhibits significant basal 
Swip. Swip in dat-1, but 
not dat-1; dop-2 is 
significantly suppressed 
by elevated osmolarity. 
Data were analyzed by 
two-way ANOVA with 
Sidak’s multiple 
comparison test 
comparing the 
osmolarity effect for 
each genotype and 
comparing genotypes at 
either osmolarity. B) 
Swip behavior at 100 
mOsm only. Loss of 
dop-2 significantly 
enhances the 
penetrance of dat-1 at 
100 mOsm. For both A 
and B, assays were 
performed and double 
mutant strains 
constructed as 
described in the 
methods. Two 
experimenters tested 
strains over the course 
of three weeks. Each 
column represents the 
average of at least 22 
trials tested over this 
period.** and **** 
indicate p<0.01 and 
0.0001 for the post tests
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Figure 85 – Loss of dop-2 
triggers significant Swip and 
enhances the Swip in the dat-1 
strain. Single worm recordings 
were performed as described in 
the methods and videos were 
analyzed using SwimR. Data were 
analyzed by two way ANOVA with 
multiple Bonferroni post tests. 
dop-2 was significantly reduced 
from N2 during point in minutes 1 
and 4-10. dat-1; dop-2 was 
significantly reduced from dat-1 
during points in minutes 1-6. 
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DISCUSSION 
Reverse genetic approaches in multiple animal model systems have become an 
invaluable tool in understanding how genes contribute to complex behaviors. 
Unfortunately, genetic experiments using mouse and zebrafish models are 
require significant time and financial investment. Reverse genetic approaches 
using these models, therefore, are usually limited to understanding how one 
gene contributes to molecular, cellular, and behavioral phenotypes. 
Furthermore, gene expression changes associated with constitutive single gene 
mutations can help reveal candidate genetic network interactions for functional 
analysis. As multiple genes function within a cellular network to mediate 
complex behavioral phenotypes, we used the highly facile genetic system 
Caenhorhabditis elegans to identify genes that function within a DA neuron 
network to mediate a hyperdopaminergic phenotype known as Swip. We chose 
this phenotype as Swip is triggered by loss of single gene, dat-1, and is 
completely penetrant with nearly all of the animals with loss of dat-1 
demonstrating Swip.  
To isolate candidates for analysis of the DA neuron Swip network, we 
performed RNAseq of wildtype and dat-1 worms. As we have demonstrated that 
the dat-1 strain demonstrates a phenotype associated with elevated 
extrasynaptic DA levels, we hypothesized that this strain may harbor 
transcriptional alterations in DA neuron enriched genes that might serve to 
normalize extrasynaptic DA levels. Following analysis of the RNAseq data and a 
comparison to a list of genes that are enriched in their DA neuron expression, 
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we identified a number of genes that were downregulated in the dat-1 mutant. 
Most notable among these genes were several individual neuropeptide genes 
and the neuropeptide proprotein convertase egl-3 (Kass, et al., 2001). Related 
work in the lab has demonstrated that egl-3 is required for Swip in the swip-10 
mutant, but it is currently unknown if egl-3-mediated neuropeptide signaling is 
required for Swip in the dat-1 mutant or other Swip-exhibiting mutants. Although 
these studies suggest that neuropeptide signaling in DA neurons may be a 
critical network contributor to Swip, neuropeptides like nlp-12 are also known to 
function postsynaptically at the neuromuscular junction to mediate locomotion 
(Zhitao Hu, Pym, Babu, Murray, & Kaplan, 2011). Thus, future studies of egl-3 
and neuropeptides will need to distinguish between pre- and postsynaptic 
mechanism of DA effects. Amongst the set of downregulated genes, we 
identified a number that had already been characterized and with known 
expression in DA neurons. To understand how several presynaptic genes 
function in a network with dat-1 to mediate Swip, we focused our genetic and 
behavioral analysis on three of them: asic-1, trp-4, and dop-2. 
 trp-4 was one of the first stretch-sensitive transient receptor potential 
(TRP) channels to be cloned and characterized in C. elegans. Li et al. found that 
a loss of trp-4 led to more exaggerated body bends and an elevated worm 
centroid velocity (Li, et al., 2006). The former is mediated by its function in the 
DVA interneuron and the latter by its function in DA neurons. To determine if trp-
4 is required for stretch-mediated elevations in neuronal activity, they imaged 
changes in intracellular Ca2= in the DVA interneuron as a proxy for neural activity 
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via the fluorescent calcium sensor GCaMP. They found that mechanical bending 
of the worm was sufficient to evoke an increase in activity of the DVA 
interneuron and that trp-4 was required for this effect. Kindt et al. further 
explored the physiological role of trp-4 in DA neurons (Kindt, et al., 2007). The 
authors demonstrated that mechanical stimulation of DA neuron dendrites at the 
amphid sensilla was sufficient to evoke activity of DA neurons and that trp-4 
functions cell autonomously in DA neurons to mediate mechanical stretch-
evoked changes in activity. In a technical tour de force, Kang et al. 
demonstrated that they could detect mechanoreceptive currents (MRCs) in DA 
neurons via whole cell patch clamp electrophysiology, that trp-4 is required for 
MRCs, and that trp-4 functions as a bona fide TRP channel to mediate changes 
in DA neuron physiology and during worm behavior (L. Kang, et al., 2010). As 
swimming produces exaggerated C-shaped body bends (Pierce-Shimomura, et 
al., 2008), we hypothesized that trp-4 might mediate MRCs and elevated DA 
neuron excitability that promote the downstream release of vesicular DA. As we 
had already demonstrated that vesicular release of DA was required for dat-1 
Swip, we hypothesized that trp-4 would be required for Swip. 
 asic-1 was cloned by Voglis et al. and demonstrated that it is required for 
dopamine and dop-1 and dop-2-mediated associative learning in the worm 
(Voglis & Tavernarakis, 2008). They found that its expression is enriched at DA 
neuron synapses and that it functions to promote synaptic vesicle fusion and 
release of DA. Surprisingly, they did not observe that it was necessary for the 
dopamine-mediated BSR. As the dat-1 Swip phenotype derives from elevated 
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extrasynaptic DA, we hypothesized that asic-1-mediated enhancement of 
vesicular release is required for dat-1 Swip.  
 dop-2 was one of the first D2-like dopamine receptors to be cloned and 
its activity characterized (Suo, et al., 2003). The authors demonstrated that this 
receptor had a high affinity for dopamine relative to other biogenic amines and 
that its expression was enriched in the DA neurons. Surprisingly, to date, there 
has been no direct exploration of its functional role specifically in DA neurons. 
Genetic experiments of dop-2 in behavioral conditioning led Voglis et al. to 
speculate that dop-2 may function in a pathway with asic-1 to promote synaptic 
velease release. Studies of somatodendritic D2 receptors in mice, however, 
have demonstrated that this receptor mediates hyperpolarization of DA neurons 
through activation of G-protein inwardly rectifying potassium (GIRK) channels 
(Beckstead, et al., 2004). Therefore, we hypothesized that dop-2 may function to 
downregulate the release of DA in parallel with dat-1 mediated DA clearance.  
 Our behavioral studies of asic-1 and trp-4 revealed that the asic-1 strain 
exhibits normal swimming behavior and that loss of trp-4 triggers a basal 
paralytic phenotype. More precise measurements of worm swimming frequency 
revealed that while loss of asic-1 does not trigger paralysis, its loss reduces the 
average thrashing frequency. In these analyses, we confirmed that loss of trp-4 
does trigger a basal Swip phenotype as we had observed by hand. As the 
published work for trp-4 suggests that its loss reduces DA signaling, we believe 
that the basal paralytic phenotype in the trp-4 strain is not mediated by an 
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increase in DA. Cell specific restoration of trp-4 in the DVA neuron and analysis 
of basal paralysis will be important to determine if this is indeed the case. 
 Our analysis of Swip in the asic-1; dat-1 strain revealed that loss of asic-1 
significantly suppresses dat-1 Swip and that its contribution is most easily 
revealed by a subtle increase in the osmolarity of the swimming media 
(Hardaway, et al., 2012). So while asic-1 demonstrates a significant genetic 
interaction with the dat-1 mutant, there exist redundant mechanisms to trigger 
Swip in the dat-1 mutant. Similarly, our assays of the trp-4; dat-1 mutant 
revealed that this strain revealed a surprising enhancement of Swip in the dat-1 
Swip phenotype which was revealed only at low osmolarity. Similar to the basal 
paralytic phenotype we observe in the trp-4 mutant strain, we hypothesize that 
loss of trp-4 alone only triggers additional paralysis through its function in a 
parallel pathway that may involve the activity of trp-4 in the DVA neuron. To 
investigate whether asic-1 and trp-4 function redundantly to mediate dat-1 
Swip, we generated the asic-1 trp-4 strain and crossed it to dat-1. Swip assays 
of the asic-1 trp-4; dat-1 strain revealed that, though it does demonstrate 
significant Swip relative to the N2 strain, there is a highly significant suppression 
of Swip relative to dat-1. We therefore conclude that asic-1 and trp-4 can 
function redundantly to promote Swip in the dat-1 strain, such that each of their 
individual contributions were only revealed when lost in combination. To 
determine if these ion channels contribute more broadly in all 
hyperdopaminergic strains, we crossed the asic-1 trp-4 strain to another 
hyperdopaminergic strain, swip-10. Importantly, loss of asic-1 and trp-4 did not 
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mediate the same level of suppression as on the dat-1. As asic-1 trp-4 did not 
completely restore dat-1 Swip either, we hypothesize that there are additional 
pathway(s) that can promote either DA neuron excitation or vesicular release 
and these pathways may underlie Swip in other previously isolated Swip-
harboring strains (Hardaway, et al., 2012).   
 To determine if asic-1 and trp-4 mediate these effects on dat-1 Swip 
through their cell autonomous function in DA neurons, we transgenically 
restored these ion channels solely in DA neurons using the asic-1 trp-4; dat-1 
background. We found that DA neuron specific expression of either asic-1 or 
trp-4 could restore the penetrance of dat-1 Swip. Using a previously validated 
pore dead version of trp-4, we determined that channel activity of trp-4 is 
required to restore dat-1 Swip. We conclude, therefore, that these ion channels 
function cell autonomously and redundantly in DA neurons to promote dat-1 
Swip. In the initial description of asic-1, the authors did not employ any 
techniques to measure asic-1’s contribution to excitability of DA neurons. Our 
studies suggest that asic-1 may have a role in mediating depolarization of either 
the DA neuron cell bodies or through local excitation of the dat-1 and asic-1-
containing presynaptic terminals.    
 Our studies of asic-1 and trp-4 on dat-1 Swip, suggested that these ion 
channels function redundantly, yet both perform vital functions to promote dat-1 
Swip. To understand if they function in more broad dopaminergic phenotypes, 
we assayed their requirement in the BSR. Consistent with published results, we 
determined that trp-4 is required for BSR. Analysis of asic-1 also revealed that it 
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is required for BSR. The difference between our studies and Voglis et al. is still 
unclear, but we speculate that there may be differences in our experimental 
protocol that are not mentioned in the published methods (Voglis & 
Tavernarakis, 2008).  
  To determine how dop-2 functions within a dat-1 network, we generated 
the dat-1; dop-2 strains and tested it for Swip at low and intermediate 
osmolarities. The dat-1; dop-2 strain demonstrated Swip with enhanced 
penetrance relative to the dat-1 strain alone such that addition of 100 mM 
sucrose did not even generate significant suppression. As in the published dat-
1; vt29 strain, we conclude that dop-2 functions in parallel to dat-1 to promote 
Swip. Consistent with this model, we observed a significant basal Swip 
phenotype in strains with mutation of dop-2 alone. DA neuron specific 
restoration of dop-2 on the dat-1; dop-2 background are necessary to 
determine if dop-2 functions cell autonomously in DA neurons to suppress the 
penetrance of Swip in this strain. Nonetheless, our genetic experiments are 
consistent with a model whereby dop-2 functions cell autonomously in DA 
neurons as a bona fide autoreceptor to inhibit 1) excitation of DA neuron cell 
bodies or presynaptic terminals, 2) activity of cat-2 and biosynthesis of DA or 3) 
activity-coupled vesicular fusion of DA-containing vesicles.   
 We used the nematode Caenhorhabditis elegans to illustrate how a 
network of presynaptic genes in DA neurons interacts to coordinate the 
penetrance and kinetic profile of the hyperdopaminergic dat-1 Swip phenotype. 
Our studies demonstrate that some of these genes, asic-1 and trp-4, function 
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together and redundantly to promote Swip in the dat-1 strain, whereas the 
dopamine autoreceptor, dop-2, functions in parallel to resist Swip.         
 
FUTURE DIRECTIONS 
The studies described above would likely benefit from replication of the RNA-
seq experiment to validate the changes in gene expression that we observed. 
Independent replication of these findings might reveal new genes that were 
previously underappreciated and, more importantly, help filter out genes that are 
not independently replicated. 
 Our first RNAseq experiment indicated a high incidence of neuropeptide-
related signaling genes. We have also observed that loss of egl-3 fully restores 
Swip in another mutant, swip-10. These studies are consistent with a model 
whereby neuropeptides exert their influence somewhere within the Swip-
generating neural circuitry. Future studies using pre- and post-synaptic related 
behavioral assays might reveal where in the circuit these neuropeptides are 
acting. Were we to determine that neuropeptides function upstream of the 
motor circuit to generate Swip, candidate based screening of dat-1-
downregulated neuropeptides on the dat-1 background using genetic or RNAi 
approaches may reveal which specific neuropeptides are critical for dat-1 Swip. 
 In this study, we concentrated our efforts on understanding trp-4’s 
function in the DA neurons. To better understand how trp-4 regulates the basal 
paralytic phenotype and Swip phenotype, we could restore trp-4 in the DVA 
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neuron(via twk-16 promoter) on the trp-4 and asic-1 trp-4; dat-1 backgrounds 
using the wildtype and pore dead versions.   
 Lastly, we observed a highly significant genetic interaction between dat-1 
and dop-2. To strengthen our model that dop-2 functions presynaptically in DA 
neurons, we might use transgenic restoration of dop-2 using DA neuron and 
non-DA neuron specific promoters on the dat-1; dop-2 background and 
investigate how dop-2 transgenic overexpression alters the penetrance and 
kinetic profile of Swip in this strain.  
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Appendix C  
LIST OF EXPERIMENTS ATTEMPTED OR IN PROGRESS 
 
General 
1. dat-1 Swip temporal window 
2. Acute pharmacology on Swip – Haloperidol, Chlorpromazine, Olanzapine, 
AMPH, Nisoxetine (Bermingham) 
3. Food Deprivation and Swip 
4. Reagent subtractions and additions in plates: Effect on Swip (Whitaker) 
swip-10 and other 
5. Overexpression of dominant negative glr-1(A/T) in DA neurons 
6. Swip with acute GLU in water (N2 and cat-2) 
7. Rescue of swip-10 with acute DNQX 
8. Reversal Analysis of swip-10 
9. Basal Swip characterization of putative xC- homologs in worms 
10. Swip with acute N-acetylcysteine treatment (N2 and cat-2) 
11. Lines built and archived but not described here: 
 aqp-1; dat-1 
 aqp-2; dat-1 
 aqp-6; dat-1 
 aqp-7; dat-1 
 che-3; dat-1 
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 ocr-2; dat-1 
 ocr-4; dat-1 
 ocr-4 ocr-2; dat-1 
 mod-5; dat-1 
 tph-1; dat-1 
 tbh-1; dat-1 
12. Lines I attempted to build, but genetics didn’t work: 
 osm-9; dat-1 
 dat-1; cat-1 
DAT-1 C-Terminus 
13. I made many C-terminal alanine substitutions in the pdat-1::GFP:dat-1 cDNA 
expression vector to map out the residues required for function and trafficking. 
See Blakely Lab plasmid archive. 
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